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ABSTRACT	  
Structure-­‐Based	  Genome	  Scale	  Function	  Prediction	  and	  Reconstruction	  
of	  the	  Mycobacterium	  tuberculosis	  Metabolic	  Network	  
	  
Mariam	  Konaté	  
Due	   to	   vast	   improvements	   in	   sequencing	   methods	   over	   the	   past	   few	   decades,	   the	  
availability	   of	   genomic	  data	   is	   rapidly	   increasing,	   thus	  bringing	   about	   the	  need	   for	   functional	  
characterization	   tools.	   Considering	   the	   breadth	   of	   data	   involved,	   functional	   assays	  would	   be	  
impractical	   and	   only	   a	   computational	  method	   could	   afford	   fast	   and	   cost-­‐effective	   functional	  
annotations.	  Therefore,	  homology-­‐based	  computational	  methods	  are	   routinely	  used	   to	  assign	  
putative	   molecular	   functions	   that	   can	   later	   be	   confirmed	   with	   targeted	   experiments.	   These	  
methods	  are	  particularly	  well	  suited	  to	  predict	  the	  function	  of	  enzymes	  because	  most	  metabolic	  
pathways	   are	   conserved	   across	   organisms.	   However,	   the	   current	   methods	   have	   limitations,	  
especially	  when	  considering	  enzymes	  that	  have	  very	  low	  sequence	  and	  structure	  homology	  to	  
well-­‐annotated	  enzymes.	  
We	  hypothesized	  that	  two	  enzymes	  with	  the	  same	  molecular	  function	  shared	  significant	  
sequence	  homology	   in	  the	  region	  surrounding	  the	  active	  site,	  even	  if	  they	  appear	  diverged	  at	  
the	   global	   sequence	   level.	   First,	   we	   have	   investigated	   the	   limits	   of	   sequence	   and	   structure	  
conservation	  for	  enzymes	  with	  the	  same	  function	  during	  divergent	  evolution.	  The	  goal	  of	  this	  
was	  to	  determine	  the	  sequence	  identity	  threshold	  beyond	  which	  functional	  annotations	  should	  
not	  be	  transferred	  between	  two	  sequences;	  that	  is	  the	  level	  of	  homology	  beyond	  which	  the	  pair	  
of	  proteins	  would	  not	  be	  expected	   to	  have	   the	   same	   function.	  Our	  analysis,	  which	  compares	  
several	   models	   of	   sequence	   evolution,	   shows	   that	   the	   sequences	   of	   orthologous	   proteins	  
catalyzing	  the	  same	  reaction	  rarely	  diverge	  beyond	  30	  %	  identity,	  even	  after	  approximately	  3.5	  
billion	  years	  of	  evolution.	  As	  for	  structure	  conservation,	  enzymes	  catalyzing	  the	  same	  reactions	  
rarely	  diverge	  beyond	  3Å	  root-­‐mean-­‐square	  distance	  (RMSD).	  We	  have	  also	  explored	  sequence	  
conservation	   constraints	   as	   a	   function	   of	   the	   distance	   to	   the	   active	   site.	   	   Although	   residues	  
closer	   to	   the	   protein	   active	   site	   (within	   a	   radius	   of	   10Å	   around	   the	   catalytic	   residues)	   are	  
mutating	   significantly	   slower,	   the	   requirement	   to	   preserve	   the	   molecular	   function	   also	  
constrains	  residues	  at	  other	  parts	  of	  the	  protein.	  
From	   these	   results,	  we	  have	  developed	  a	   structure-­‐based	   function	  prediction	  method	  
where	   we	   employ	   active	   site	   conservation	   in	   addition	   to	   global	   sequence	   homology	   for	  
functional	  characterization.	  We	  then	  integrated	  this	  method	  with	  a	  probabilistic	  whole-­‐genome	  
function	  prediction	  framework	  previously	  developed	  in	  the	  Vitkup	  group,	  GLOBUS.	  The	  original	  
version	   of	   GLOBUS	   uses	   sampling	   of	   probability	   space	   to	   assign	   functions	   to	   all	   putative	  
metabolic	   genes	   in	   an	   input	   genome	  by	   considering	   sequence	   homology	   to	   known	   enzymes,	  
gene-­‐gene	   context	   and	   EC	   co-­‐occurrence.	   Applying	   this	   novel	  method	   to	   the	   whole-­‐genome	  
metabolic	  reconstruction	  of	  Mycobacterium	  tuberculosis,	  we	  made	  several	  novel	  predictions	  for	  
genes	  with	  apparent	  links	  to	  pathogenesis.	  Notably,	  our	  predictions	  allowed	  us	  to	  reconstruct	  
the	  cholesterol	  degradation	  pathway	  in	  M.	  tuberculosis,	  which	  has	  been	  implicated	  in	  bacterial	  
persistence	  in	  the	  literature	  but	  remains	  to	  be	  fully	  characterized.	  This	  pathway	  is	  absent	  from	  
previously	  published	  metabolic	  models	  of	  M.	  tuberculosis.	  Our	  new	  model	  can	  now	  be	  used	  to	  
simulate	  different	  environments	  and	  conditions	  in	  order	  to	  gain	  a	  better	  understanding	  of	  the	  
metabolic	  adaptability	  of	  M.	  tuberculosis	  during	  pathogenesis......………………………………………………
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Over	  the	  past	  twenty	  years	  the	  number	  of	  fully	  sequenced	  bacterial	  genomes	  has	  been	  
increasing	  exponentially.	  It	  is	  expected	  that	  this	  number	  will	  have	  exceeded	  10,000	  in	  20201	  (fig.	  
1.1).	  
	  
Figure	  1.1.	  Number	  of	  fully	  sequenced	  bacterial	  genomes.	  
Since	  2000,	  the	  number	  of	  determined	  sequences	  has	  been	  increasing	  exponentially.	  This	  graph	  
represents	  the	  exponential	  increase	  in	  the	  number	  of	  completed	  bacterial	  genome	  sequencing	  
projects.	  (Data	  from	  NCBI	  Genome).	  
	  
This	  is	  in	  part	  due	  to	  the	  prevalence	  of	  metagenomic	  studies	  that	  are	  shedding	  a	  light	  on	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organisms,	  their	  metabolism,	  and	  how	  they	  interact	  with	  each	  other	  and	  their	  environment,	  it	  is	  
critical	   to	  fully	   functionally	  characterize	  their	  genomes.	  Because	  of	  the	   large	  quantity	  of	  data,	  
experimental	   validation	   cannot	   be	   systematically	   conducted.	   Therefore,	   to	   tackle	   this	   issue,	  
there	  is	  a	  need	  for	  a	  fast	  and	  reliable	  computational	  method	  for	  genomic	  functional	  annotation.	  
Classically,	  such	  methods	  involve	  annotation	  transfer	  from	  a	  homologous	  sequence.	  Specifically,	  
to	  predict	  the	  function	  of	  an	  uncharacterized	  sequence,	  a	  BLAST2	  homology	  search	  is	  conducted	  
to	   identify	   its	   closest	   homologues.	   The	   function	  of	   the	   top	  BLAST	  hit	   is	   then	   assigned	   to	   the	  
uncharacterized	   sequence.	   However	   this	   method	   has	   limitations	   when	   considering	   query	  
sequences	   with	   low	   homology	   to	   functionally	   annotated	   sequences.	   It	   has	   been	   shown	  
previously	   that	   functional	   annotation	   cannot	   be	   reliably	   transferred	   between	   proteins	   that	  
share	   less	  than	  60	  %	  sequence	   identity	  and	  this	  threshold	  may	  vary	  across	  protein	  families3-­‐7.	  
However,	   for	   a	   typical	   newly	   sequenced	  bacterial	   genome,	   the	  majority	   of	   its	   gene	   products	  
have	  less	  than	  60	  %	  homology	  to	  know	  proteins	  (fig.1.2).	  
	  
Figure	  1.2.	  Fraction	  of	  microbial	  proteins	  against	  maximal	  sequence	  homology	  to	  an	  enzyme	  
in	  Swiss-­‐Prot.	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Most	  of	  the	  new	  genomes	  that	  are	  being	  added	  to	  UniProtKB/TrEMBL	  are	  not	  closely	  related	  to	  
any	  well-­‐characterized	  organism.	  This	  plot	  represents	  the	  distribution	  of	  bacterial	  proteins	  as	  a	  
function	  of	  the	  maximum	  sequence	  identity	  to	  a	  sequence	  in	  the	  manually	  curated	  Swiss-­‐Prot.	  
These	   bacterial	   proteins	   sequenced	   from	   metagenomic	   samples	   and	   cover	   199	   species	  
according	  to	  small	  subunit	  ribosomal	  RNA8.	  
	  
	  	  This	   region	   of	   low	   sequence	   homology	   has	   been	   termed	   “twilight	   zone	   of	   sequence	  
space”	  by	  Rost9.	  The	  goal	  of	  this	  thesis	  was	  first	  to	  investigate	  this	  threshold	  and	  identify	  new	  
ways	   to	   make	   functional	   predictions	   by	   studying	   the	   limits	   of	   sequence	   and	   structure	  
divergence	   through	   divergent	   evolution.	   Additionally,	   we	   aimed	   to	   use	   these	   findings	   to	  
develop	   a	   functional	   annotation	   method	   applicable	   to	   whole	   genomes	   for	   simultaneous	  
characterization	   of	   all	   gene	   products.	   Namely,	   the	   goal	   of	   this	   project	   was	   to	   incorporate	  
structural	   information	   to	   the	   previous	   version	   of	   the	   probabilistic	   whole-­‐genome	   prediction	  
algorithm	  GLOBUS,	   in	   the	  hope	   that	   it	  would	   further	   improve	  prediction,	  especially	   for	   those	  
genes	  with	   low	   sequence	   homology	   to	   known	   enzymes.	   This	  way,	  we	   aimed	   to	   improve	   the	  
ability	  to	  propose	  candidate	  functions	  for	  proteins	   in	  the	  “twilight	  zone”	  of	  sequence	   identity	  
through	  the	  identification	  of	  orthologues.	  
	  
1.2	  ORTHOLOGY	  AND	  DEFINING	  FUNCTION	  
1.2.1	  Orthology	  
Orthology	   is	   a	   case	   of	   vertical	   divergence.	   Orthologues	   are	   genes	   in	   different	   species	  
whose	  evolutionary	  history	   can	  be	   traced	  back	   to	   the	   same	  gene	   in	  a	   common	  ancestor	   (fig.	  
1.3).	   Orthology	   between	   genes	   can	   be	   established	   with	   phylogenetic	   methods	   such	   as	   tree	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construction,	  or	  through	  whole-­‐genome	  sequence	  comparison.	  This	  second	  technique	  consists	  
in	  identifying	  mutually	  top	  scoring	  BLAST	  hits	  from	  each	  genome.	  Oftentimes,	  orthologues	  have	  
the	   same	   molecular	   function	   as	   opposed	   to	   paralogues,	   which	   are	   the	   result	   of	   a	   gene	  
duplication	  event	  within	  a	  genome.	   In	   that	  case,	  one	  copy	  of	   the	  gene	  maintains	   the	  original	  
function,	  while	  the	  second	  “redundant”	  copy	  is	  free	  to	  diverge	  into	  a	  new	  function10-­‐12.	  
	  
Figure	  1.3.	  Schematic	  representation	  of	  divergent	  evolution.	  
We	  assume	  that	  all	  species	  can	  be	  traced	  back	  to	  a	  universal	  common	  ancestor	  (LUCA)	  dating	  
back	  to	  about	  4	  billion	  years.	  We	  simplify	  phylogeny	  from	  a	  tree	  form	  to	  a	   linear	  form	  where	  
the	  enzyme	  sequence	  for	  each	  species	  considered	  in	  this	  study	  represents	  a	  “snapshot”	  of	  the	  
ancestral	  enzyme	  throughout	  divergent	  evolution.	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The	  function	  of	  a	  protein	  corresponds	  to	  the	  role	  that	  it	  has	  inside	  the	  cell	  and	  can	  range	  
from	  transporting	  small	  molecules	  to	  ensuring	  proper	  folding	  of	  other	  proteins,	  or	  carrying	  out	  
specific	  chemical	  reactions.	  
1.2.2	  The	  Gene	  Ontology	  Project	  
Function	   can	  be	  defined	  a	  number	  of	  different	  ways.	   For	  example	   the	  Gene	  Ontology	  
(GO)	   classification	   system	   uses	   a	   structured	   and	   “controlled-­‐vocabulary”	   (i.e.	   ontologies)	   to	  
characterize	  three	  different	  functionally	  associated	  features	  of	  a	  protein.	  These	  three	  features	  
are	  Biological	  Process,	  Cellular	  Component	  and	  Molecular	  Function13.	  For	  a	  protein,	  a	  biological	  
process	   corresponds	   to	   a	   specific	   set	   of	   chemical	   reactions	   or	   a	   given	   pathway,	   for	   example	  
“Carbohydrate	  Metabolic	  Process”	  (GO:0005985).	  The	  cellular	  components	  category	  tells	  where	  
in	   the	   cell	   the	   protein	   is	   localized,	   for	   example	   in	   the	   cytosol	   (GO:0005829).	   The	   molecular	  
function	  is	  the	  most	  specific	  functional	  category	  and	  it	  describes	  the	  biochemical	  activity	  of	  the	  
protein;	  for	  example	  GO:0046882	  corresponds	  to	  the	  activity	  “metal	  ion	  biding”.	  A	  protein	  can	  
be	  associated	  to	  multiple	  GO	  terms,	  each	  term	  giving	  additional	  information	  on	  the	  function	  of	  
the	   protein	   in	   the	   cell.	   However	   the	   GO	   categories	   can	   be	   broad,	   and	   therefore	   yield	   non-­‐
specific	  information	  on	  the	  function	  of	  a	  protein.	  
1.2.3	  The	  Enzyme	  Commission	  Number	  
Another	  way	  to	  define	  protein	  function	  is	  through	  the	  Enzyme	  Commission	  number14,15.	  
As	   the	   name	   indicates,	   the	   EC	   hierarchical	   system	   classifies	   the	   function	   of	   enzymes	   only	   as	  
opposed	   to	   other	   classes	   of	   proteins.	   First	   devised	   in	   1955,	   the	   EC	   system	   links	   a	   four-­‐part	  
numerical	  code	  termed	  EC	  number	  to	  a	  specific	  catalytic	  activity	  or	  reaction.	  	  That	  is,	  different	  
6	  
enzymes	   from	  different	  organisms	  can	  have	   the	   same	  EC	  number	  annotation	   if	   they	   catalyze	  
the	   same	   chemical	   reaction	   regardless	   of	   mechanism.	   Each	   part	   of	   the	   EC	   code	   gives	   more	  
detailed	   information	  on	   the	   type	  of	   reaction	   catalyzed.	   The	   first	   number	   is	   the	  most	   general	  
category	  (table	  1.1)	  and	  each	  subsequent	  number	  adds	  to	  the	  specificity	  of	  the	  reaction.	  
	  
	  
Table	  1.1.	  Enzyme	  Commission	  classification	  scheme.	  
EC Class Class Name 
EC 1 Oxidoreductases 
EC 2 Transferases 
EC 3 Hydrolases 
EC 4 Lyases 
EC 5 Isomerases 
EC 6 Ligases 
	  
For	  example	  an	  enzyme	  annotated	  with	  the	  EC	  3.2.1.24	  is	  an	  α–mannosidase.	  The	  first	  
digit	  of	  the	  code,	  EC	  3,	  tells	  us	  that	  the	  enzyme	  is	  a	  hydrolase;	  that	  is,	  the	  enzyme	  catalyzes	  the	  
hydrolysis	  of	  a	  bond.	  The	  second	  digit	  added	  to	  the	  first,	  EC	  3.2,	  specifies	  that	  the	  enzyme	  is	  a	  
glycolase.	   The	   third	   digit,	   EC	   3.2.1,	   tells	   us	   that	   the	   enzyme	   hydrolyzes	   O-­‐	   or	   S-­‐glycosyl	  
compounds.	  Finally	   the	   last	  number,	  EC	  3.2.1.24,	   reveals	   the	  exact	  chemical	   specificity	  of	   the	  
enzyme	  for	  the	  substrate	  α-­‐D-­‐mannose.	  The	  ENZYME	  data	  bank	  is	  updated	  periodically	  so	  that	  
almost	  all	  enzymatic	  activities	  known	  to	  occur	  in	  nature	  have	  an	  associated	  EC	  number16-­‐19.	  As	  
of	   the	   release	   of	  March	   19,	   2014	   there	  were	   6,370	   distinct	   enzymatic	   activities	   listed	   in	   the	  
ENZYME	  data	  bank.	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1.2.4	  Other	  Classification	  Systems	  
A.	  Clusters	  of	  orthologous	  groups	  
Unlike	   Gene	   Ontology	   and	   the	   EC	   nomenclature	   system,	   there	   are	   other	   protein	  
classification	   approaches	   in	   use	   that	   have	   less	   stringent	   definitions	   of	   function.	   One	   such	  
system	  is	  the	  Cluster	  of	  Orthologous	  Groups	  (COG),	  a	  phylogenetic	  classification	  system	  where	  
proteins	  from	  complete	  genomes	  are	  placed	  in	  a	  given	  COG	  if	  they	  have	  apparent	  orthology	  (i.e.	  
related	  by	  vertical	  evolution)	   to	  another	  protein	  already	   in	   the	  COG20-­‐22.	  COGs	  are	  essentially	  
families	  of	  homologous	  proteins,	  and	  by	  that	  logic	  they	  may	  include	  not	  only	  orthologues,	  but	  
also	  paralogues;	  that	  is	  pairs	  of	  proteins	  that	  originate	  from	  a	  duplication	  event,	  and	  therefore	  
may	  not	  have	  the	  same	  molecular	  function23.	  	  In	  fact,	  a	  quick	  analysis	  of	  the	  572	  COGs	  thought	  
to	  have	  originated	   in	   the	   last	   common	  ancestral	   species20,24	   (LUCA)	   reveals	   that	  only	  30	  %	  of	  
these	   COGs	   are	   monofunctional.	   Another	   20	   %	   are	   populated	   with	   non-­‐enzymes,	   while	   the	  
remaining	  half	  of	  the	  572	  COGs	  contains	  a	  heterogeneous	  set	  of	  enzymes	  (fig.	  1.4).	  Therefore,	  
for	  our	  purposes	  the	  COG	  classification	  system	  is	  not	  indicated.	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Figure	  1.4.	  Functional	  diversity	  of	  572	  Clusters	  of	  Orthologous	  Groups	  from	  the	  Last	  Universal	  
Common	  Ancestor	  (LUCA).	  
Several	   studies	   have	   postulated	   that	   572	   proteins	   families	   emerged	   in	   the	   last	   universal	  
common	  ancestor	  and	  were	  passed	  down	  to	  most	  of	  the	  organisms	  in	  existence	  today.	  This	  plot	  
shows	  the	  percentages	  of	  these	  572	  COGs	  that	  are	  not	  associated	  to	  an	  any	  EC	  number	  (non-­‐
enzymes),	   the	   percentage	   that	   are	   associated	   to	   a	   single	   (monofunctional)	   or	   multiple	   EC	  
numbers	  (multifunctional).	  
	  
B.	  Protein	  domain	  families:	  Pfam	  and	  PROSITE	  
Proteins	  can	  also	  be	  organized	  into	  families	  based	  on	  the	  presence	  of	  specific	  domains	  
or	  sequence	  motifs.	  For	  instance,	  the	  Pfam	  database	  is	  a	  collection	  of	  protein	  domain	  families25.	  
A	   domain	   can	   be	   defined	   as	   a	   functional	   region	   with	   conserved	   sequence	   and	   structure.	  
Proteins	  may	  have	  more	  than	  one	  domain	  so	  that	  in	  combination,	  multiple	  domains	  may	  yield	  a	  
specific	  molecular	   function.	   PROSITE	   operates	   in	   the	   same	  way,	  with	   PROSITE	   families	   being	  











C.	  Structural	  classification:	  SCOP	  and	  CATH	  
Not	   all	   protein	   classification	   systems	   are	   based	   on	   sequence	   similarity.	   Classification	  
schemes	   based	   on	   secondary	   and	   tertiary	   structure	   similarity	   also	   exist.	   The	   secondary	  
structure	  corresponds	  to	  the	  general	  pattern	  of	  hydrogen	  bonding	  of	  the	  peptide	  backbone	  of	  a	  
protein.	   The	   two	  most	   common	   kinds	   of	   secondary	   structure	   elements	   are	   α-­‐helices	   and	   β-­‐
sheets27,28.	   The	   tertiary	   structure	   of	   a	   protein	   is	   its	   geometric	   shape	   in	   three	   dimensions.	  
Despite	  some	  differences	  in	  implementation,	  the	  SCOP29	  and	  CATH30	  classification	  systems	  are	  
both	  hierarchical	   in	  nature.	  The	  four	  levels	  of	  SCOP	  are	  structural	  class	  (i.e.	  type	  of	  secondary	  
structure	   elements),	   fold	   (configuration	   of	   secondary	   structure	   elements	   in	   3D	   space),	  
superfamily	   and	   family,	   while	   CATH	   (class,	   architecture,	   topology,	   homologous	   family)	   sorts	  
protein	   domains	   into	   class,	   architecture,	   topology	   and	   superfamily31.	   The	   rationale	   for	   using	  
structural	   elements	   for	   functional	   classification	   is	   that	   structures	   being	   more	   robust	   to	  
evolutionary	   divergence	   than	   sequence,	   functionally	   related	   proteins	   tend	   to	   retain	   highly	  
similar	   three-­‐dimensional	   folds32,33.	   Of	   course	   these	   systems	   require	   the	   availability	   of	   a	  
structure	  which	  is	  rarely	  the	  case	  for	  the	  gene	  products	  of	  newly	  completed	  genomes.	  
In	   this	   project,	  we	   investigated	   the	   link	   between	   sequence,	   structure	   and	   function	   of	  
enzymes,	   therefore	   the	   EC	   system	   was	   well-­‐suited	   as	   a	   definition	   of	   function.	   We	   defined	  




1.3	  ENZYMES	  AND	  METABOLISM	  
Most	  enzymes	  are	  proteins	  whose	  function	  is	  to	  facilitate	  chemical	  reactions	  in	  the	  cell	  
by	  accelerating	   the	  rate	  of	   the	  reactions,	  although	  some	  RNA	  molecules	  called	  ribozymes	  are	  
also	  known	  to	  have	  a	  catalytic	  role34-­‐36.	  Enzymatic	  proteins	  account	  for	  20-­‐40	  %	  of	  all	  proteins	  in	  
a	   genome37,38.	   Enzymes	   catalyze	   reactions	   involving	   a	   specific	   compound	   or	   substrate	   and	  
release	   a	   product.	   In	   general,	   only	   a	   handful	   of	   amino	   acids	   out	   of	   the	   full	   sequence	   are	  
catalytic	  and	  must	  be	  absolutely	  conserved	  across	  enzymes	  with	  the	  same	  EC	  number.	  However,	  
the	  entire	  catalytic	  pocket,	  that	  is	  the	  set	  of	  all	  amino	  acids	  that	  form	  the	  substructure	  of	  the	  
active	  site,	  must	  also	  be	  constrained	  to	  maintain	  the	  specificity	  of	  the	  enzymatic	  reaction.	  In	  an	  
organism,	   reactions	   occur	   in	   a	   particular	   sequence	  where	   the	   product	   of	   one	   reaction	   is	   the	  
substrate	  of	  the	  following,	  and	  a	  set	  of	  subsequent	  reactions	  form	  a	  pathway.	  The	  collection	  of	  
all	  pathways	   in	  a	  cell	   is	  called	  a	  metabolic	  network.	  Some	  pathways	  have	  emerged	   in	  a	  given	  
organism	  as	  a	  means	  of	  adaptation	  to	  a	  particular	  environment.	  Therefore,	  not	  all	  pathways	  are	  
conserved	  across	  genomes.	  On	  the	  other	  hand,	  some	  pathways	  responsible	  for	  basic	  functions	  
are	   critical	   to	   life	   and	   therefore	   will	   be	   found	   across	   all	   domains	   of	   life	   because	   of	   their	  
essentiality	  for	  cellular	  growth.	  These	  pathways	  include	  all	  reactions	  associated	  with	  glycolysis	  
or	   the	  TCA	  cycle	  and	  constitute	  the	  core	  carbon	  metabolism.	  Because	  these	  core	  metabolism	  
reactions	   are	   present	   across	   organisms,	   we	   postulate	   that	   they	   have	   emerged	   in	   the	   last	  
universal	  common	  ancestor.	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1.4	  SEQUENCE	  DATABASES	  AND	  FUNCTIONAL	  ANNOTATIONS	  
Several	   protein	   databases	   are	   available	   for	   research	   purposes	   including	   the	   Universal	  
Protein	   Resource	   KnowledgeBase39	   (UniProtKB),	   the	   Protein	   Data	   Bank40	   (PDB),	   the	   protein	  
family	   database	   Pfam25,	   the	   Structural	   Classification	   of	   Proteins	   database29	   (SCOP)	   and	   the	  
Braunschweig	   Enzyme	   Database41	   (BRENDA).	   Only	   the	   PDB	   and	   BRENDA	   contain	  
experimentally-­‐validated	   protein	   entries	   with	   literature	   references.	   The	   other	   databases	   are	  
populated	   with	   proteins	   functionally	   annotated	   through	   both	   experimental	   evidence	   and	  
computational	  data	  mining.	  
1.4.1	  The	  Protein	  Data	  Bank	  
The	   Protein	   Data	   Bank	   (PDB)	   is	   a	   database	   of	   experimentally-­‐determined	   three-­‐
dimensional	   structures40.	   There	   are	   currently	   87,755	   three-­‐dimensional	   structures	   resulting	  
from	   X-­‐ray	   crystallography	   experiments.	   An	   additional	   10,384	   structures	   were	   elucidated	   by	  
nuclear	  magnetic	   resonance	   (NMR).	  The	  structures	  may	  or	  may	  not	  contain	  bound	   ligands	  or	  
co-­‐factors.	   The	   PDB	   has	   seen	   an	   exponential	   increase	   in	   the	   number	   of	   deposited	   three	  
dimensional	  structures	  over	  the	  past	  few	  decades.	  However,	  not	  all	   the	  structures	   in	  the	  PDB	  
have	  a	  known	  molecular	   function.	   Indeed,	   thanks	   to	  structural	  genomics	  projects	  such	  as	   the	  
Protein	  Structure	   Initiative	   (PSI),	  over	  10,000	  previously	  uncharacterized	  protein	   targets	  were	  
chosen	   to	   be	   crystallized,	   in	   the	   hope	   that	   a	   solved	   structure	   would	   shed	   a	   light	   on	   their	  
potential	  biochemical	  function.	  Currently,	  there	  are	  57,360	  three	  dimensional	  structures	  in	  the	  
PDB	  with	  at	  least	  partial	  EC	  number	  annotation.	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1.4.2	  The	  Universal	  Protein	  Resource	  Knownledgebase	  
Another	  well	   known	   resource	   for	  protein	   sequences	   is	   the	  Universal	  Protein	  Resource	  
KnowledgeBase39	  (UniProtKB).	  It	  contains	  translated	  gene	  products	  from	  all	  major	  nucleic	  acid	  
databases	   (EMBL,	   GeneBank,	   DDBJ).	   UniProtKB	   is	   divided	   into	   two	   sub-­‐databases;	   Swiss-­‐Prot	  
and	  TrEMBL	  (translated	  EMBL	  nucleotide	  sequence	  data	  library).	  The	  latter	  contains	  sequences	  
which	  may	  have	  been	  experimentally	  or	  computationally	  annotated;	  however	  the	  contents	  of	  
Swiss-­‐Prot	  are	  manually-­‐curated.	  Efforts	  are	  also	  made	  to	  prevent	  redundancy	  from	  Swiss-­‐Prot	  
by	  merging	  all	  sequences	  encoded	  by	  the	  same	  gene.	  Swiss-­‐Prot	  now	  contains	  544,996	  entries	  
(456,429	   at	   100	   %	   redundancy),	   with	   214,898	   proteins	   with	   at	   least	   partial	   EC	   number	  
annotation.	  In	  other	  words,	  53	  %	  of	  the	  proteins	  in	  Swiss-­‐Prot	  are	  either	  non-­‐enzymes	  or	  they	  
lack	  molecular	   function	   annotation.	   In	   contrast	   to	   Swiss-­‐Prot,	   TrEMBL	   is	   populated	  with	   any	  
gene	  product	  whether	  it	  has	  a	  verified	  annotation	  or	  not.	  To	  date,	  TrEMBL	  is	  composed	  of	  over	  
54	  million	  sequences	  (28.5	  million	  at	  100	  %	  redundancy).	  Both	  components	  of	  UniProtKB	  have	  
been	  expanding	  exponentially	  over	  the	  past	  20	  years39	  (fig.	  1.5),	  due	  to	  the	  improved	  efficiency	  
of	   sequencing	   methods.	   Notably,	   the	   growth	   of	   UniProtKB/TrEMBL	   has	   overwhelmingly	  




Figure	  1.5.	  Growth	  of	  sequence	  databases.	  
Since	  2000,	  the	  number	  of	  determined	  sequences	  has	  been	  increasing	  exponentially.	  This	  graph	  
represents	  the	  growth	  of	  3	  sequence	  databases;	  the	  Protein	  Data	  Bank	  (which	  contains	  proteins	  
with	   experimentally	   determined	   3D	   structure),	   UniProtKB/Swiss-­‐Prot	   and	   UniProtKB/TrEMBL.	  
The	   latter	   shows	   the	   most	   dramatic	   progression	   and	   it	   includes	   any	   determined	   protein	  
sequence.	  Functional	  annotations	  of	  TrEMBL	  sequences	  are	  computationally-­‐generated	  with	  no	  
manual	  curation.	  Unsurprisingly,	  74	  %	  of	  TrEMBL	  sequences	  are	  bacterial	  gene	  products.	  
	  
Computational	   methods	   may	   help	   bridge	   the	   gap	   between	   sequencing	   and	  
characterization	   through	   utilization	   of	   homology-­‐based	   approaches.	   In	   fact,	   functional	  
annotations	   in	   TrEMBL	   result	   from	   such	   methods.	   However,	   homology-­‐based	   methods	   can	  
introduce	  mis-­‐annotations	   that	   could	   later	   be	   propagated	   as	   the	   erroneous	   annotation	   gets	  
transferred	  by	  homology	  to	  other	  uncharacterized	  proteins42-­‐44.	   In	  order	  to	  avoid	  such	  errors,	  
one	  may	  use	  databases	  such	  as	  the	  manually	  curated	  database	  UniProtKB/Swiss-­‐Prot.	  However,	  
as	  much	  as	  70	  %	  of	  Swiss-­‐Prot	  entries	  were	   inferred	   from	  homology39.	  Therefore	   it	  would	  be	  
useful	   to	   determine	   the	   fraction	   of	   Swiss-­‐Prot	   which	   has	   significant	   homology	   to	  
experimentally-­‐validated	   proteins.	   This	  way	  we	   can	   get	   a	   better	   idea	   of	   the	   extent	   to	  which	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Swiss-­‐Prot	   database	   annotations	   can	   be	   trusted.	   For	   this	   purpose,	   we	   turn	   to	   the	   largest	  
enzyme	  information	  system	  available,	  the	  Braunschweig	  Enzyme	  Database.	  
1.4.3	  The	  Braunschweig	  Enzyme	  Database	  
The	   BRaunschweig	   ENzyme	   DAtabase41	   (BRENDA)	   is	   a	   comprehensive	   database	   of	  
experimental	   biochemical	   and	   molecular	   enzyme	   data.	   The	   functional	   information,	   which	  
includes	  data	  on	  enzyme	  occurrence,	  reaction	  kinetics	  and	  other	  physicochemical	  properties,	  is	  
directly	  extracted	  from	  the	  literature,	  and	  is	  manually	  verified	  by	  scientists.	  BRENDA	  contains	  all	  
enzymes	  with	  known	  enzyme	  classification	  (E.C.)	  as	  well	  as	  some	  physicochemical	  properties	  as	  
referenced	   in	  the	   literature.	   It	  contains	  close	  to	  20,000	  enzymes	  with	  experimental	  validation	  
spanning	   3,074	   unique	   E.C.	   functions.	   Just	   over	   half	   of	   experimentally-­‐validated	   BRENDA	  
sequences	  are	  cross-­‐referenced	   in	  Swiss-­‐Prot	   (Fig.	  1.6)	  and	  this	  makes	  up	  1.9	  %	  of	   the	  Swiss-­‐
Prot	   database.	   The	   other	   47	   %	   belong	   to	   TrEMBL	   (database	   of	   unreviewed,	   automatic	  
annotations).	  
	  
Figure	  1.6.	  Source	  of	  BRENDA	  sequences.	  
BRENDA	  is	  a	  database	  of	  proteins	  with	  experimentally	  determined	  physico-­‐chemical	  properties	  
and	   function	   (N	   =	   19.415).	   Among	   the	   proteins	   listed	   in	   BRENDA,	   9,033	   are	   cross-­‐listed	   in	  




The	   set	   of	   experimentally-­‐verified	   BRENDA	   entries	   cover	   3,074	   unique	   E.C.	   numbers	  
while	   Swiss-­‐Prot	   has	   3,971.	   The	   distribution	   of	   E.C.	   classes	   (1-­‐6)	   represented	   in	   BRENDA	   is	  
virtually	   the	  same	  as	   the	  distribution	  of	  E.C.	   classes	   in	  Swiss-­‐Prot	   (Fig.	  1.7).	   In	  both	  cases	   the	  
first	   three	   classes	   (oxidoreductases,	   transferases,	   hydrolases)	   make	   up	   around	   80	   %	   of	   the	  
dataset.	  This	  shows	  that	  experimental	  BRENDA	  is	  not	  biased	  in	  its	  composition	  but	  still	  covers	  
all	  classes	  of	  enzymatic	  functions.	  
	  
Figure	  1.7.	  Distribution	  of	  EC	  functional	  classes	  in	  Swiss-­‐Prot	  and	  BRENDA.	  
The	  distribution	  of	  proteins	  per	  EC	  functional	  class	  in	  Swiss-­‐Prot	  and	  BRENDA	  are	  very	  similar,	  
with	  classes	  EC1,	  EC2	  and	  EC3	  representing	  over	  80	  %	  of	  both	  sets.	  
	  
Functional	  prediction	  can	  be	  made	  robust	  with	  a	  careful	  choice	  of	  reference	  sequence	  
set.	  For	  our	  purposes	  the	  SwissProt	  and	  BRENDA	  database	  constitute	  reliable	  sources.	  However,	  
as	   mentioned	   above,	   sequence	   homology	   alone	   is	   not	   enough	   to	  make	   reliable	   predictions.	  
Therefore	   we	   propose	   to	   add	   a	   structure-­‐derived	   component	   to	   sequence	   homology	   for	  
function	  prediction.	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1.5	  STATEMENT	  OF	  HYPOTHESIS	  
Given	   that	   the	   amino	   acids	   contained	   in	   the	   region	   extending	   around	   the	   catalytic	  
residues	  should	  be	  significantly	  more	  conserved	   than	   the	  overall	   sequence	  between	  enzymes	  
with	  the	  same	  molecular	  function,	  active	  site	  region	  conservation	  can	  be	  used	  to	  complement	  
global	   sequence	   identity	   to	   make	   functional	   predictions,	   especially	   when	   a	   BLAST	   search	  
returns	  no	  high	  homology	  hits.	  More	  specifically,	  measuring	  the	  level	  of	  sequence	  conservation	  
between	   two	   protein	   sequences	   at	   the	   active	   site	   region	   should	   allow	   us	   to	   confidently	  
determine	  whether	  the	  two	  proteins	  have	  the	  same	  molecular	  function.	  
We	  know	  that	  global	  sequence	   is	  not	  enough	  for	  accurate	  predictions	  below	  a	  certain	  
level	   of	   homology	   to	   known	   enzymes.	   Indeed	   purely	   computational	   methods	   of	   function	  
prediction	   relying	   on	   annotation	   transfer	   from	   a	   homologue	   tend	   to	   fail	   below	   a	   certain	  
homology	   threshold6,45.	  We	  expect	   residues	  surrounding	   the	  catalytic	   region	  of	  an	  enzyme	  to	  
be	  more	   conserved	   than	   the	   global	   sequence	  when	   comparing	   two	   enzymes	  with	   the	   same	  
function.	  
To	  investigate	  the	  limits	  of	  sequence	  homology	  between	  orthologous	  enzymes,	  as	  well	  
as	  the	  size	  of	  the	  conserved	  region	  around	  the	  active	  site	  we	  conducted	  the	  study	  described	  in	  
Chapter	   2.	   We	   found	   that	   enzymes	   diverging	   from	   a	   common	   ancestor	   must	   retain	   ~30	   %	  
sequence	   identity	   in	   order	   for	   function	   to	   be	   maintained.	   Similarly,	   the	   structures	   diverging	  
enzymes	  with	  the	  same	  function	  are	  no	  more	  distant	  than	  about	  3.5	  Å	  root	  mean	  square	  distance	  
(RMSD).	  We	  also	  showed	  that	   the	   level	  of	  conservation	  at	  a	  given	  site	  along	  an	  enzyme	  sequence	  
actually	   depends	   on	   how	   distant	   this	   site	   is	   to	   the	   catalytic	   site.	   In	   other	   words,	   the	   region	  
surrounding	  catalytic	  residues	  undergo	  fewer	  mutations	  over	  the	  course	  of	  divergent	  evolution.	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  Subsequently,	   we	   used	   the	   result	   of	   that	   study	   to	   devise	   a	   probabilistic	   functional	  
annotation	  method	  integrating	  active	  site	  region	  conservation	  with	  global	  sequence	  homology	  
and	  genomic	  context	  information,	  as	  shown	  in	  Chapter	  3.	  We	  first	  compared	  the	  performance	  
of	  3D-­‐GLOBUS	  to	  that	  of	  GLOBUS	  in	  order	  to	  quantify	  the	  improvements	  in	  prediction	  accuracy	  
and	   precision	   afforded	   by	   the	   addition	   of	   structure-­‐derived	   local	   sequence	   conservation	  
information.	  We	   also	   demonstrated	   that	   the	   aforementioned	  method,	   3D-­‐GLOBUS,	   performs	  
better	   than	   high	   performing	  methods	   Argot2	   and	   EFICAz2.5	   in	   predicting	   the	   function	   of	   low	  
homology	   genes.	   The	   improvement	   in	   precision	   and	   recall	   of	   3D-­‐GLOBUS	   over	   GLOBUS	   is	  
particularly	  observable	   for	  genes	  with	   less	   than	  40	  %	  to	   the	  closest	  homologue	   in	  Swiss-­‐Prot.	  
For	  this	  subset,	  3D-­‐GLOBUS	  shows	  a	  36	  %	  increase	  in	  precision	  over	  GLOBUS	  (precision	  of	  0.6	  
and	  0.44).	  Similarly,	  we	  observe	  a	  40	  %	  increase	  in	  recall	  over	  GLOBUS	  (recall	  of	  0.35	  and	  0.25	  
respectively).	  
Finally,	  we	  describe	  how	  3D-­‐GLOBUS	  was	  applied	  to	  the	  whole-­‐genome	  reconstruction	  
of	  the	  Mycobacterium	  tuberculosis	  H37Rv	  metabolic	  network	  in	  Chapter	  4.	  Through	  3D-­‐GLOBUS,	  
we	  make	   several	   novel	   functional	   predictions	   that	  were	   not	   in	   the	   published	  models	   of	   this	  
organism.	  We	  propose	  for	  functional	  characterization	  7	  genes	  that	  were	  absent	  from	  published	  
models	  of	  the	  bacterium	  and	  for	  which	  3D-­‐GLOBUS	  has	  made	  high	  probability	  predictions.	  This	  
set	   of	   7	   genes	   constitutes	   a	   case-­‐study	   of	   low	   global	   sequence	   conservation	   vs.	   high	   local	  
sequence	  homology	  to	  enzymes	  with	  known	  function.	  
Interestingly,	   we	   were	   also	   able	   to	   identify	   a	   large	   number	   of	   genes	   involved	   in	   the	  
degradation	   of	   cholesterol.	   This	   is	   an	   exciting	   finding	   because	   several	   studies	   have	   been	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published	   these	   past	   few	   years	   showing	   that	   cholesterol	   is	   an	   important	   nutrient	   for	   M.	  
tuberculosis	   persistence	   during	   infection.	   However	   at	   this	   time	   the	   exact	   mechanisms	   and	  
genes	  involved	  have	  not	  been	  fully	  elucidated	  and	  no	  published	  model	  contained	  this	  pathway.	  
The	  findings	  from	  3D-­‐GLOBUS	  led	  us	  to	  build	  an	  updated	  metabolic	  model	  for	  M.	  tuberculosis	  
with	   is	   better	   able	   to	   replicate	   real	   experimental	   data,	   as	   well	   as	   to	   simulate	   and	   predict	  
phenotypic	   states	   of	   interest.	   We	   hope	   that	   our	   model	   will	   help	   further	   understand	   what	  
happens	   during	   persistent	   infection	   and	   shed	   light	   on	   the	   metabolic	   adaptations	   that	   M.	  
tuberculosis	  undergoes	  when	  faced	  with	  different	  environments	  and	  conditions.	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Although	  many	   previous	   studies	   investigated	   the	  main	   determinants,	   constraints,	   and	  
mechanisms	   of	   protein	   molecular	   evolution46-­‐49,	   relatively	   little	   attention	   has	   been	   given	   to	  
understanding	  possible	  limits	  in	  the	  evolution	  of	  protein	  sequences	  and	  structures	  sharing	  the	  
same	  molecular	  function.	  The	  molecular	  function13	  is	  defined	  as	  the	  specific	  protein	  activity	  at	  
the	   molecular	   level,	   such	   as	   the	   ability	   to	   catalyze	   a	   specific	   enzymatic	   reaction.	   Several	  
examples	  of	  convergent	  protein	  evolution	  suggest	  that	  the	  same	  molecular	  functions	  could	  be	  
shared	  by	  proteins	  with	  sequence	   identity	  as	   low	  as	  the	  sequence	   identity	  expected	  between	  
two	   unrelated	   enzymes50-­‐52.	   Nevertheless,	   for	   proteins	   that	   are	   diverging	   from	   the	   same	  
ancestral	   sequence	   it	   is	   possible	   that	   crucial	   residues	   are	   strongly	   conserved	   in	   order	   to	  
preserve	   common	   functions.	   The	   main	   goal	   of	   this	   study	   is	   to	   explore	   the	   extent	   to	   which	  
enzyme	   sequences	   and	   structures	   can	   diverge	   while	   continuously	   maintaining	   the	   same	  
molecular	  function.	  Understanding	  the	  long-­‐term	  constrains	  of	  protein	  evolution	  is	  not	  only	  an	  
important	   fundamental	   question,	   but	   it	   should	   also	   advance	   our	   understanding	   of	   the	  main	  
determinants	   of	   protein	  molecular	   functions	   and	   thus	   improve	   computational	   algorithms	   for	  
functional	  annotations53-­‐55.	  
Recently,	  Povolotskaya	  and	  Kondrashov	   investigated	  whether	   the	  global	  divergence	  of	  
protein	   sequences	   has	   reached	   a	   limit56.	   The	   analysis	   showed	   that	   distant	   homologues	  
belonging	  to	  the	  same	  Cluster	  of	  Orthologous	  Groups	  (COG)20	  are	  still	  diverging.	  However,	  the	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limit	  of	  protein	  evolution	  was	  not	  specifically	   investigated	  and	  it	   is	  not	  clear	   if	  proteins	  would	  
be	  able	  to	  diverge	  beyond	  the	  limit	  of	  sequence	  recognition	  methods.	  Importantly,	  as	  COGs	  are	  
constructed	  based	  on	  a	  network	  of	  best	  sequence	  hits	  across	  genomes20,	  proteins	  in	  the	  same	  
COG	  do	  not	   necessarily	   share	   the	   same	  molecular	   function.	   Consequently,	   the	   impact	   of	   the	  
requirement	  to	  continuously	  maintain	  the	  molecular	  function	  on	  protein	  divergence	  remains	  to	  
be	  elucidated.	  
In	   the	  present	  study	  we	   focus	  on	   the	  evolution	  of	  enzymes	  given	   that	   their	  molecular	  
function	   is	   relatively	   well	   defined.	   The	   Enzyme	   Commission	   (EC)	   classification	   organizes	  
enzymatic	  functions	  using	  a	  hierarchical	  4-­‐digit	  code19.	  Specifically,	  sharing	  of	  all	  4	  digits	  in	  the	  
EC	  classification	   indicates	   the	  same	  molecular	   function,	   i.e.	   catalysis	  of	   the	   same	  biochemical	  
reaction.	   Sharing	   less	   than	   4	   digits,	   indicates	   different	   degrees	   of	   similarity	   in	   molecular	  
function;	   for	   example,	   sharing	   the	   first	   3	   EC	   digits	   of	   the	   EC	   classification	   usually	   indicates	  
identity	  of	   the	  catalyzed	  reaction,	  but	  not	   the	  reaction	  substrates.	   In	   this	  chapter	  we	  analyze	  
sequence	  evolution	  of	  enzymes	  catalyzing	   thirty	  metabolic	  activities	   in	  a	  diverse	  collection	  of	  
organisms	   from	   all	   domains	   of	   life.	  We	   compare	   several	   models	   of	   sequence	   evolution	   and	  
investigate	  the	  effective	  limits	  on	  sequence	  and	  structural	  divergence	  imposed	  by	  the	  necessity	  
to	  continuously	  preserve	  the	  same	  molecular	  function.	  We	  also	  investigate	  how	  the	  constraint	  
to	   preserve	   molecular	   function	   helps	   in	   distinguishing	   between	   divergent	   and	   convergent	  
evolution	  of	  enzymes.	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2.2	  MATERIALS	  AND	  METHODS	  
2.2.1	  Homology	  between	  Swiss-­‐Prot	  and	  BRENDA	  enzymes	  
In	  order	   to	  determine	   specifically	   the	   fraction	  of	   Swiss-­‐Prot	  enzymes	   for	  which	  a	  high	  
confidence	   annotation	   can	   be	   made,	   the	   list	   of	   all	   enzymes	   with	   experimentally	   validated	  
function	  in	  BRENDA	  was	  retrieved	  with	  the	  Simple	  Object	  Access	  Protocol	  (SOAP)	  client.	  Then	  
all	  of	  the	  Swiss-­‐Prot	  entries	  were	  blasted	  against	  this	  subset	  of	  BRENDA.	  	  For	  each	  Swiss-­‐Prot,	  
query	   all	   self-­‐hits	   were	   removed	   (because	   BRENDA	   contains	   both	   Swiss-­‐Prot	   and	   TrEMBL	  
entries,	  Fig.	  1.6).	  The	  hit	  within	  BRENDA	  with	  the	  lowest	  E-­‐value	  was	  retained	  as	  the	  best	  hit	  for	  
the	  Swiss-­‐Prot	  query	  if	  any.	  
About	   half	   of	   Swiss-­‐Prot	   proteins	   (253,904)	   are	   annotated	   with	   a	   full	   or	   partial	   EC	  
number,	  and	  therefore	  are	  likely	  to	  be	  enzymes.	  	  Fifty-­‐two	  percent	  have	  a	  hit	  in	  BRENDA	  at	  the	  
0.05	  significance	  level.	  The	  other	  48	  %	  are	  likely	  to	  be	  mostly	  non-­‐enzymes.	  The	  distribution	  of	  
pair-­‐wise	   sequence	   identity	  between	  Swiss-­‐Prot	  proteins	  and	   their	  best	  hit	   in	  BRENDA	  across	  
sequence	  identity	  bins	  reveals	  that	  the	  majority	  of	  Swiss-­‐Prot/BRENDA	  best	  hit	  pairs	  are	  in	  the	  
30	  –	  40	  %	  sequence	  identity	  range	  (Fig.2.1).	  Indeed,	  about	  50	  %	  of	  all	  pairs	  cluster	  in	  the	  20	  –	  
50	  %	  sequence	  identity	  bin.	  The	  cumulative	  distribution	  plot	  shows	  that	  in	  accordance	  with	  the	  
aforementioned	   hypothesis,	   over	   90	   %	   of	   Swiss-­‐Prot	   enzymes	   have	   at	   least	   30	   %	   sequence	  
identity	  to	  an	  experimentally	  validated	  enzyme	  from	  BRENDA	  (Fig.	  2.1).	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Figure	  2.1.	  Distribution	  of	  pairwise	  sequence	  identity	  between	  Swiss-­‐Prot	  enzymes	  and	  best	  
BLAST	  hit	  in	  BRENDA.	  
This	  plot	  shows	  that	  on	  average	  Swiss-­‐Prot	  enzymes	  have	  about	  40	  %	  sequence	  identity	  to	  an	  
experimentally	   characterized	  protein	   in	  BRENDA.	   Therefore,	   a	   considerable	  number	  of	   Swiss-­‐
Prot	   enzymes	   that	   are	   either	   un-­‐annotated,	   partially	   annotated	   or	  mis-­‐annotated	   cannot	   be	  
assigned	  function	  with	  confidence	  through	  sequence	  homology.	  
	  
2.2.2	  Sequence	  homology	  and	  alignments	  
All	  database	  searches	  in	  this	  work	  were	  done	  with	  the	  PSI-­‐BLAST	  algorithm.	  PSI-­‐BLAST	  is	  
better	   indicated	   to	   identify	   remote	   homologues	   than	  BLAST	   because	   it	   generates	   a	   position-­‐
specific	  scoring	  matrix	  (PSSM),	  and	  uses	  it	  to	  make	  more	  sensitive	  sequence	  comparisons2.	  
To	  build	   the	  phylogenetic	   tree	  shown	   in	  Fig.	  2.2	  a	  multiple	  sequence	  alignment	  of	   the	  
strongly	   conserved	   small	   subunit	   ribosomal	   RNA	   was	   performed	   with	   CLUSTALW57.	   Then	   a	  
maximal-­‐likelihood	  phylogenetic	  analysis	  was	  conducted	  with	  FastML58.	  
Orthology	  between	   two	  enzymes	  was	  defined	  as	   a	   full	  match	   in	   E.C.	   number	   and	   the	  
enzymes	  being	  best	  bi-­‐directional	  hits	  in	  a	  PSI-­‐BLAST	  search2.	  The	  BLOSUM6259	  matrix	  was	  used	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along	   with	   E-­‐value	   cutoff	   of	   0.005.	   Only	   enzymes	   with	   experimentally	   validated	   EC	   number	  
were	  used	   to	  avoid	  bias	   from	  mis-­‐annotations.	  To	   fulfill	   this	   requirement	  we	  only	  considered	  
Swiss-­‐Prot	   sequences	   also	   listed	   in	   BRENDA	   as	   having	   functional	   annotation	   verified	  
experimentally41.	  CLUSTALW	  was	  used	  to	  carry	  out	  multiple	  sequence	  alignments	   for	  each	  EC	  
set.	  Times	  of	  divergence	  between	  pairs	  of	  species	  are	  from	  the	  TimeTree	  database60.	  In	  all	  cases	  
time	  of	  divergence	  was	  determined	  with	  a	  global	  or	  local	  clock	  method	  on	  conserved	  molecules	  
such	  as	  ribosomal	  RNA.	  
2.2.3.	  Models	  of	  divergent	  evolution	  
The	   3	   regression	   models	   were	   derived	   from	   the	   Poisson	   model61-­‐63	   and	   Gamma	  
correction64-­‐66	   methods	   routinely	   applied	   to	   sequence	   divergence	   problems.	   The	   fits	   of	   the	  
models	  were	  evaluated	  with	  coefficient	  of	  determination	  R2:	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑅! = 1− !""
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  (4)	  
where	  RSS	  is	  the	  residual	  sum	  of	  squares	  and	  TSS	  is	  the	  total	  sum	  of	  squares.	  Because	  model	  1	  
is	  nested	  in	  model	  2	  we	  could	  compare	  their	  fits	  with	  the	  F-­‐test	  (Eqn.	  5).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
€ 
F = (RSS1 − RSS2) /(df1 − df 2)
RSS2 /df 2
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (5)	  
where	  RSS1	  and	  RSS2	  are	  the	  residual	  sum	  of	  squares	  for	  model	  1	  and	  model	  2	  respectively,	  and	  
df1	  and	  df2	  are	  the	  number	  of	  degrees	  of	  freedom	  for	  model	  1	  and	  model	  2.	  
Structures	   annotated	  with	   the	   EC	  numbers	   considered	   in	   this	   study	   and	  pertaining	   to	  
the	  24	  organisms	  from	  Figure	  1	  were	  retrieved	  from	  the	  PDB40.	  All	  pairs	  of	  structures	  with	  the	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same	   EC	   number	   annotation	   were	   then	   aligned	   using	   the	   Combinatorial	   Extension	   (CE)67	  
algorithm.	  
2.2.4	  Nonlinear	  regression	  
The	  equation	  for	  a	  nonlinear	  model	  is	  the	  following:	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑌 = 𝑓 𝑋,𝑝 + 𝜀	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
where	  Y	  is	  the	  observed	  data,	  X	  =	  (x1,	  x2,	  …,	  xk)’	  are	  independent	  variables,	  p	  =	  (p1,	  p2,	  …,	  pk)’	  are	  
the	  model	  parameters,	  and	  ε	  are	  the	  residual	  errors.	  
The	  process	  of	  curve	  fitting	  corresponds	  to	  solving	  a	  least	  squares	  problem.	  The	  goal	  is	  to	  find	  
the	  set	  of	  parameters	  that	  minimize	  the	  sum	  of	  the	  weighed	  residuals	  X2	  






!!! 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
where	  Yj	  is	  the	  observed	  data,	  ŷ(x’I;p)	  is	  the	  estimate	  given	  the	  set	  of	  parameters	  p,	  and	  σi	  is	  the	  
variance.	  
To	  estimate	  the	  set	  of	  parameters	  p	  that	  minimize	  X2,	  one	  must	  set	  the	  partial	  derivative	  of	  X2	  
with	  respect	  to	  p	  to	  0.	  If	  the	  curve-­‐fit	  function	  is	  non-­‐linear,	  there	  are	  no	  explicit	  solutions	  so	  we	  
reduced	   X2	   iteratively	   by	   introducing	   a	   perturbation	   to	   the	   parameters	   at	   each	   iteration.	   In	  
order	  to	  achieve	  this,	  we	  use	  the	  Levenberg-­‐Marquardt	  algorithm	  which	  is	  a	  combination	  of	  the	  
steepest	   descent	   method	   and	   the	   Gauss-­‐Newton	   method.	   The	   parameter	   update	   equation	  
contains	  a	  factor	  λ	  which	  is	  adjusted	  depending	  on	  which	  of	  these	  two	  methods	  one	  wants	  to	  
use.	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  (3)	  
where	  for	  observations	  1	  ≤	  i	  <	  n,	  xi+1	  is	  the	  updated	  parameter,	  xi	  the	  previous	  step	  parameter,	  
H	  the	  Hessian	  is	  a	  matrix	  of	  secondary	  derivatives	  (accounts	  for	  curvature),	  λ	  is	  the	  “decision”	  
factor,	  I	  is	  the	  identity	  matrix,	  and	  ∇f(xi)	  is	  the	  gradient.	  
At	  each	  step,	  if	  the	  parameters	  are	  far	  from	  optimal	  (i.e.	  X2	  is	  not	  reduced)	  we	  increase	  λ	  so	  that	  
the	  steepest	  descent	  method	  is	  applied.	  When	  λ	  is	  large	  the	  update	  equation	  if	  approximately	  
the	  following:	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  (4)	  
	  Conversely,	   when	   the	   parameters	   are	   closer	   to	   optimal	   we	   decrease	   λ	   in	   order	   to	   use	   the	  
Gauss-­‐Newton	  method	  and	  the	  update	  equation	  approximates:	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  (5)	  
2.2.5	  Hubble-­‐like	  derivation	  
In	   order	   to	   smooth	   out	   variations	   and	   increase	   coverage,	   for	   each	   data	   set	   of	  
evolutionary	  distance	  as	  a	   function	  of	  divergence	  time,	   the	  data	  was	  binned	  by	  distance	  with	  
bin	  size	  =	  0.25.	  
For	   each	   distance	   bin,	   the	   corresponding	   time	   value	  was	   defined	   as	   the	   average	   time	   of	   all	  
points	  within	   the	   bin.	   Then	  we	   shifted	   the	  window	   by	   a	   step	   size	   of	   0.05	   and	   repeated	   this	  
process.	  
The	  rate	  of	  change	  of	  evolutionary	  distance	  as	  a	  function	  of	  time	  !"
!"






where	   D’(xi)	   is	   the	   derivative	   as	   a	   function	   of	   time	   at	   point	   xi,	   D(xi+1)	   and	   t(xi+1)	   are	   the	  
evolutionary	  distance	  and	  divergence	  time	  of	  the	  point	  following	  point	  xi,	  and	  D(xi-­‐1)	  and	  t(xi-­‐1)	  	  
are	  the	  evolutionary	  distance	  and	  the	  divergence	  time	  of	  the	  point	  preceding	  xi	  respectively.	  
When	  a	  gap	  greater	  than	  0.1	  distance	  units	  was	  present	  between	  two	  points	  we	  did	  not	  take	  
the	  derivative	  at	  these	  points	  to	  avoid	  outlier	  derivative	  values.	  
	  
2.3	  COMPARING	  MODELS	  OF	  SEQUENCE	  EVOLUTION	  
In	   order	   to	   investigate	   the	   long-­‐term	   divergence	   of	   orthologous	   sequences	   we	  
considered	  30	  enzymes	  from	  24	  diverse	  organisms	  (Fig.	  2.2,	  table	  2.1).	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Figure	  2.2.	  Phylogenetic	  tree	  of	  the	  24	  organisms	  considered	  in	  this	  study.	  
The	  set	  contains	  12	  eukaryotic	  species	  (red)	  including	  2	  plant	  species	  (Arabidopsis	  thaliana	  and	  
Oryza	   sativa),	   a	   fungi	   (Saccharomyces	   cerevisiae),	   and	   2	   protozoans	   (Plasmodium	   falciparum	  
and	  Trypanosoma	  brucei).	  It	  also	  contains	  3	  archaeal	  species	  (green)	  and	  9	  bacteria	  (blue).	  The	  








Table	  2.1.	  List	  of	  30	  enzymatic	  functions	  considered	  in	  this	  study.	  
Enzymatic function EC Number Metabolism Pathway 
IMP dehydrogenase 1.1.1.205 Nucleotide/Xenobiotics 
Malate dehydrogenase  1.1.1.37 Carbohydrate/Energy 
Dihydrolipoyl dehydrogenase  1.8.1.4 Carbohydrate/Amino Acid 
Thioredoxin-disulfide reductase  1.8.1.9 Nucleotide 
Thymidylate synthase  2.1.1.45 Nucleotide/Cofactors & Vitamins 
Acetyl-CoA C-acetyltransferase  2.3.1.9 Lipid/Amino Acid/Carbohydrate 
Citrate (Si)-synthase  2.3.3.1 Carbohydrate 
Amidophosphoribosyltransferase  2.4.2.14 Nucleotide/Amino Acid 
Uracil phosphoribosyltransferase  2.4.2.9 Nucleotide 
Glutamine-fructose-6-phosphate transaminase  2.6.1.16 Carbohydrate/Amino Acid 
Phosphoglycerate kinase  2.7.2.3 Carbohydrate/Energy 
Ribose-phosphate diphosphokinase  2.7.6.1 Carbohydrate/Nucleotide 
UDP-N-acetylglucosamine diphosphorylase  2.7.7.23 Carbohydrate 
UTP-glucose-1-phosphate uridylyltransferase  2.7.7.9 Carbohydrate 
Inositol-phosphate phosphatase  3.1.3.25 Carbohydrate/Secondary Metabolite 
Inorganic diphosphatase  3.6.1.1 Energy 
Fructose-bisphosphate aldolase  4.1.2.13 Carbohydrate/Energy 
Phosphopyruvate hydratase  4.2.1.11 Carbohydrate/Energy 
Fumarate hydratase  4.2.1.2 Carbohydrate/Energy 
UDP-glucose 4-epimerase  5.1.3.2 Carbohydrate 
Triose-phosphate isomerase  5.3.1.1 Carbohydrate/Energy 
Ribose-5-phosphate isomerase  5.3.1.6 Carbohydrate/Energy 
Phosphoglycerate mutase  5.4.2.1 Carbohydrate/Energy 
Phosphoglucomutase  5.4.2.2 Carbohydrate/Nucleotide/Secondary Metabolites 
Phosphomannomutase  5.4.2.8 Carbohydrate 
Acetate-CoA ligase  6.2.1.1 Carbohydrate/Energy 
Succinate-CoA ligase  6.2.1.5 Carbohydrate/Energy 
SAICAR synthetase  6.3.2.6 Nucleotide 
Adenylsuccinate synthase  6.3.4.4 Nucleotide/Amino Acid 
GMP synthase  6.3.5.2 Nucleotide/Xenobiotics 
	  
The	  selected	  enzymatic	  activities	  represent	  important	  metabolic	  functions	  maintained	  in	  
species	  from	  all	  domains	  of	  life	  covering	  all	  6	  classes	  of	  enzymes	  (oxidoreductases,	  transferases,	  
hydrolases,	  lyases,	  isomerases	  and	  ligases).	  For	  most	  of	  the	  30	  EC	  numbers	  a	  sequence	  could	  be	  
found	   in	   all	   24	   organisms.	   Importantly,	   to	   prevent	   biases	   due	   to	   computational	   transfer	   of	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molecular	   functions	  based	  on	  sequence	  homology,	  we	  selected	  for	  our	  analysis	  only	  enzymes	  
for	  which	  molecular	  function	  was	  experimentally	  validated	  in	  all	  species41	  (see	  Methods).	  
We	   performed	   pairwise	   sequence	   alignments	   across	   all	   24	   organisms	   and	   compared	  
sequence	   identity	   to	   divergence	   times	   between	   each	   pair	   of	   species	   for	   each	   enzyme.	  
Divergence	   times,	   spanning	   ~4	   billion	   years	   of	   evolution,	   were	   taken	   from	   the	   TimeTree	  
database60	  (Appendix	  2.1).	  
First,	  we	  considered	  a	  simple	  model	  of	  sequence	  evolution	  that	  assumes	  that	  the	  rate	  of	  
amino	  acid	   substitution	  at	  each	  site	   is	   independent	  and	   follows	   the	  Poisson	  distribution.	  This	  
model	  is	  commonly	  used	  to	  estimate	  the	  number	  of	  substitutions	  that	  have	  occurred	  between	  
two	  sequences61-­‐63.	  Using	  this	  model	  (Eqn.	  1)	  we	  fitted	  the	  pairwise	  sequence	  identity	  of	  each	  
enzyme	   considered	   as	   a	   function	   of	   the	   time	   of	   divergence	   between	   the	   species.	   The	   fit	  
corresponds	  to	  an	  exponential	  decay	  with	  a	  single	  parameter	  (R0)	  representing	  the	  average	  rate	  
of	   amino	   acid	   substitution	   (see	   Methods).	   The	   obtained	   fits	   can	   be	   seen	   in	   Figure	   2.3	   and	  
appendix	  2.2	  (green	  lines).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
€ 
y =100*e−R0 *t 	   	   	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
In	  the	  second	  model,	  we	  considered	  two	  distinct	  types	  of	  residues	  A	  and	  B.	  Residues	  of	  
type	  A	  are	  absolutely	  conserved	  in	  protein	  sequences,	  while	  residues	  of	  type	  B	  have	  constant	  
substitution	  rates	  in	  accordance	  with	  the	  Poisson	  correction,	  as	  in	  model	  1.	  Using	  this	  model	  we	  
fitted	  an	  exponential	  decay	  (Eqn.	  2)	  with	  the	  additional	  parameter	  y0	   that	  corresponds	  to	  the	  
percentage	   of	   un-­‐mutable	   amino	   acids	   and	   represents	   the	   minimum	   sequence	   identity	  
between	  any	  two	  proteins,	  i.e.	  a	  limit	  to	  sequence	  divergence.	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€ 
y =y 0+(100− y0)*e
−R0 *t	   	   	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
From	   the	  R2	   values	   (table	   2.2)	   and	   a	   visual	   examination	   of	   the	   fitted	   curves	   (Fig.	   2.3,	  
appendix	  2.2,	  red	  lines),	  this	  model	  is	  a	  better	  representation	  of	  divergent	  sequence	  evolution	  
than	  model	  1.	  	  
	  
Figure	  2.3.	  Fitting	  models	  of	  sequence	  divergence.	  
For	  all	  30	  enzymatic	  activities	  we	  plotted	  pairwise	  sequence	  identity	  against	  time	  of	  divergence	  
for	  all	  pairs	  of	  organisms	  and	  fitted	  the	  data	  with	  3	  models	  of	  amino	  acid	  substitution	  described	  
in	   the	   text.	   Here	   we	   show	   4	   representative	   plots	   with	   the	   fits	   from	   model	   1	   (green	   lines)	  
assuming	  that	  the	  rate	  of	  amino	  acid	  substitution	  is	  independent	  between	  sites	  and	  follows	  the	  
Poisson	   distribution	   (Eqn.	   1),	   model	   2	   (red)	   assuming	   that	   a	   fraction	   of	   residues	   remains	  
unchanged	   (Eqn.	   2),	   and	   model	   3	   (blue)	   that	   uses	   Gamma	   correction	   (Eqn.	   4)	   to	   model	  
substitution	  rate	  heterogeneity	  between	  sites.	  A)	  EC:	  1.1.1.205,	  B)	  EC:	  2.7.7.9,	  C)	  EC:	  3.1.3.25	  
and	  D)	  EC:	  6.2.1.5.	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Table	  2.2.	  Comparisons	  of	  the	  fits	  of	  models	  1,	  2	  and	  3	  of	  sequence	  divergence.	  
The	  fits	  of	  model	  1	  (Poisson	  correction),	  model	  2	  (effective	  limit	  to	  sequence	  divergence),	  and	  
model	  3	  (Gamma	  correction)	  to	  the	  data	  were	  compared.	  The	  P-­‐value	  for	  the	  F-­‐test	  comparing	  
nested	  models	  1	  and	  2	  is	  in	  the	  third	  column.	  
Enzymatic function Model 1 R2 Model 2 R2 
F-test 
P-value Model 3 R
2 
1.1.1.205 0.07 0.65 1.00x10-20 0.60 
1.1.1.37 0.55 0.68 1.96x10-11 0.66 
1.8.1.4 0.62 0.75 4.44x10-16 0.75 
1.8.1.9 -0.25 0.56 1.00x10-20 0.53 
2.1.1.45 0.24 0.42 6.93x10-9 0.48 
2.3.1.9 0.28 0.61 2.22x10-16 0.64 
2.3.3.1 0.73 0.77 3.89x10-6 0.77 
2.4.2.14 -0.15 0.74 1.00x10-20 0.64 
2.4.2.9 0.45 0.67 9.97x10-14 0.67 
2.6.1.16 0.08 0.71 1.00x10-20 0.64 
2.7.2.3 0.60 0.77 1.00x10-20 0.77 
2.7.6.1 0.58 0.68 7.75x10-11 0.67 
2.7.7.23 -0.33 0.62 1.00x10-20 0.58 
2.7.7.9 0.57 0.76 1.00x10-20 0.75 
3.1.3.25 -0.03 0.81 1.00x10-20 0.77 
3.6.1.1 -0.14 0.61 1.00x10-20 0.58 
4.1.2.13 0.60 0.70 3.64x10-5 0.71 
4.2.1.11 0.64 0.77 1.11x10-16 0.77 
4.2.1.2 0.78 0.78 0.226 0.79 
5.1.3.2 0.37 0.70 1.00x10-20 0.74 
5.3.1.1 0.44 0.69 1.11x10-16 0.67 
5.3.1.6 -0.07 0.74 1.00x10-20 0.64 
5.4.2.1 0.15 0.61 9.75x10-12 0.52 
5.4.2.2 0.80 0.84 2.10x10-5 0.84 
5.4.2.8 0.35 0.57 1.12x10-7 0.57 
6.2.1.1 -1.33 0.47 1.00x10-20 0.45 
6.2.1.5 0.29 0.72 1.00x10-20 0.71 
6.3.2.6 0.60 0.83 1.11x10-16 0.82 
6.3.4.4 0.64 0.79 1.00x10-20 0.80 
6.3.5.2 -0.50 0.44 1.00x10-20 0.33 
	  
The	  parameter	  y0	  represents	  the	  proportion	  of	  amino	  acids	   in	  a	  sequence	  that	  cannot	  
be	  mutated	  if	  that	  sequence	  has	  to	  retain	  its	  molecular	  function.	  If	  we	  plot	  its	  distribution	  for	  all	  
30	  enzymatic	  activities	  the	  majority	  of	  the	  density	  is	  at	  30-­‐40	  %	  sequence	  identity	  (Fig.	  2.4).	  We	  
32	  
can	   conclude	   that	   diverging	   enzymes	   require	   conservation	   of	   ~30	  %	   of	   their	   amino	   acids	   to	  
retain	  the	  same	  molecular	  function.	  
	  
Figure	  2.4.	  Distribution	  of	  model	  2	  parameter	  y0	  across	  30	  enzymatic	  functions.	  
A)	  all	  species,	  B)	  eurakyotes	  only.	  The	  parameter	  y0	  corresponds	  to	  the	  faction	  of	  residues	  that	  
will	  remain	  unchanged	  throughout	  divergence.	  The	  analysis	  was	  repeated	  comparing	  only	  pairs	  
of	   eukaryotes	   to	   discount	   any	   possible	   effect	   of	   horizontal	   gene	   transfer	   which	   is	   known	   to	  
occur	   between	   prokaryotes.	   It	   should	   be	   noted	   that	   consideration	   of	   all	   species	   allows	   us	  
survey	   long	   evolutionary	   times	   (up	   to	   4Byr)	   whereas	   the	   eukaryotic	   evolutionary	   history	   is	  
much	  shorter	  so	  it	  may	  be	  less	  accurate	  in	  simulating	  long-­‐term	  divergence	  behavior.	  
	  
The	   second	   model	   has	   one	   extra	   parameter	   compared	   to	   the	   first	   model,	   and	   it	   is	  
therefore	  more	  complex.	  Consequently	  it	  comes	  as	  no	  surprise	  that	  it	  offers	  a	  better	  fit	  to	  the	  
data.	  To	  determine	  whether	  the	  fit	  improvement	  is	  worth	  the	  cost	  of	  an	  additional	  parameter	  
we	  used	  the	  F-­‐test,	  which	  can	  be	  applied	  in	  this	  case	  because	  model	  1	  is	  nested	  in	  model	  268.	  
We	  calculated	  the	  F	  statistic	  (Eqn.	  5,	  See	  Methods)	  and	  determined	  the	  corresponding	  p-­‐value	  
for	  each	  enzymatic	  activity	  analyzed	  (Table	  2.2).	  In	  all	  but	  one	  of	  the	  cases	  the	  F-­‐test	  rejects	  the	  
hypothesis	  that	  the	  additional	  parameter	  does	  not	  contribute	  any	  additional	  information	  to	  the	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fit	   (p	   <	   0.05)	   Therefore	   we	   accept	   model	   2	   as	   a	   better	   representation	   of	   divergent	   protein	  
evolution.	  
Models	  1	  and	  2	  assume	  that	  substitution	  rates	  are	  uniform	  at	  all	  sites,	  with	  residues	  of	  
type	  A	  in	  model	  2	  having	  a	  substitution	  rate	  of	  zero.	  A	  more	  realistic	  method	  is	  to	  use	  Gamma	  
correction	   to	   model	   rate	   heterogeneity	   at	   different	   sites64-­‐66.	   The	   Gamma	   correction	   model	  
assumes	   that	   the	  substitution	   rates	  across	  all	   residues	   in	  a	   sequence	  are	  Gamma-­‐distributed.	  
The	   shape	  parameter	  α	   (Eqn.	  3)	   is	  a	  measure	  of	   substitution	   rate	  variability	  across	   sites.	  The	  
parameter	   α	  was	   determined	   empirically	   along	   with	   the	   substitution	   rate	   R0.	   The	   equation	  
relating	  evolutionary	  distance	  and	  time	  of	  divergence	  is	  as	  follows:	  















	  	   	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(3)	  
From	   figure	   2.3	   and	   the	   R2	   values	   in	   table	   2.2,	   we	   observe	   that	   models	   2	   and	   3	   are	  
approximately	   equally	   good	   at	   fitting	   the	   data.	   Notably,	   according	   to	   model	   2,	   diverging	  
enzymes	  that	  retain	  the	  same	  function	  will	  never	  reach	  5	  %	  sequence	   identity,	   the	  homology	  
level	   for	   a	   randomly	   chosen	   pair	   of	   proteins69.	   According	   to	   the	   more	   realistic	   Gamma-­‐
corrected	  model,	  it	  will	  take	  hundreds	  to	  thousands	  of	  billions	  of	  years	  (Byr)	  for	  said	  enzymes	  to	  
diverge	   to	   5	   %	   sequence	   identity	   (appendix	   2.3).	   The	   lifetime	   of	   the	   sun	   being	   of	   9	   Byr,	  
diverging	   othologues	   will	   never	   diverge	   to	   the	   level	   of	   random	   enzymes	   if	   they	   are	   to	  
continuously	   retain	   the	   same	   molecular	   function.	   Similar	   results	   were	   observed	   when	   we	  
applied	   our	   models	   to	   computationally-­‐annotated	   enzymes	   comprising	   300	   different	   EC	  
numbers	  from	  Swiss-­‐Prot70	  (fig.	  2.5).	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Figure	  2.5.	  Analysis	  of	  300	  functional	  sets	  from	  Swiss-­‐Prot.	  
A)	  Distribution	  of	  the	  goodness	  of	  fit	  for	  all	  3	  models	  across	  300	  enzymatic	  activities.	  Model	  1	  
which	   postulates	   that	   sequence	   divergence	   has	   a	   limit	   has	   the	   worst	   fit.	   Models	   2-­‐3	   show	  
equivalent	  performance.	  B)	  Distribution	  of	  y0	  parameter	  of	  model	  2	  determined	  empirically	  for	  
each	  EC	  dataset.	  The	  average	  value	  for	  y0,	  which	  corresponds	  to	  the	  percentage	  of	  amino	  acids	  
that	  have	  to	  remain	  the	  same	  for	  sequence	  to	  be	  preserved,	  is	  34.06	  ±	  0.69	  %.	  C)	  Distribution	  
across	  the	  300	  EC	  datasets	  of	  the	  time	  of	  divergence	  required	  to	  reach	  5	  %	  sequence	  identity	  
(average	  identity	  of	  unrelated	  sequences)	  between	  pairs	  or	  orthologues	  based	  on	  fits	  to	  model	  
3.	  
	  
From	   these	   observations	   we	   conclude	   that	   there	   is	   indeed	   a	   constraint	   placed	   on	  
diverging	  sequences	   to	   retain	   their	   function.	  This	  constraint	   translates	   to	  an	  effective	   limit	   to	  
sequence	  divergence.	  
	  
2.4	  HUBBLE	  LAW-­‐LIKE	  DERIVATION	  
We	  can	  express	   the	  Gamma	  correction	  model	   (model	  3)	  as	  evolutionary	  distance	  as	  a	  
function	  of	  divergence	  time.	  




                                    




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	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where	  y	  is	  the	  sequence	  identity	  between	  two	  orthologous	  enzymes,	  and	  D	  is	  the	  evolutionary	  
distance	  defined	  as	  D	  =	  1-­‐	  y.	  From	  this	  we	  can	  derive	  an	  equation	  for	  the	  rate	  of	  change	  of	  the	  
evolutionary	  distance	  with	  respect	  to	  divergence	  time.	  




∝ 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
where	  Ro	  and	  α	  are	  the	  rate	  and	  shape	  parameters	  of	  model	  3.	  
Equation	   2	   bears	   similarity	   to	   the	   Hubble	   law	   which	   relates	   the	   velocity	   v	   at	   which	  
galaxies	  recede	  from	  the	  Earth	  to	  the	  distance	  D	  between	  the	  galaxies	  and	  the	  observer.	  The	  
velocity	  corresponds	  to	  the	  derivative	  of	  D	  with	  respect	  to	  cosmological	  time	  t.	  H0	  is	  the	  Hubble	  
constant.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  !"
!"
= 𝑣 = 𝐻!𝐷	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (3)	  
In	   contrast	   to	   the	   Hubble	   law,	   which	   depicts	   a	   linear	   relationship	   between	  !"
!"
	  and	  D,	  
equation	   2	   shows	   that	  !"
!"
	  follows	   the	   power	   law.	   Therefore	   divergence	   slows	   down	   as	   the	  
evolutionary	  distance	  increases.	  
We	   can	   show	   this	   empirically	   by	   plotting	   evolutionary	   distance	   as	   a	   function	   of	  
divergence	  time	  for	  a	  given	  set,	  calculating	  !"
!"
	  at	  different	  evolutionary	  distances	  and	  compare	  
the	  fit	  of	  the	  points	  with	  equation	  2	  to	  the	  fit	  obtained	  from	  plugging	  in	  model	  3	  parameters.	  To	  
show	   that	   across	   different	   enzymatic	   functions	  !"
!"
	  slows	   down	   with	   increasing	   evolutionary	  
distance	  we	  compare	  the	  fit	  with	  equation	  2	  to	  a	  linear	  fit	  with	  the	  Akaike	  Information	  Criterion	  
(appendix	  2.4).	  In	  all	  cases	  the	  non-­‐linear	  model	  outperforms	  the	  linear	  fit	  with	  likelihood	  ratio	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>	   5.0	   (figure	   2.6,	   appendix	   2.5).	   In	   all	   cases	   the	   empirical	   data	   fits	   the	   Hubble-­‐like	   model,	  
suggesting	  that	  model	  3	   is	   the	  best	  approximation	  of	   true	  sequence	  divergence,	  and	  that	   the	  
velocity	   of	   divergence	   at	   the	   sequence	   level	   is	   increasingly	   dampened	   with	   increasing	  
evolutionary	  distance.	  In	  other	  words	  the	  more	  two	  enzymes	  are	  distant	  from	  each	  other,	  the	  
slower	   they	   diverge	   from	   each	   other.	   This	   result	   is	   consistent	   with	   our	   hypothesis	   that	  
divergent	  evolution	  of	  enzymes	  that	  must	  retain	  their	  molecular	  function	  has	  an	  effective	  limit.	  
	  
Figure	  2.6.	  Hubble-­‐like	  model	  of	  sequence	  divergence.	  
For	   all	   30	   enzymatic	   activities	   we	   plotted	   the	   pairwise	   rate	   of	   change	   of	   the	   evolutionary	  
distance	   (velocity	   of	   divergence)	   between	   pairs	   of	   enzymes	   against	   evolutionary	   distance	  
between	  the	  two	  corresponding	  species.	  The	  black	  points	  are	  empirically	  calculated	  dD/dt	  (see	  
methods).	   For	   each	   enzymatic	   function,	   to	   obtain	   the	   green	   line	   we	   plugged	   in	   the	  
corresponding	  α	   and	  R0	   parameters	   obtained	   from	   the	   gamma-­‐corrected	  model	   of	   sequence	  
divergence	   (model	   3,	   )	   into	  equation	   (2).	   The	  dotted	  blue	   line	   represents	   an	  actual	   fit	   of	   the	  




2.5	  FUNCTIONAL	  CONSTRAINTS	  ON	  THE	  EVOLUTION	  OF	  PROTEIN	  STRUCTURE	  	  
The	  next	   step	   in	   the	  analysis	  was	   to	  study	   the	  conservation	  of	  enzyme	  structures.	  For	  
this	  we	  performed	  structural	  alignments	  between	  Swiss-­‐Prot	  enzymes	  annotated	  with	   the	  30	  
EC	  numbers	  in	  table	  2.2	  and	  with	  corresponding	  atomic	  coordinates	  in	  the	  Protein	  Data	  Bank40.	  
Structures	  were	   aligned	   using	   the	   Combinatorial	   Extension	   (CE)	   algorithm67,	  which	  measures	  
the	   root	   mean	   square	   distance	   (RMSD)	   between	   C-­‐α	   atoms	   over	   the	   length	   of	   the	   aligned	  
residues.	  The	  average	  RMSD	  for	  each	  pair	  of	  organisms	  in	  our	  24	  species	  set	  was	  plotted	  against	  
their	  divergence	  time	  (Fig.	  2.7,	  panel	  A).	  
	  
Figure	  2.7.	  Structural	  divergence	  of	  enzymes	  with	  the	  same	  molecular	  function.	  
Structural	   divergence	   of	   enzymes	   with	   the	   same	   function.	   A)	   To	   investigate	   the	   extent	   of	  
structural	  divergence	  for	  enzymes	  during	  evolution	  we	  compared	  the	  RMSD	  between	  pairs	  of	  
orthologous	  enzymes	   from	  the	  enzyme	  database	  BRENDA	  to	  the	  time	  of	  divergence	  between	  
the	   corresponding	   species.	   The	   red	   line	   is	   the	   linear	   regression	   	   (p	   <	   0.05).	  B)	  Distribution	  of	  
RMSD	  values	  for	  pairs	  of	  orthologs	  used	  in	  this	  study	  (blue	  bars)	  vs.	  pairs	  of	  identical	  sequences	  





Although	  one	  would	  expect	  structural	  similarity	  between	  orthologous	  enzymes	  to	  decay	  
over	  time,	  it	  has	  been	  shown	  that	  structure	  is	  more	  robust	  to	  divergence	  than	  sequence71,72.	  As	  
shown	   in	   the	   figure,	   we	   observe	   that	   the	   structures	   of	   pairs	   of	   enzymes	   sharing	   the	   same	  
function	   do	   not	   significantly	   diverge	   as	   a	   function	   of	   time	   (Pearson	   correlation	   coefficient	  
between	  time	  and	  RMSD	  is	  0.042).	  Moreover,	  most	  structures	  are	  within	  3.5	  Å	  RMSD	  even	  after	  
~3.5	   Byr	   of	   evolution,	   which	   seems	   to	   indicate	   that	   functional	   restraints	   prevent	   structural	  
divergence	   beyond	   this	   limit.	   The	   variability	   in	   RMSD	   at	   each	   point	   is	   partly	   attributed	   to	  
expected	   differences	   in	   crystal	   structures	   (fig.	   2.7,	   panel	   B).	   Even	   for	   identical	   amino	   acid	  
sequences	  different	  crystallization	  conditions	  (e.g.	  presence	  of	   ligand,	  conformational	  change)	  
lead	  to	  average	  RMSD	  values	  of	  around	  1	  Å.	  
	   Despite	   this	   structural	   conservation	   it	   is	   apparent	   from	   the	   study	   of	   sequence	  
divergence	  that	  the	  substitution	  rates	  vary	  between	  sites	  across	  a	  sequence.	  If	  this	  is	  the	  case,	  
we	  would	  expect	   certain	   residues	   to	  be	  more	   constrained	   than	  others	   and	   therefore	   show	  a	  
higher	   conservation	   across	   long	   evolutionary	   distances.	   We	   carried	   out	   triplet	   sequence	  
alignments	   for	   the	  30	  enzymatic	   functions	   in	   this	   study	  using	   representative	   sequences	   from	  
each	  domain	  of	  life	  (Bacteria,	  Archaea	  and	  Eukarya;	  Fig.	  2.8).	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Figure	  2.8.	  Average	  pairwise	  and	  triplet	  sequence	  identity	  for	  proteins	  in	  different	  domains	  of	  
life;	  Prokarya,	  Archaea	  and	  Eukarya.	  
The	   2-­‐branch	   conservation	   bar	   (red)	   corresponds	   to	   the	   the	   average	   conserved	   sequence	  
identity	  between	  pairs	  of	  enzymes	  with	  the	  same	  molecular	  function	  but	  belonging	  to	  different	  
domains	  of	  life	  (e.g.	  eukaryote	  vs.	  archaea	  or	  bacteria	  vs.	  archaea).	  The	  3-­‐branch	  conservation	  
bar	  (blue)	  represents	  the	  average	  sequence	  identity	  between	  sets	  of	  3	  enzymes	  with	  the	  same	  
molecular	  function	  where	  one	  enzyme	  is	  bacterial,	  another	  one	  is	  archaeal	  and	  the	  third	  one	  is	  
from	   a	   eukaryotic	   genome.	  We	   observe	   significant	   conservation	   across	   all	   3	   domains	   of	   life	  
despite	  long	  times	  of	  divergence,	  consistent	  with	  the	  notion	  that	  the	  same	  set	  of	  residues	  has	  
been	  conserved	  throughout	  divergent	  evolution.	  
	  
While	  the	  sequence	  identity	  shared	  by	  sequences	  from	  all	  3	  domains	  of	  life	  is	  lower	  than	  
the	  identity	  between	  pairs	  of	  sequences	  from	  different	  domains	  (~30	  %	  vs.	  40-­‐50	  %),	   it	   is	  still	  
significantly	   higher	   than	   the	   homology	   level	   of	   unrelated	   enzymes	   (~8	   %).	   The	   fact	   that	   a	  
significant	   subset	   of	   amino	   acids	   is	   conserved	   across	   the	   3	   domains	   of	   life	   shows	   that	   the	  
mutations	   that	   do	   occur	   do	   not	   do	   so	   at	   random,	   otherwise	  we	  would	   observe	   very	   little	   3-­‐
branch	  conservation.	  The	  same	  residues	  that	  have	  to	  be	  conserved	  for	  function	  in	  bacteria	  also	  
have	   to	  be	  conserved	   for	  archaeal	  and	  eukaryotic	   species.	  This	   should	  ensure	   that	  no	  pair	  of	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diverging	  enzymes	  with	  the	  same	  molecular	  function	  should	  reach	  sequence	  homology	  levels	  of	  
unrelated	  proteins,	  no	  matter	  how	  long	  they	  have	  been	  diverging	  from	  their	  common	  ancestor.	  	  
	  
2.6	  ACTIVE	  SITE	  REGION	  CONSERVATION	  
Because	   the	   condition	   to	   maintain	   the	   same	   function	   imposes	   a	   limit	   on	   sequence	  
divergence,	   we	   hypothesize	   that	   the	   rate	   of	   amino-­‐acid	   substitution	   increases	   with	   distance	  
from	   functionally	   important	   residues73.	   To	   test	   this	   idea,	  we	   focused	  on	   enzyme	  active	   sites,	  
which	  are	  responsible	  for	  catalytic	  activity	  and	  reaction	  specificity.	  For	  our	  set	  of	  enzymes,	  the	  
active	  site	  was	  defined	  as	  the	  centroid	  of	  the	  active	  site	  residues.	  Annotations	  of	  these	  residues	  
were	   retrieved	   from	  UniprotKB	  or	   the	   PDB,	   and	   visually	   verified	  with	   the	  molecular	   graphics	  
system	  PyMOL74.	  Five-­‐angstrom	  layers	  starting	  at	  the	  active	  site	  centroid	  were	  determined	  in	  a	  
representative	  3D	  structure	  for	  each	  enzymatic	  activity	  (fig.	  2.9).	  
	  
	  
Figure	  2.9.	  Sequence	  conservation	  as	  a	  function	  of	  the	  distance	  to	  the	  active	  site.	  
Sequence	  conservation	  as	  a	  function	  of	  distance	  to	  active	  site.	  A)	  For	  illustration	  purposes	  the	  
surface	  representation	  of	  the	  T.	  maritima	  enzyme	  IMP	  dehydrogenase	  (PDB	  1VRD)	  color-­‐coded	  
for	   distance	   to	   active	   site	   is	   shown.	   B)	   This	   graph	   represents	   30	   enzymes	   of	   the	   central	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metabolism	   from	  24	  model	  organisms.	  For	  each	  enzymatic	   function	  we	  plotted	   the	  sequence	  
identity	  between	  all	  pairs	  of	   species	  against	   the	  divergence	  time	  between	  the	  species.	  C)	  We	  
plotted	   sequence	   identity	   as	   a	   function	   of	   distance	   to	   the	   active	   site	   centroid	   at	   0.25	   Byr	   of	  




Multiple	  sequence	  alignments	  were	  performed	  and	  the	  sequence	  identity	  in	  each	  layer	  
was	   determined	   as	   a	   function	   of	   divergence	   times	   between	   species	   (Fig.	   2.9).	   As	   expected,	  
sequences	   are	   more	   conserved	   around	   the	   active	   site	   than	   at	   greater	   distances.	   Also	   the	  
estimated	  rate	  of	  divergence	  R0	  was	  faster	  farther	  from	  the	  active	  site.	  Importantly,	  residues	  far	  
away	  from	  the	  active	  site	  do	  not	  diverge	  to	  the	  level	  expected	  of	  random	  enzymes,	  but	  they	  still	  
maintain	  a	  significant	  level	  of	  sequence	  identity	  (34.8	  %	  on	  average	  across	  enzymes	  for	  amino	  
acids	  in	  region	  5,	  Fig.	  2.9).	  
Enzymes	   have	   only	   a	   handful	   of	   catalytic	   residues	   in	   their	   active	   sites.	   The	   residues	  
directly	  around	  these	  amino	  acids	  form	  and	  probably	  help	  maintain	  the	  structural	   integrity	  of	  
the	   catalytic	   pocket	   to	   prevent	   steric	   clashes	   and	   accommodate	   the	   substrate.	   Therefore,	  
functional	  restrictions	  apply	  a	  greater	  pressure	  on	  sequence	  and	  structure	  conservation	  closer	  
to	  the	  active	  site,	  consistent	  with	  previous	  findings75.	  The	  first	  two	  layers	  closest	  to	  the	  active	  
site	   centroid	   contain	   fewer	   residues	   than	   the	   outer	   three;	   this	   explains	   the	   larger	   observed	  
error	  in	  the	  sequence	  identities	  of	  layers	  1	  and	  2	  (Fig.	  2.9,	  panel	  B,	  black	  and	  red	  lines).	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2.7	  DIVERGENT	  VS.	  CONVERGENT	  EVOLUTION	  
In	  1998,	  Rost	  studied	  the	  conservation	  of	  protein	  structures	  with	  divergent	  sequences	  
and	   determined	   that	   at	   low	   sequence	   identities	   (i.e.	   ≤25	   %)	   it	   is	   impossible	   to	   differentiate	  
between	  products	  of	  evolutionary	  divergence	  and	  convergence69.	   In	  other	  words,	   convergent	  
and	  divergent	  evolution	  would	  have	  reached	  equilibrium.	  Proteins	  below	  25	  %	  identity	  are	  said	  
to	  be	   in	   the	  “twilight	   zone”	  of	  protein	   space	  because	   their	  weak	  homology	   to	  other	  proteins	  
makes	   it	   impossible	   to	   trace	   evolutionary	   relationships9,76.	   To	   gain	   a	   better	   understanding	  of	  
“twilight	   zone”	   enzymes	   and	   to	   determine	   how	   stable	   protein	   structure	   is	   with	   respect	   to	  
sequence	  changes,	  all-­‐against-­‐all	   structural	  alignments	  of	  all	  enzyme	  structures	   from	  the	  PDB	  
cross-­‐listed	  in	  Swiss-­‐Prot	  with	  EC	  annotations	  were	  conducted.	  This	  set	  encompasses	  over	  150	  
enzymatic	   functions	   across	   diverse	   species.	   A	   plot	   of	   RMSD	   vs.	   sequence	   identity	   was	  
constructed	  to	  observe	  the	  density	  of	  structure	  pairs	  over	  structure	  and	  sequence	  space	  (Fig.	  
2.10,	  appendix	  2.6).	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Figure	  2.10.	  Density	  plot	  of	  RMSD	  vs.	  sequence	  identity.	  
Density	  plot	  of	  RMSD	  vs.	  sequence	  identity.	  The	  figure	  represents	  the	  density	  of	  enzyme	  pairs	  
sharing	  all	  4	  EC	  digits.	  The	  inset	  on	  the	  left	  represents	  enzyme	  pairs	  sharing	  only	  the	  first	  3	  EC	  
digits,	  and	  the	  inset	  on	  the	  right	  corresponds	  to	  random	  enzyme	  pairs.	  
	  
	  
As	   seen	   in	   figure	   2.10,	   there	   are	   two	   distinct	   high-­‐density	   areas	   that	   correspond	   to	  
enzymes	   having	   converged	   to	   the	   same	   function	   (high	   RMSD,	   low	   sequence	   identity)	   and	  
enzymes	  diverging	  from	  a	  common	  ancestor	  (low	  RMSD,	  high	  sequence	  identity).	  This	  suggests	  
that	   diverging	   orthologues	   are	   limited	   in	   their	   sequence	   and	   structural	   divergence	   and	   are	  
distinguishable	   from	   enzymes	   that	   converged	   to	   the	   same	   function.	   As	   a	   control,	   we	   only	  
considered	  pairs	  of	  enzymes	   sharing	   the	   first	  3	  EC	  digits	   (A.B.C.x)	   (fig.	  2.10,	   left	   inset).	   These	  
enzyme	   pairs	   perform	   similar	   enzymatic	   reactions	   but	   have	   distinct	   specificities.	   When	   the	  
molecular	   function	  definition	   is	   relaxed	  this	  way,	  enzyme	  pairs	  are	  free	  to	  diverge	  and	  we	  do	  
44	  
not	   observe	   a	   clear	   limit	   in	   structure	   or	   sequence,	   similar	   to	   the	   case	   of	   randomly	   chosen	  
enzyme	   pairs	   (Fig.	   2.10,	   right	   inset).	   We	   conclude	   that	   conservation	   of	   the	   same	   function,	  
defined	   by	   specific	   enzymatic	   activities	   in	   the	   EC	   nomenclature,	   restricts	   sequence	   and	  
structure	  divergence	  to	  a	  limit	  of	  20-­‐30	  %	  and	  3.5	  Å	  respectively.	  
	  
2.8	  DISCUSSION	  
We	   have	   shown	   that	   sequence	   divergence	   for	   enzymes	   sharing	   the	   same	   molecular	  
function	  has	  a	  limit.	  Enzymes	  diverging	  from	  a	  common	  ancestor	  must	  retain	  ~30	  %	  sequence	  
identity	   in	   order	   for	   function	   to	   be	   maintained.	   Also	   the	   difference	   in	   structures	   of	   same-­‐
function	   diverging	   enzymes	   is	   capped	   at	   ~3.5	   Å.	  While	   horizontal	   gene	   transfer	   (HGT)	   could	  
reduce	   the	   observed	   sequence	   divergence	   between	   orthologues,	   we	   do	   not	   expect	   a	  
substantial	  effect	  of	  HGT	  in	  our	  results.	  All	  30	  enzymes	  considered	  carry	  out	  central	  metabolic	  
functions	  and	  are	  therefore	  less	  likely	  to	  be	  transferred	  across	  widely	  diverged	  lineages77,78.	  On	  
the	  other	  hand,	  we	  observe	  a	  similar	  pattern	  of	  sequence	  divergence	  and	  similar	  limits	  for	  most	  
enzymes	  studied.	  
Our	   structural	   analysis	   shows	   that	   sequence	   divergence	   is	   heterogeneous	   across	   the	  
enzyme	  sequence,	  with	  residues	  closer	  to	  the	  catalytic	  site	  mutating	  at	  a	  slower	  rate.	  Notably,	  
we	   were	   able	   to	   develop	   a	   Hubble	   Law-­‐like	   model	   that	   is	   a	   good	   fit	   to	   the	   data,	   and	   that	  
confirms	   that	   sequence	   divergence	   slows	   down	   as	   evolutionary	   distance	   increases.	  
Consequently,	  in	  cases	  where	  global	  sequence	  identity	  between	  enzymes	  is	  low,	  examination	  of	  
residues	   close	   to	   the	   catalytic	   site	   may	   be	   useful	   for	   function	   prediction.	   These	   results	   are	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significant	  because	   the	  majority	  of	   sequenced	  enzymes	  have	   less	   than	  60	  %	  global	   sequence	  
identity	  to	  their	  closest	  homologues6,9.	  Therefore,	  the	  identified	  limit	  of	  sequence	  evolution	  has	  
important	  applications	  for	  understanding	  the	  conservation	  of	  catalytic	  functions	  and	  for	  reliably	  

























It	   is	   estimated	   that	   30-­‐50	   %	   of	   genes	   in	   a	   given	   genome	   are	   either	   un-­‐annotated,	  
improperly	   or	   incompletely	   annotated42,43,79.	   A	   big	   challenge	   of	   the	   post-­‐genomic	   era	   is	   the	  
systemic	  functional	  annotation	  of	  every	  gene	  in	  a	  genome,	  which	  in	  turn	  will	  allow	  us	  to	  further	  
our	  understanding	  of	  organisms	  as	  a	  whole.	  	  
3.1.1	  Sequence-­‐Based	  Function	  Prediction	  Methods	  
The	   most	   widely	   used	   method	   of	   protein	   functional	   prediction	   is	   through	   sequence	  
homology	  to	  functionally	  characterized	  proteins7,80-­‐82.	  In	  fact,	  about	  50	  %	  of	  all	  gene	  products	  of	  
a	   newly	   sequenced	   genome	  may	   be	   annotated	   using	   sequence	   homology	   based	   annotation	  
transfer45,83.	  The	  rationale	  behind	  this	  method	  is	  that	  homologous	  proteins	  should	  have	  related	  
functions84.	  A	  query	  sequence	  of	  unknown	  function	  is	  compared	  to	  a	  database	  of	  functionally	  
annotated	   proteins	   such	   as	   Swiss-­‐Prot70,85	   with	   BLAST2	   so	   that	   the	   annotation	   of	   the	   top	  
homologue	   is	   proposed	   as	   the	   true	   annotation	   of	   the	   query.	   However	   this	  method	   requires	  
close	   homologues	   with	   functional	   annotation.	   It	   has	   been	   demonstrate	   that	   at	   least	   60	   %	  
sequence	   identity	   is	   required	   for	   an	   accurate	   transfer	   of	   molecular	   function4,6,7.	   A	   sizeable	  
proportion	   of	   gene	   products	   fall	   in	   a	   region	   of	   low	   sequence	   homology	   to	   any	   functionally	  
annotated	   enzymes,	   the	   so-­‐called	   “twilight	   zone”9,86,	   thus	   rendering	   the	   sequence	   homology	  
method	   ineffective	   in	   those	   cases.	   Additionally,	   high	   sequence	   homology	   is	   not	   always	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synonymous	  with	   identical	   function.	   For	   instance,	   gene	   duplication	   events	   that	   are	   common	  
during	  evolution	  give	  rise	  to	  paralogues,	  that	  may	  diverge	  and	  give	  rise	  to	  new	  functions44	  (fig.	  
3.1).	  Because	  the	  two	  paralogues	  come	  from	  the	  same	  ancestor	  protein,	  they	  are	  evolutionarily	  
related	  and	  may	  share	  substantial	  sequence	  identity	  while	  having	  different	  functions12,87,88.	  For	  
these	   reasons,	   predicting	   function	   based	   solely	   on	   global	   sequence	   homology	   may	   lead	   to	  
errors	  in	  annotation3,5,7.	  
	  
Figure	  3.1.	  Orthology	  and	  paralogy.	  
Two	  proteins	  with	   sequence	   homology	  may	   be	   either	   paralogues	   or	   orthologues.	   Paralogues	  
emerge	  as	  a	  result	  of	  a	  gene	  duplication	  event	  within	  a	  single	  organism.	  One	  copy	  of	  the	  gene	  
evolves	   into	   a	   new	   function	   so	   that	   genes	   A	   and	   B	   have	   similar	   sequences	   but	   different	  
functions.	  
	  
3.1.2	  Structure-­‐Based	  Function	  Prediction	  Methods	  	  
In	   such	   cases	   one	   can	   resort	   to	   structure	   to	   help	   shed	   light	   on	   potential	   functions.	  
Indeed	  structure	  is	  much	  more	  robust	  to	  changes	  throughout	  evolution	  than	  sequence.	  In	  fact,	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two	  proteins	  with	  low	  pairwise	  sequence	  identity	  may	  have	  the	  same	  fold	  and	  their	  active	  site	  
may	   have	   the	   same	   spatial	   location,	   thus	   indicating	   some	   functional	   ties	   that	   sequence	  
homology	   alone	   could	   not	   reveal32,45.	   Structure-­‐based	   methods	   can	   be	   divided	   into	   two	  
categories.	  The	  first	  type	  operates	  by	  comparing	  the	  overall	  structure	  of	  the	  unknown	  query	  to	  
a	  database	  of	  structures	  with	  known	  functional	  annotation	  such	  as	  the	  PDB83,89,90.	  The	  second	  
type	  employs	  geometric	  analysis	  to	  identify	  active	  sites,	  either	  with	  cavity	  detection91-­‐93,	  or	  by	  
local	  structure	  homology94-­‐97.	  Subsequently,	   ligand	  docking	  approaches	  may	  be	  used	  to	  refine	  
the	   predicted	   ligand	   specificity	   of	   the	   protein	   query83,89,98.	   These	   methods	   require	   that	   the	  
uncharacterized	  protein	  query	  has	  an	  experimentally	  determined	  3D	  structure	  or	  a	  high	  quality	  
homology	  model.	   As	   a	   result	   of	   improvements	   in	   structure	   determination	   efforts	   in	   the	   past	  
decade,	  there	  are	  now	  close	  to	  80,000	  experimentally	  determined	  3D	  structure	  in	  the	  Protein	  
Data	  Bank40.	  The	  structural	  coverage	  of	  sequence	  gene	  product	  is	  still	  imperfect,	  but	  over	  time	  
such	  methods	  will	  become	  increasingly	  more	  applicable	  and	  useful.	  
	  
3.2	  MATERIALS	  AND	  METHODS	  
3.2.1	  Determination	  of	  the	  active	  site	  region	  
The	  first	  step	  is	  to	  find	  candidate	  functions	  for	  the	  uncharacterized	  query	  sequence.	  
This	   is	   done	   through	   a	  BLAST	   search	   against	   Swiss-­‐Prot.	   The	   reason	   for	   this	   is	   that	   two	  
sequences	  with	  the	  same	  molecular	  function	  are	  expected	  to	  share	  some	  level	  of	  sequence	  
homology.	  But	  because	  global	  sequence	  homology	  might	  be	  low	  we	  want	  to	  measure	  local	  
sequence	  homology,	  at	  the	  region	  surrounding	  the	  active	  site	  residues.	  To	  do	  this	  we	  need	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to	  know	   the	   structure	  of	   the	  query	  or	   the	  hit	   otherwise	  we	   cannot	  determine	   active	   site	  
region	  residues	  from	  the	  sequence	  alone.	  We	  find	  structural	  representatives	  by	  searching	  
the	  PDB	  database	  of	  experimentally	  determined	  3D	  structures.	  We	  get	  active	  site	  residue	  
annotations	  from	  the	  PDB,	  CSA	  or	  Swiss-­‐Prot.	  	  We	  define	  the	  active	  site	  region	  as	  the	  set	  of	  
all	  residues	  contained	  within	  a	  radius	  of	  8	  Å	  around	  the	  centroid	  of	  the	  catalytic	  residues	  in	  
space.	  Finally,	  we	  can	  map	  the	  region	  onto	  the	  sequence	  and	  compute	  local	  conservation	  at	  
all	  residues	  comprising	  the	  active	  site	  region.	  This	  will	  serve	  as	  input	  for	  3D-­‐GLOBUS.	  
3.2.2	  Gibbs	  sampling	  
GLOBUS	  is	  a	  method	  to	  assign	  probability	  to	  functional	  annotations;	  it	  gives	  a	  probability	  
for	   each	   possible	   assignment	   for	   a	   given	   gene.	   GLOBUS	   uses	   Gibbs	   sampling	   to	   effectively	  
sample	   from	   the	   network	   probability	   space,	   placing	   more	   emphasis	   on	   regions	   of	   high	  
likelihood.	  The	  first	  step	  in	  performing	  whole-­‐genome	  functional	  assignments	  with	  GLOBUS	  was	  
to	  build	  a	  generic	  EC	  network	  corresponding	   to	  all	  known	  enzymatic	  activities	   involving	  small	  
molecules.	   The	  nodes	  of	   the	  network	  are	   reactions,	   and	   the	  edges	   linking	  2	  nodes	   represent	  
shared	  metabolites	  (substrates	  or	  products).	  We	  used	  both	  global	  and	  local	  sequence	  homology	  
to	   initialize	   the	   network	   by	   randomly	   assigning	   every	   gene	   to	   one	   of	   its	   candidate	   locations.	  
Then,	   at	   each	   iteration	   of	   the	   Gibbs	   sampler,	   gene-­‐gene	   context	   was	   used	   to	   evaluate	   the	  
likelihood	   of	   the	   network	   assignment.	   We	   defined	   a	   fitness	   function	   to	   be	   minimized	  
throughout	  the	  sampling	  process.	  The	  overall	  fitness	  function	  was	  evaluated	  on	  the	  basis	  of	  a	  
given	  global	  assignment	  of	  metabolic	  genes.	  This	  function	  consists	  of	  different	  terms,	  each	  term	  
is	  a	  product	  of	  an	  f	  variable	  (functional	  descriptor)	  and	  a	  b	  variable	  associated	  weight	  (eqn.	  1).	  
𝐸 𝑔!,𝑔!,… ,𝑔! = −𝑏!!"!#!$%𝑓!!"!#!$% − 𝑏!"#!!"!!"𝑓!"#!!"!#$ − 𝑏!"#$%&$𝑓!"#$%&$	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−𝑏!"!"!!""#$%&"%𝑓!"!"!!""#$%&"% + 𝑏!"#!!"!!"#$%&'.𝑓!"#!!"!!"#$%&'	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
From	  the	  fitness	  function	  we	  derived	  global	  probabilities	  of	  a	  network	  assignment	  (eqn.	  
2).	  
𝑃 𝑔!,𝑔!,… ,𝑔! =
!
!
×𝑒!!(!!,!!,…,!!)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
For	  a	  step	  in	  the	  simulation	  we	  take	  a	  random	  gene,	  determine	  the	  probability	  of	  correct	  
functional	  prediction	  for	  the	  gene	  at	  all	  candidate	   locations,	  and	  assign	   it	   to	  the	   location	  that	  
affords	   best	   overall	   probability	   for	   a	   given	   network.	   We	   do	   this	   until	   convergence	   of	   gene	  
assignments,	  and	  the	  marginal	  probability	  for	  each	  gene	  corresponds	  to	  the	  number	  of	  times	  it	  
was	  successfully	  placed	  in	  a	  given	  location	  over	  the	  simulation.	  
3.2.3	  Performance	  evaluation	  
We	   evaluate	   the	   performance	   of	   the	   different	   methods	   by	   plotting	   precision-­‐recall	  
curves.	  In	  order	  to	  do	  this	  we	  first	  filter	  all	  functional	  predictions	  to	  keep	  only	  the	  best	  one	  for	  
each	   gene.	   The	   best	   prediction	   corresponds	   to	   the	   one	  with	   the	   highest	   relevant	   score	   (i.e.	  
probability	   from	   GLOBUS	   and	   3D-­‐GLOBUS,	   global	   sequence	   identity	   for	   homology-­‐based	  
function	  prediction,	  Argot2	  score,	  or	  fraction	  of	  EFICAZ	  components	  in	  agreement).	  We	  are	  left	  
with	  a	  single	  functional	  prediction	  per	  gene.	  Afterward	  for	  each	  method	  we	  want	  to	  evaluate	  
we	   rank	   the	  genes	  according	   to	   their	   respective	   score.	  To	  build	   the	  precision	   recall	   curve	  we	  
calculate	  precision	  and	  recall	  at	  different	  cutoff	  values	  of	  the	  score.	  
51	  
3.3	  INTEGRATING	  LOCAL	  SEQUENCE	  CONSERVATION	  
3.3.1	  Structural	  Coverage	  
	   Although	   several	   methods	   for	   structure-­‐based	   functional	   predictions	   have	   been	  
developed54,90,99,100,	   to	  our	   knowledge	   structural	   data	  had	  never	  been	   integrated	  before	  with	  
genomic	  context	  data	  and	  phenotypic	  data	  under	  a	  unified	  probabilistic	  framework.	  The	  main	  
advantage	  of	  using	  structural	  information	  to	  identify	  the	  molecular	  function	  of	  a	  protein	  is	  high	  
evolutionary	  conservation	  of	  structural	  residues	  responsible	  for	  specificity	  and	  catalysis.	   It	  has	  
been	   demonstrated	   that	   at	   least	   60	   %	   of	   the	   overall	   sequence	   identity	   is	   required	   for	   an	  
accurate	   transfer	  of	  molecular	   function,	   for	   example	   all	   4	   digits	   of	   EC	   classification,	   between	  
homologous	  proteins4,6.	   It	  has	  also	  been	  shown	  that	  across	  enzymes	  with	  the	  same	  molecular	  
function,	   protein	   residues	   located	   close	   to	   an	   active	   site	   remain	   highly	   conserved	   even	   after	  
billions	  of	  years	  of	  evolution33,101-­‐103.	  Our	  main	  idea	  for	  incorporating	  structural	  information	  into	  
the	  GLOBUS	  framework	  was	  to	  identify	  residues	  of	  the	  query	  sequence	  that	  are	  responsible	  for	  
ligand-­‐binding,	  specificity,	  and	  catalysis.	  Because	  it	  is	  not	  possible	  to	  determine	  which	  residues	  
are	  part	  of	  the	  active	  site	  region	  merely	  by	  looking	  at	  the	  sequence,	  this	  method	  relies	  on	  the	  
availability	  of	  a	  structure	  or	  structural	  representative,	  in	  addition	  to	  knowledge	  of	  the	  position	  
of	  the	  catalytic	  residues	  in	  the	  sequence.	  
For	  a	  query	  protein	  of	  unknown	  function	  we	  may	  observe	  two	  types	  of	  cases;	  either	  the	  
3D	   structure	   of	   the	   protein	   has	   been	   experimentally	   determined,	   or	   it	   is	   unknown.	   To	  
determine	  whether	  the	  structure	  is	  known,	  we	  compare	  the	  query	  sequence	  to	  a	  database	  of	  
sequences	   with	   experimentally	   determined	   structures,	   the	   Protein	   Data	   Bank	   (PDB)40.	   If	   the	  
query	  sequence	  has	  full	  homology	  to	  a	  sequence	  in	  the	  PDB,	  then	  the	  true	  3D	  structure	  of	  the	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query	   is	   known,	   and	   we	   can	   use	   it	   to	   determine	   which	   amino	   acids	   in	   the	   sequence	   are	  
associated	  with	  the	  active	  site.	  Conversely,	  if	  the	  query	  sequence	  has	  no	  exact	  match	  in	  the	  PDB,	  
the	  structure	  of	  the	  closest	  homologue	  in	  the	  PDB	  may	  act	  as	  a	  proxy	  for	  the	  true	  structure.	  The	  
rationale	   behind	   this	   is	   that	   structure	   remains	   strongly	   conserved	   so	   that	   proteins	  with	   very	  
diverged	   sequences	   may	   still	   share	   significant	   structural	   similarity.	   By	   the	   same	   token,	   the	  
position	  of	  the	  active	  site	  in	  the	  tertiary	  structure	  should	  also	  be	  conserved,	  even	  in	  somewhat	  
distant	  proteins.	  This	   is	   the	  case	  because	  a	  protein	  has	   to	   remain	   functional	  during	  divergent	  
evolution,	  or	  be	  eliminated	  by	  the	  laws	  of	  natural	  selection.	  Therefore,	  the	  catalytic	  region	  has	  
to	  be	  preserved	  at	  the	  structural	  level	  in	  order	  to	  continue	  accommodating	  a	  substrate,	  so	  it	  is	  
unlikely	  for	  two	  evolutionarily	  related	  enzymes	  to	  have	  very	  different	  topologies.	  Therefore,	  to	  
increase	  the	  structural	  coverage,	  it	  is	  acceptable	  to	  use	  the	  structure	  of	  the	  closest	  homologue	  
to	  the	  query	   in	  PDB	  to	   identify	  the	  position	  of	  the	  active	  site	  residues	   in	  the	  query	  sequence.	  
Because	   of	   the	   relative	   ease	   of	   purification	   and	   crystallization,	   current	   structural	   coverage	   is	  
particularly	   good	   for	   bacterial	   enzymes.	   For	   example,	   our	   calculations	   demonstrate	   that	  
currently	   in	   an	   average	   bacterial	   genome,	   over	   60	   %	   of	   metabolic	   genes	   have	   significant	  
sequence	  identity	  to	  a	  protein	  with	  a	  known	  structure	  (fig.	  3.2).	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Figure	  3.2.	  Cumulative	  structural	  coverage	  for	  microbial	  and	  Swiss-­‐Prot	  enzymes.	  
This	  plot	  shows	  the	  structural	  coverage	  when	  we	  allow	  the	  use	  of	  a	  structural	   representative	  
with	   different	   sequence	   homology	   cutoffs.	   When	   we	   BLAST	   the	   sequence	   of	   Swiss-­‐Prot	  
enzymes	  against	  the	  sequences	  in	  the	  PDB	  to	  find	  a	  representative	  structure,	  we	  see	  that	  87	  %	  
of	  Swiss-­‐Prot	  enzymes	  have	  at	  least	  30	  %	  homology	  to	  an	  enzyme	  with	  known	  structure.	  In	  the	  
case	  of	  newly	  sequenced	  bacteria,	  67	  %	  of	  enzymes	  have	  at	  least	  30	  %	  homology	  to	  an	  enzyme	  
with	   known	   structure.	   The	   percentage	   goes	   up	   to	   92	   %	   and	   86	   %	   respectively	   when	   no	  
homology	  cutoff	  is	  applied.	  
	  
Moreover,	  we	  can	   further	   increase	   the	   structural	   coverage	  of	  bacterial	   genes	   through	  
the	  use	  of	  the	  transitive	  property	  of	  structure	  conservation,	  and	  turn	  to	  remote	  homologues	  to	  
find	   the	   location	   of	   active	   site	   using	   structure104,105.	   Consider	   three	   proteins	  Q,	   I	   and	   T	   that	  
originate	  from	  a	  common	  ancestor,	  so	  that	  they	  must	  have	  significant	  structural	  similarity.	  Q	  is	  
the	  protein	  of	  interest,	  however,	  only	  T	  has	  an	  experimentally	  determined	  structure.	  Because	  of	  
long	  times	  of	  divergence,	  the	  query	  Q	  and	  target	  T	  have	  very	  low	  sequence	  homology	  therefore	  
we	  would	  not	  be	  able	  to	   identify	  them	  as	  functionally	  related	  with	  a	  simple	  BLAST	  search.	  To	  
find	  a	  structure	  for	  Q	  we	  blast	  it	  against	  Swiss-­‐Prot	  and	  find	  the	  closest	  homologue	  I,	  which	  has	  
no	  known	  structure	  as	  well.	  If	  we	  do	  a	  blast	  search	  for	  I	  against	  the	  PDB,	  we	  find	  T.	  Therefore,	  T	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and	  I	  have	  similar	  structures,	  and	  by	  transitive	  property,	  T	  and	  Q	  must	  share	  structural	  similarity	  
as	  well	  (fig.	  3.3).	  
	  
Figure	  3.3.	  Illustration	  of	  the	  transitive	  properties	  for	  structural	  homology.	  
This	  figure	  illustrates	  the	  concept	  of	  the	  transitive	  property	  of	  structure	  conservation.	  Structure	  
is	  robust	  to	  changes	  in	  sequence	  so	  that	  two	  proteins	  with	  low	  global	  sequence	  homology	  may	  
still	  have	  similar	  structures.	  In	  order	  to	  uncover	  this	  relationship,	  an	  intermediate	  protein	  with	  
significant	  homology	  to	  both	  query	  and	  target	  is	  necessary.	  
	  
In	  our	  case,	  we	  blasted	  bacterial	  query	  sequences	  against	  Swiss-­‐Prot	  to	  find	  functionally-­‐
annotated	   intermediate	  sequences	   I,	  which	  we	  subsequently	  blasted	  against	   the	  PDB,	  so	  that	  
the	  active	  site	  sequence	   identity	  could	  be	  determined	  between	  the	  unknown	  query	  and	  each	  
functionally	  characterized	  Swiss-­‐Prot	  hit.	  With	  this	  procedure,	  structural	  coverage	  of	  bacterial	  









Table	  3.1.	  Structural	  coverage	  of	  metabolic	  gene	  products	  in	  5	  species.	  
Species  
Genes w/ significant 
BLAST hit in Swiss-
Prot Enzyme Set 
Gene with structural 
representative through direct 
homology (Coverage) 
Genes with structural 
representative through 
Swiss-Prot hit (Coverage) 
S. cerevisiae  1,124 997 (88.7 %) 1,077 (95.82 %) 
B. subtilis  1,615 1,452 (89.91 %) 1,488 (92.14 %) 
E. coli 1,120 1,025 (91.52 %) 1,076 (96.07 %) 
M. tuberculosis  1,638 1,419 (86.63 %) 1,543 (94.20 %) 
S. aureus  1,084 934 (86.16 %) 1,008 (92.99 %) 
	  
3.3.2	  Localizing	  the	  active	  site	  region	  
Once	  we	  identified	  a	  structural	  representative	  for	  the	  query	  sequence	  or	  for	  the	  Swiss-­‐
Prot	  hits,	  we	  first	  found	  the	  catalytic	  residues	  of	  this	  protein	  through	  annotations	  in	  Swiss-­‐Prot,	  
the	   PDB,	   or	   the	   Catalytic	   Site	   Atlas106,107.	   As	   mentioned	   previously,	   catalytic	   residues	   only	  
account	   for	   three	   to	   five	  amino	  acids	  out	  of	   the	  whole	  enzyme	  sequence.	  However,	  we	  have	  
shown	  in	  Chapter	  2	  that	  the	  amino	  acids	  contained	  in	  a	  region	  extending	  up	  to	  10	  Å	  around	  the	  
catalytic	  residues	  are	  significantly	  more	  conserved	  than	  the	  overall	  sequence	  between	  enzymes	  
with	   the	   same	   molecular	   function.	   Spatially	   close	   residues	   are	   not	   necessarily	   close	   in	   the	  
sequence.	  Therefore	  we	  needed	  a	  structure	  to	  disambiguate	  the	  amino	  acids	  of	  the	  active	  site	  
region	  from	  the	  rest	  of	  the	  sequence.	  We	  then	  mapped	  the	  active	  site	  region	  residues	  onto	  the	  
sequence	   and	   aligned	   the	   sequence	   of	   the	   3D	   structure	   with	   the	   sequence	   of	   the	   bacterial	  
query	   and	   the	   Swiss-­‐Prot	   hits.	   For	   each	   Swiss-­‐Prot	   hit,	   we	   computed	   active	   site	   sequence	  
identity	   as	   the	   conservation	   between	   bacterial	   query	   sequence	   and	   Swiss-­‐Prot	   hit	   sequence	  
only	   at	   the	   positions	   of	   residues	   of	   the	   active	   site	   region	   (fig.	   3.4).	   The	   active	   site	   region	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sequence	   homology	   was	   then	   used,	   in	   addition	   to	   the	   overall	   sequence	   homology,	   in	   the	  
GLOBUS	  fitness	  function	  during	  Gibbs	  sampling.	  
	  
Figure	  3.4.	  Schematic	  representation	  of	  the	  function	  prediction	  method.	  
To	  make	   a	   prediction	   on	   the	   function	   of	   an	   uncharacterized	   protein	   sequence,	   we	   BLAST	   it	  
against	  the	  subset	  of	  Swiss-­‐Prot	  sequences	  with	  known	  EC	  number	  annotation.	  Then	  we	  parse	  
the	  BLAST	  hits	  so	  that	  for	  each	  candidate	  EC	  number	  we	  only	  retain	  the	  best	  hit.	  Subsequently,	  
we	  BLAST	  each	  of	  the	  retained	  hits	  against	  the	  PDB	  to	  find	  structural	  representatives	  for	  which	  
we	  known	  the	  place	  of	  the	  catalytic	  site.	  Then	  we	  determine	  the	  active	  site	  region	  residues	  and	  
map	  them	  onto	  the	  sequence	  of	  the	  structural	  representative.	  An	  triple	  alignment	  of	  the	  query,	  
the	  hit	  and	   its	   structural	   representative	  allows	  us	   to	  compute	   local	   sequence	  conservation	  at	  
the	  active	  site	  region.	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3.3.3	  Size	  of	  active	  site	  region	  
	   To	   determine	   the	   size	   of	   the	   active	   site	   region	   to	   be	   considered,	   we	   first	   studied	  
sequence	  conservation	  as	  a	  function	  of	  the	  distance	  to	  the	  active	  site.	  As	  described	  above,	  for	  a	  
given	   enzyme	  with	   known	   structure,	   the	   active	   site	   was	   represented	   by	   the	   centroid	   of	   the	  
annotated	  active	  site	  residues.	  For	  each	  of	  the	  30	  enzymatic	  functions	  introduced	  in	  Chapter	  2,	  
we	   found	   an	   experimentally	   determined	   representative	   3D	   structure	   in	   the	   PDB.	   We	   then	  
aligned	  all	  sequences	  in	  each	  of	  the	  30	  sets,	  and	  used	  the	  structure	  to	  label	  the	  positions	  in	  the	  
alignment	   with	   their	   corresponding	   distance	   to	   the	   active	   site	   centroid.	   Pairwise	   sequence	  
identity	   for	   all	   residues	   contained	   in	   regions	   2-­‐angstrom-­‐wide	   around	   the	   active	   site	   was	  
determined	   as	   a	   function	   of	   divergence	   times	   between	   species.	   Subsequently,	   the	   average	  
sequence	  conservation	  across	  the	  30	  enzymatic	  functions	  after	  4	  billion	  years	  of	  divergence	  was	  
calculated	   for	   each	   2	   Å	   bin,	   from	   0	   to	   18	   Å	   around	   the	   active	   site	   centroid	   (fig.	   3.5).	   The	  
remaining	   sequence	   identity	   at	   4	  Byr	   represents	   the	  percentage	  of	   slowly	  mutating	   residues,	  
whose	  rate	  of	  divergence	  is	  probably	  slowed	  because	  of	  the	  requirement	  to	  maintain	  function	  
(i.e.	   these	   residues	   are	   related	   to	   the	   function	   of	   the	   protein	   either	   catalytically	   or	   through	  
structural	  role).	  This	  plot	  illustrates	  that	  the	  set	  of	  all	  residues	  contained	  in	  a	  region	  up	  to	  8	  Å	  
from	  the	  active	  site	  centroid	  are	  considerably	  more	  conserved	   (≥	  40	  %)	   than	  residues	   farther	  




Figure	  3.5.	  Sequence	  identity	  after	  4	  billion	  years	  of	  divergence	  as	  a	  function	  of	  the	  distance	  
to	  the	  active	  site.	  
The	  plot	   shows	   the	  bimodal	   behavior	   of	   enzyme	   residues.	  One	   type	  of	   sites	   in	   an	   enzymatic	  
sequence	   is	   strongly	   conserved,	   and	   that	   corresponds	   to	   residues	   that	   are	  within	   8	  Å	   to	   the	  
active	  site.	  The	  other	  type	  of	  sites	  corresponding	  to	  sites	  more	  distant	  from	  the	  active	  site	  that	  
have	  more	  freedom	  to	  diverge	  without	  affecting	  molecular	  function.	  
	  
	   Subsequently,	  we	  investigated	  the	  size	  of	  the	  active	  size	  region	  in	  terms	  of	  the	  number	  
of	   residues	   for	  regions	  ranging	   from	  having	  a	  radius	  of	  3	  Å	  to	  8	  Å	  around	  the	  centroid	  of	   the	  
annotated	  catalytic	  residues	  for	  all	  fully	  annotated	  enzymes	  in	  the	  PDB	  (N	  =	  51,539).	  We	  found	  
regions	  with	  a	   radius	  of	  5	  Å	  are	  small	   in	  size	  with	  an	  average	  number	  of	   residues	   that	  barely	  
exceeds	   7.	   This	   close	   region	   is	   not	   significantly	   larger	   than	   the	   set	   of	   catalytic	   residues.	  
Therefore,	  to	  increase	  statistical	  significance	  of	  the	  computed	  local	  sequence	  conservation,	  we	  
define	   the	   active	   site	   region	   as	   being	   the	   set	   of	   all	   residues	  within	   a	   radius	   of	   8	   Å	   from	   the	  
active	  site	  centroid.	  Such	  a	  region	  contains	  about	  22	  amino	  acids	  on	  average	  (fig.	  3.6).	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Figure	  3.6.	  Average	  number	  of	  residues	  within	  a	  given	  radius	  from	  the	  active	  site.	  
Whether	  using	  a	  single	  residue	  of	  the	  catalytic	  site	  or	  the	  centroid	  of	  the	  active	  site	  residues,	  
the	   average	   number	   of	   residues	   per	   region	   at	   a	   given	   distance	   from	   the	   active	   remains	  
essentially	  the	  same.	  
	  
We	  also	  tried	  defining	  the	  active	  site	  region	  as	  any	  residue	  within	  a	  specified	  distance	  to	  
any	  of	  the	  catalytic	  residues.	  Similarly	  to	  the	  centroid	  method,	  the	  average	  number	  of	  residues	  
at	  a	  distance	  of	  8	  Å	  is	  about	  20	  (fig.	  3.6).	  
	  
3.4	  GLOBAL	  vs.	  LOCAL	  SEQUENCE	  CONSERVATION	  
	   Following	  the	  results	  shown	  above,	  we	  hypothesized	  that	   local	  sequence	  conservation	  
would	  be	  more	  informative	  than	  global	  sequence	  identity	  to	  predict	  enzyme	  function	  through	  
the	   identification	   of	   distant	   orthologs.	  We	   further	   determined	   that	   a	   region	  with	   radius	   8	  Å	  
from	  the	  active	  site	  centroid	   is	   significantly	  more	  conserved	  than	  the	  global	   sequence,	  and	   is	  
large	   enough	   to	   capture	   the	   substructure	   of	   the	   active	   site,	   which	   by	   definition	   should	   be	  
conserved.	  A	  3D	   structure	   representative	  of	   the	  query	  was	  necessary	   in	  order	   to	   localize	   the	  
60	  
residues	   of	   interest.	   Then,	   it	   was	   possible	   to	   calculate	   local	   sequence	   conservation	   at	   those	  
sites	  between	  the	  query	  sequence	  and	  its	  closest	  homologues	  as	  found	  by	  BLAST.	  
Next,	  we	  tested	  our	  hypothesis	  by	  applying	  our	  method	  to	  the	  genome-­‐wide	  EC	  number	  
annotation	  of	  an	  eukaryotic	  species,	  Saccharomyces	  cerevisiae,	  as	  well	  as	  four	  bacterial	  species,	  
Bacillus	   subtilis,	  Escherichia	   coli,	  Mycobacterium	   tuberculosis	   and	  Staphylococcus	  aureus.	   This	  
choice	  of	  organisms	  was	  made	  because	  they	  vary	  in	  size,	  complexity	  and	  extent	  of	  knowledge.	  
For	   instance,	  S.	   cerevisiae	   and	  E.	   coli	   and	  B.	   subtilis	   are	  all	  model	  organisms,	   specifically	   they	  
have	  been	  extensively	  studied	  and	  their	  metabolism	  is	  rather	  well	  understood108-­‐110.	  Conversely,	  
M.	  tuberculosis	  and	  S.	  aureus	  are	  both	  dangerous	  pathogens	  that	  necessitate	  additional	  study	  
in	   order	   to	   advance	   drug	   development	   efforts.	   For	   these	   5	   species,	   the	   structural	   coverage	  
using	  our	  method	  can	  be	  found	  in	  table	  3.1.	  Interestingly,	  even	  the	  more	  unknown	  species	  M.	  
tuberculosis	  and	  S.	  aureus	  have	  considerable	  structural	  coverage.	  Using	  the	  transitive	  property	  
of	   structural	   conservation,	   we	  were	   able	   to	   assign	   a	   representative	   structure	   to	   upwards	   of	  
90	  %	  of	  their	  predicted	  enzymes	  of	  unknown	  function,	  in	  accordance	  with	  the	  results	  shown	  in	  
figure	   3.2.	   Consequently,	   our	   method	   is	   applicable	   to	   the	   whole-­‐genome	   functional	  
characterization	  of	  a	  wide	  range	  of	  organisms.	  
Because	   the	  method	   that	   we	   propose	   is	   probabilistic	   in	   nature,	   the	   next	   step	   in	   this	  
project	   was	   to	   determine	   the	   probabilities	   associated	   with	   different	   levels	   of	   sequence	  
conservation.	   Furthermore,	   we	   had	   to	   compare	   the	   predictive	   power	   of	   local	   sequence	  
conservation	  against	   that	  of	  global	   sequence	  conservation.	  To	   investigate	   the	  effect	  of	   taking	  
into	   account	   active	   site	   region	   conservation	   for	   function	   prediction,	   we	   calculated	   the	  
probabilities	  of	  correctly	  predicting	  the	  function	  of	  all	  the	  metabolic	  genes	  in	  S.	  cerevisiae	  and	  E.	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coli	   together	   in	   one	   set	   comprising	   1,742	   genes	   in	   total.	   For	   this,	   we	   used	   functional	  
annotations	  from	  the	  well-­‐curated	  models	  of	  E.	  coli	  (iAF1260)	  and	  S.	  cerevisiae	  (iLL672)	  as	  gold	  
standards.	   We	   computed	   the	   probability	   of	   correctly	   predicting	   the	   EC	   number	   annotation	  
against	   the	   global	   sequence	   identity	   between	   uncharacterized	   query	   and	   functionally	  
annotated	  hits	  in	  Swiss-­‐Prot	  (table	  3.2).	  
	  


























In	  order	  to	  also	  consider	  local	  sequence	  conservation,	  we	  determined	  the	  probability	  of	  
correctly	  predicting	   function	  at	  different	   levels	  of	  global	   sequence	   identity,	   given	   the	   level	  of	  
local	  sequence	  conservation	  of	  the	  active	  site	  region	  (appendix	  3.1).	  Plots	  of	  the	  probability	  of	  
correct	   functional	   prediction	   against	   query-­‐hit	   global	   sequence	   conservation	   for:	   i)	   global	  
sequence	  identity	  only,	  ii)	  global	  sequence	  identity	  given	  low	  active	  site	  region	  identity	  (≤	  50	  %),	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Figure	  3.7.	  Probability	  of	  correct	  prediction	  given	  global	  sequence	  identity	  for	  Escherichia	  coli	  
and	  Saccharomyces	  cerevisiae.	  
When	  considering	  active	  site	  conservation	  instead	  of	  global	  sequence	  conservation,	  we	  obtain	  
more	  robust	  predicts	  because	  probability	  of	  correct	  prediction	  shifts	  to	  higher	  values	  compared	  
to	  global	  sequence	  identity	  alone.	  And	  conversely	  if	  the	  active	  site	  region	  is	  very	  conversely	  if	  
the	  active	  site	  region	  is	  more	  diverged	  the	  probability	  of	  correct	  prediction	  will	  shift	  downwards.	  
	  
	  
In	  this	  figure,	  we	  see	  that	  accounting	  for	  local	  sequence	  conservation	  allows	  us	  to	  shift	  
the	   probability	   of	   correct	   prediction	   higher	   if	   the	   active	   site	   region	   is	   very	   conserved,	   and	  
conversely	   if	   the	   active	   site	   region	   is	  more	   diverged.	   Consequently,	  we	   proposed	   to	   use	   this	  
additional	   source	   of	   evidence	   to	   improve	   the	   robustness	   of	   function	   prediction	   made	   with	  
GLOBUS.	  
63	  
3.5	  GLOBAL	  BIOCHEMICAL	  RECONSTRUCTION	  USING	  SAMPLING	  (GLOBUS)	  
	   It	  is	  a	  known	  fact	  that	  purely	  homology-­‐based	  methods	  are	  unreliable	  in	  the	  context	  of	  
making	  functional	  assignments	  for	  genes	  with	  very	  distant	  homologues3,4,6.	  As	  noted	  above	  (fig.	  
2.1),	   for	   a	   typical	   bacterial	   genome,	   about	   60	   %	   of	   enzymes	   have	   less	   than	   40	   %	   sequence	  
identity	   to	   a	   homologous	   enzyme	   in	   Swiss-­‐Prot.	   As	   a	   resort,	   context-­‐based	  methods	  may	   be	  
used	  to	  complement	  global	  sequence	  homology	  to	  improve	  functional	  predictions.	  In	  contrast	  
to	  sequence	  homology	  methods,	  context-­‐based	  approaches	  reveal	  information	  on	  the	  genomic	  
context	  of	  a	  gene	  of	  interest,	  thus	  drawing	  from	  evolutionary	  relationships	  between	  neighbors	  
in	   the	   genome.	   Context-­‐based	   methods	   include	   gene	   fusion,	   gene	   clustering,	   mRNA	   co-­‐
expression	  and	  phylogenetic	  profiling.	  Such	  methods	  have	  successfully	  been	  used	  in	  the	  past	  to	  
uncover	  functional	  associations,	  elucidate	  molecular	  pathways	  and	  determine	  macromolecular	  
interaction	  networks111-­‐114.	  Therefore,	  we	  postulated	  that	  combining	  sequence	  homology	  with	  
genomic	   context	   information	   under	   a	   unified	   framework	   would	   markedly	   improve	   on	  
homology-­‐based	   predictions.	   To	   this	   end,	   Global	   Biochemical	   Reconstruction	   Using	   Sampling	  
(GLOBUS)	   was	   developed	   in	   lab	   previously55.	   This	   method	   was	   shown	   to	   afford	   some	  
improvements	  over	  sequence-­‐based	  functional	  prediction	  schemes.	  
The	   goal	   of	   GLOBUS	   is	   to	   do	   probabilistic	   genome-­‐wide	   functional	   assignments	   for	  
bacterial	   genomes	   on	   the	   basis	   of	   both	   sequence	   homology	   and	   genomic	   context.	   The	  
probabilistic	   aspect	  of	   the	  method	  comes	   from	   the	   fact	   that	   functional	  predictions	  are	  made	  
computationally	   combining	   several	   sources	   of	   information;	   therefore	   there	   may	   be	   several	  
possible	  functions	  for	  a	  given	  gene.	  Defining	  probabilities	  allows	  us	  to	  propose	  the	  most	  likely	  
function	  as	  well	  as	  potential	  alternative	  functions	  for	  a	  gene	  of	  interest.	  Another	  advantage	  of	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the	  method	   is	   that	   functional	   assignments	   are	  made	   simultaneously	   for	   the	  whole	  metabolic	  
genome,	  so	  that	  predictions	  are	  evaluated	   in	  the	  context	  of	  a	  network	  (i.e.	  genes	  assigned	  to	  
neighboring	  locations	  in	  the	  generic	  metabolic	  network	  should	  have	  high	  correlation	  in	  terms	  of	  
genomic	  context).	  
3.5.1	  Sources	  of	  evidence	  
A.	  Sequence	  homology	  
The	  starting	  point	  to	  most	  functional	  annotation	  methods	  is	  a	  homology	  search	  against	  
a	  database	  of	   functionally	   characterized	  sequences,	  with	  an	  algorithm	  such	  as	  FASTA115,116	  or	  
BLAST2,117,118.	   This	   procedure	   returns	   a	   number	   of	   hits	   which,	   depending	   on	   their	   degree	   of	  
sequence	   identity	   to	   the	  query	  sequence,	  are	  more	  or	   less	   likely	   to	  share	   the	   function	  of	   the	  
query.	  Therefore,	  sequence	  homology	  is	  useful	  to	  decrease	  the	  scope	  of	  candidate	  functions	  for	  
a	   given	   query	   sequence.	   However,	   sequence	   homology	   alone	  may	   not	   be	   sufficient	   to	  make	  
reliably	   assign	   functional	   annotations	   to	   query	   sequences.	   For	   that	   reason,	   it	   is	   necessary	   to	  
take	  into	  consideration	  another	  source	  of	  evidence	  that	  would	  help	  elucidate	  the	  true	  function	  
of	   the	   query.	   Such	   a	   method	   should	   not	   be	   sequence-­‐based,	   so	   that	   it	   may	   afford	  
complementary	  information	  that	  is	  not	  sequence	  homology	  cannot	  reveal.	  
B.	  Genomic	  context	  
	   Gene	   context	   information	   is	   not	   based	   on	   sequence	   homology,	   and	   therefore	   it	   is	   a	  
suitable	   choice	   of	   complementary	   evidence	   for	   function	   prediction.	   Gene	   context	   reveals	  
functional	  relationships	  between	  genes	  through	  patterns	  of	  co-­‐regulation	  and	  co-­‐evolution.	  In	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GLOBUS,	   three	   types	   of	   genomic	   context	  methods	   are	   applied;	   gene	   clustering,	   phylogenetic	  
correlation	  and	  mRNA	  co-­‐expression.	  
Gene	  clustering	  corresponds	  to	  the	  tendency	  of	  genes	  with	  related	  functions	  to	  cluster	  
together	   in	  the	  genome.	  This	   is	  very	  common	  in	  bacterial	  genomes	  where	  sets	  of	  functionally	  
related	   genes	   form	   operons.	   The	   spatial	   clustering	   can	   be	   explained	   by	   the	   fact	   that	   such	  
functional	   clusters	  need	   to	  be	   simultaneously	   induced	  or	   repressed,	  and	  are	   likely	   to	   share	  a	  
promoter119.	   Here	   we	   measured	   gene	   clustering	   by	   ranking	   the	   genes	   for	   a	   given	   genome	  
according	  to	  their	  order	  in	  genome,	  and	  we	  calculated	  the	  gene	  order	  difference	  between	  pairs	  
of	  genes	  (see	  methods).	  The	  null	  hypothesis	  states	  that	  genes	  are	  randomly	  distributed	  across	  
the	   chromosomes.	   The	   smaller	   the	   gene	   order	   distance,	   the	   higher	   the	   gene	   clustering	  
correlation	  coefficient.	  	  
	   Similarly,	  genes	  that	  are	  functionally	  related	  (e.g.	  parts	  of	  the	  same	  pathway)	  will	  tend	  
to	  have	  highly	   correlated	  phylogenetic	  profiles.	   Specifically,	   two	  genes	  with	   related	   functions	  
will	  tend	  to	  either	  coexist	  or	  both	  be	  absent	  across	  different	  genomes.	  The	  phylogenetic	  profile	  
of	  a	  given	  gene	  is	  a	  binary	  vector	  of	  length	  N,	  where	  n	  is	  a	  number	  of	  genomes	  that	  may	  or	  may	  
not	  contain	  an	  orthologue	  of	  the	  query.	  For	  example,	  the	  ith	  element	  (i	  ∈	  [1,N])	  of	  the	  vector	  is	  
either	   1	   if	   an	   orthologue	   of	   the	   query	   exists	   in	   genome	  Gi,	   or	   0	   if	   the	   opposite	   is	   true.	  We	  
determine	  the	  similarity	  of	  phylogenetic	  profiles	  of	  two	  genes	  by	  calculating	  the	  probability	  of	  
observing	  these	  profiles	  using	  the	  hypergeometric	  distribution.	  
Finally,	   the	   third	   genomic	   context	   method	   used	   in	   GLOBUS,	   mRNA	   co-­‐expression,	  
corresponds	  to	  whether	  pairs	  of	  genes	  have	  similar	  expression	  levels	  across	  different	  genomes	  
and	   different	   conditions.	   The	   rationale	   for	   this	   method	   is	   that	   if	   one	   gene	   is	   up-­‐	   or	   down-­‐
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regulated	  as	  a	   result	  of	   a	   specific	   stimulus,	   genes	   that	  are	  part	  of	   the	   same	   functional	   group	  
should	  react	  in	  the	  same	  way.	  For	  each	  condition	  and	  genome,	  the	  genes	  are	  ranked	  according	  
to	   their	   level	  of	  expression.	  We	  compute	   the	  mRNA	  expression	  correlation	  by	  comparing	   the	  
ranks	  of	  gene	  pairs	  with	  a	  Spearman’s	  rank	  correlation.	  
3.5.2	  The	  generic	  metabolic	  network	  
	   We	   defined	   a	   generic	   metabolic	   network	   containing	   the	   enzymatic	   activities	   of	   the	  
Enzyme	  Commission	  system,	  which	  involve	  small	  molecule	  substrates.	  We	  could	  then	  use	  this	  
generic	  network	  as	  a	  starting	  point	  to	  build	  organism-­‐specific	  metabolic	  networks.	  All	  nodes	  of	  
the	  network	  are	  enzymatic	  activities	  (i.e.	  EC	  numbers),	  and	  the	  edges	  connecting	  two	  nodes	  are	  
shared	   metabolites	   between	   these	   two	   activities	   (i.e.	   the	   product	   of	   one	   reaction	   is	   the	  
substrate	   of	   another).	   We	   disregarded	   any	   activity	   that	   did	   not	   involve	   a	   small	   molecule	  
substrate;	  for	  example	  “RNA	  polymerase”	  or	  “protein	  phosphatase”	  were	  not	  made	  part	  of	  the	  
generic	   network.	  We	   also	   removed	   all	   edges	   based	   on	   the	   top	   40	  most	   common	   ligands	   or	  
cofactors	   such	   as	   H2O	   and	   ATP	   because	   they	   are	   likely	   to	   be	   common	   to	   many	   different	  
reactions	   which	   do	   not	   necessarily	   have	   a	   similar	   function.	   The	   resulting	   generic	   network	  
includes	   4049	   enzymatic	   activities.	   The	   distribution	   of	   Enzyme	   Commission	   system	   classes	  
represented	  in	  the	  generic	  network	  is	  shown	  in	  table	  3.3,	  and	  it	  is	  similar	  to	  the	  distribution	  of	  















3.5.3	  The	  fitness	  function	  
	   The	  next	  step	  was	  to	  reconstruct	  the	  metabolic	  network	  for	  a	  given	  genome	  by	  finding	  
the	  highest	  probability	   location	  of	  every	  gene	   in	   the	  generic	  network.	   In	  order	   to	  do	   this,	  we	  
used	   Gibbs	   sampling	   to	   sample	   from	   all	   candidate	   locations	   for	   every	   gene.	   We	   defined	   a	  
Markov-­‐like	  fitness	  function	  (eqn.	  1)	  that	  we	  minimized	  in	  order	  to	  find	  the	  best	  solution	  to	  the	  
network	  reconstruction	  problem.	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−𝑏!"!"!!""#$%&"%𝑓!"!"!!""#$%&"% + 𝑏!"#!!"!!"#$%&'.𝑓!"#!!"!!"#$%&'	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
	  
where	   𝑔!,𝑔!,… ,𝑔! 	  are	  all	  the	  genes	  in	  a	  given	  network,	  f	  variables	  represent	  homology	  and	  
context-­‐based	   functional	   descriptors	   and	   b	   constants	   are	   the	   weights	   associated	   with	   these	  
descriptors.	  We	   used	   two	   descriptors	   for	   homology.	   The	   first	   one	   corresponds	   to	   the	   global	  
sequence	  identity	  to	  the	  best	  hit	   in	  Swiss-­‐Prot	  with	  a	  given	  functional	  annotation.	  The	  second	  
homology-­‐based	  descriptor	   is	   binary,	   and	   its	   value	   is	   1	   if	   an	  orthologue	   in	   another	   species	   is	  
annotated	  with	  that	  same	  enzymatic	  activity.	  We	  used	  three	  context-­‐based	  descriptors:	  gene-­‐
clustering,	  phylogenetic	  profile	  and	  mRNA	  co-­‐expession	  of	  a	  given	  gene	  and	  genes	  assigned	  at	  
neighboring	  positions	   in	   the	  network.	  We	  also	  accounted	   for	   the	  possibility	   that	   a	   gene	  with	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very	  low	  homology	  to	  any	  Swiss-­‐Prot	  enzyme	  or	  low	  context	  correlation	  to	  any	  location	  may	  not	  
be	  in	  the	  network	  with	  the	  𝑏!"#!!"!!"#$%&'𝑓!"#!!"!!"#$%&'	  term.	  From	  the	  fitness	  function	  we	  
derived	  an	  equation	  for	  the	  probability	  of	  a	  given	  whole-­‐network	  functional	  assignment	  (eqn.	  2).	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  (2)	  
	  
where	  Z	  is	  a	  normalizing	  partition	  factor	  to	  ensure	  that	  the	  probabilities	  sum	  to	  1.	  
3.5.4	  Gibbs	  sampling	  
We	  used	  Gibbs	   Sampling,	   a	   version	  of	  Markov	  Chain	  Monte	  Carlo,	   to	   sample	   from	  all	  
possible	  functional	  assignments	  for	  every	  gene	  proportionally	  to	  their	  likelihood.	  Our	  goal	  was	  
to	  find	  an	  optimized	  set	  of	  parameters	  that	  maximizes	  the	  probability	  of	  the	  overall	  network	  (i.e.	  
minimizes	  the	  fitness	  function).	  This	  is	  a	  vast	  combinatorial	  problem;	  however,	  we	  reduced	  the	  
sampling	  space	  by	  restricting	  candidate	  locations	  for	  a	  given	  gene	  to	  the	  activities	  of	  its	  closest	  
BLAST	   hits	   in	   Swiss-­‐Prot.	   Also,	   the	   pre-­‐computed	   probabilities	   of	   a	   gene	   having	   a	   certain	  
function	   given	   each	   descriptor	   allowed	   us	   to	   concentrate	   the	   search	   on	   higher	   probability	  
candidate	  functions.	  
The	   process	   of	   Gibbs	   sampling	   starts	   by	   assigning	   every	   gene	   to	   one	   of	   its	   candidate	  
locations	   at	   random.	   Candidate	   locations	   correspond	   to	   the	   enzymatic	   activities	   of	   the	  
homologues	   in	   Swiss-­‐Prot.	   At	   each	   step	   a	   gene	   is	   placed	   at	   random	   at	   one	   of	   its	   candidate	  
locations	  and	  we	  then	  evaluate	  the	  fitness	  function	  (fig	  3.8).	  GLOBUS	  allows	  us	  to	  only	  sample	  
the	  regions	  of	  highest	  likelihood	  with	  Gibbs	  sampling	  because	  only	  the	  function	  of	  enzymes	  that	  
are	  homologous	   to	  a	  query	  sequence	  will	  be	  considered	  as	  candidate	   functions.	  That	   is,	  each	  
gene	  can	  only	  be	  assigned	  to	  a	  limited	  number	  of	  sites	  in	  the	  network.	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Figure	  3.8.	  Illustration	  of	  GLOBUS.	  
A)	  We	  define	  a	  generic	  metabolic	  network	  where	  the	  nodes	  represent	  metabolic	  activities	  (i.e.	  
reactions),	  and	  the	  edges	  represent	  shared	  metabolites	  between	  two	  reactions.	  B)	  For	  a	  given	  
genome,	  we	  assign	  gene	  products	  to	  locations	  in	  the	  generic	  network	  using	  Gibbs	  sampling.	  We	  
use	  sequence	  homology	  to	  identify	  candidate	  locations	  in	  the	  network	  for	  all	  genes.	  Then,	  we	  
use	   gene-­‐gene	   context	   correlations	   to	   evaluate	  whole-­‐genome	  metabolic	   assignments	  with	   a	  
fitness	  function.	  The	  output	  of	  this	  process	  is	  a	  set	  of	  probabilities	  that	  a	  gene	  belongs	  in	  any	  of	  
its	  possible	  location	  corresponding	  to	  the	  fraction	  of	  times	  the	  gene	  was	  successfully	  placed	  at	  
each	  location	  during	  the	  simulation.	  
	  
We	  learn	  the	  set	  of	  parameters	  (or	  weights)	  that	  should	  be	  assigned	  to	  each	  descriptor	  
to	   optimize	   probabilities	   of	   correct	   functional	   assignments	   by	   training	   on	   a	   well-­‐annotated	  
metabolic	  network	  (e.g.	  S.	  cerevisiae	  iLL672,	  E.	  coli	  iAF1260,	  see	  appendix	  3.2).	  This	  optimal	  set	  
of	  parameters	  could	  then	  be	  applied	  to	  the	  reconstruction	  of	  any	  bacterial	  genome.	  
	   	  
3.6	  STRUCTURAL	  GLOBUS	  (3D-­‐GLOBUS)	  
	   We	  could	  integrate	  the	  structural	  component	  to	  GLOBUS	  in	  one	  of	  two	  ways.	  This	  could	  
either	  be	  achieved	  by	  adding	  an	  additional	  term	  to	  the	  objective	  function	  that	  corresponds	  to	  
active	  site	  region	  conservation,	  or	  by	  combining	  global	  and	  local	  sequence	  conservation	  into	  a	  
single	  term.	  Then	  we	  could	  re-­‐train	  on	  a	  well-­‐annotated	  genome	  in	  order	  to	  learn	  a	  new	  set	  of	  
weights	   optimized	   for	   each	   source	   of	   evidence	   (i.e.	   global	   and	   local	   homology,	   genomic	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context).	  We	  opted	   to	  define	  a	   single	   sequence	  conservation	   term	  encompassing	  both	  global	  
and	  local	  sequence	  homology.	  To	  that	  end,	  we	  computed	  the	  probability	  of	  correct	  functional	  
prediction	   at	   a	   certain	   global	   sequence	   conservation	   level,	   given	   the	   local	   sequence	   identity	  
score	  (appendix	  3.1).	  We	  then	  proceeded	  to	  compare	  the	  performance	  of	  3D-­‐GLOBUS	  with	  the	  
performance	  of	  GLOBUS,	  and	  of	  global	  sequence	  conservation	  alone.	  
	   We	   applied	   3D-­‐GLOBUS,	   GLOBUS	   and	   global	   sequence	   homology	   to	   assign	   functional	  
annotations	   to	   the	   gene	   products	   of	   B.	   subtilis,	   E.	   coli,	  M.	   tuberculosis,	   S.	   cerevisiae	   and	   S.	  
aureus.	   In	  order	   to	  compare	  the	  performance	  of	   these	  different	  methods,	   for	  any	  given	  gene	  
we	  only	  retained	  the	  functional	  annotation	  with	  the	  highest	  score	  (probability	  for	  GLOBUS	  and	  
3D-­‐GLOBUS;	  global	  sequence	  identity	  for	  the	  global	  sequence	  homology	  method).	  Subsequently,	  
for	  each	  method	  we	  ranked	  all	  the	  genes	  from	  the	  five	  species	  listed	  above	  according	  to	  their	  
score.	  Next,	  we	  made	  precision-­‐recall	  curves	  for	  all	  three	  methods	  (fig.	  3.9).	  
	  
	  
Figure	  3.9.	  Precision	  and	  recall	  performance	  for	  5	  species.	  
Using	  known	  annotations	  of	  metabolic	  genes	  for	  S.	  cerevisiae,	  B.	  subtilis,	  E.	  coli,	  M.	  tuberculosis	  
and	  S.	  aureus,	  we	  compared	  the	  performance	  of	  sequence	  homology,	  GLOBUS	  and	  3D-­‐GLOBUS	  
in	   prediction	   function.	   Precision	   and	   recall	   was	   computed	   at	   different	   thresholds	   of	   correct	  
prediction	   probability.	   For	   gene	   products	   with	   less	   than	   40	   %	   sequence	   identity	   to	   known	  
proteins,	  A)	   fraction	   increase	   in	  precision	  at	   set	   recall	   for	   3D-­‐GLOBUS	   relative	   to	  GLOBUS.	  B)	  




We	   found	   that	   across	   all	   5	   species,	   the	   information	   added	   by	   local	   sequence	  
conservation	   improves	  both	  precision	  and	   recall.	   This	   improvement	   is	   even	  more	  marked	   for	  
the	   functional	  prediction	  of	  genes	  with	   low	  sequence	  homology	   to	  all	   characterized	  enzymes	  
(fig.	  3.9,	  D,	  E,	  F).	  Both	  GLOBUS	   (red	   line)	  and	  3D-­‐GLOBUS	   (green	   line)	  performed	  significantly	  
better	  than	  the	  sequence	  homology	  method	  (blue	  line).	  3D-­‐GLOBUS	  also	  shows	  an	  increase	  in	  
precision	   and	   recall	   compared	   to	   GLOBUS.	   	   The	   improvement	   in	   precision	   and	   recall	   of	   3D-­‐
GLOBUS	  over	  GLOBUS	   is	   particularly	   observable	   for	   genes	  with	   less	   than	  40	  %	   to	   the	   closest	  
homologue	  in	  Swiss-­‐Prot.	  For	  this	  subset,	  3D-­‐GLOBUS	  shows	  a	  36	  %	  increase	  in	  precision	  over	  
GLOBUS	  (precision	  of	  0.6	  and	  0.44).	  Similarly,	  we	  observe	  a	  40	  %	  increase	  in	  recall	  over	  GLOBUS	  
(recall	  of	  0.35	  and	  0.25	  respectively).	  These	  results	  are	  exciting	  because	  as	  mentioned	  above,	  
the	   majority	   of	   newly	   sequenced	   bacterial	   gene	   products	   fall	   in	   that	   region	   of	   low	   global	  
sequence	   homology	   to	   any	   functionally-­‐characterized	   protein.	   Therefore,	   3D-­‐GLOBUS	   is	   a	  
useful	   tool	   for	   the	   genome-­‐wide	   functional	   annotation	   of	   bacterial	   species.	   Comparing	   the	  
precision	  of	  predictions	  made	  with	  3D-­‐GLOBUS	   (red	   line)	  and	  GLOBUS	   (blue	   line)	  at	  different	  
probability	   scores	   shows	   that	   3D-­‐GLOBUS	   has	   better	   precision,	   especially	   at	   lower	   values	   of	  
correct	   functional	   assignment	   probability	   (fig.	   3.9,	   A).	   Similarly,	   3D-­‐GLOBUS	   displays	   better	  
recall	  than	  GLOBUS	  at	  a	  given	  probability	  score	  (fig.	  3.9,	  B).	  We	  can	  infer	  from	  these	  results	  that	  
the	  addition	  of	  a	  structural	  component	  to	  GLOBUS	  allows	  incorrect	  predictions	  to	  be	  shifted	  to	  
lower	   probabilities	   (hence	   the	   improved	   precision).	   Likewise,	   accounting	   for	   local	   sequence	  
conservation	   shifts	   correct	   predictions	   to	   higher	   probabilities	   so	   that	   3D-­‐GLOBUS	   recall	   is	  





Figure	  3.10.	  Precision	  and	  recall	  vs.	  probability	  for	  5	  species.	  
For	   the	   known	   genes	   of	   S.	   cerevisiae,	   B.	   subtilis,	   E.	   coli,	  M.	   tuberculosis	   and	   S.	   aureus,	   we	  
determined	  A)the	  precision	  of	  functional	  prediction	  as	  a	  function	  of	  probability,	  and	  B)the	  recall	  
of	  known	  genes	  as	  a	  function	  of	  probability.	  The	  probabilities	  are	  from	  GLOBUS	  (blue	  line)	  and	  
3D-­‐GLOBUS	  (red	  line)	  functional	  assignments.	  
	  
	   We	   showed	   that	   taking	   into	   account	   local	   sequence	   conservation	   via	   the	   use	   of	   a	  
structural	   template	   to	   identify	   active	   site	   location	   adds	   information	   that	   allows	   us	   to	   make	  
robust	   functional	   predictions.	   3D-­‐GLOBUS	   performs	   remarkably	   better	   than	   sequence-­‐based	  
homology	   methods	   when	   no	   close	   homologue	   can	   be	   found	   in	   Swiss-­‐Prot.	   3D-­‐GLOBUS	   also	  
performs	  significantly	  better	  than	  GLOBUS	  for	  genes	  with	  less	  than	  40	  %	  sequence	  identity	  to	  a	  
homologue	   in	   Swiss-­‐Prot.	   These	   results	   are	   significant	   because	   they	   validate	   the	   use	   of	   3D-­‐
GLOBUS	  for	  the	  genome-­‐wide	  functional	  annotation	  of	  bacterial	  metabolic	  genes.	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3.7	  COMPARISON	  TO	  OTHER	  METHODS	  
	   After	   querying	   the	   performance	   of	   3D-­‐GLOBUS	   in	   the	   prediction	   of	   enzyme	   function	  
using	   global/local	   and	   gene	   context	   information,	   we	   were	   interested	   in	   comparing	   this	  
performance	  to	  that	  of	  other	  automated	  protein	  annotation	  systems.	  We	  turned	  to	  the	  Critical	  
Assessment	   of	   Functional	   Annotation	   (CAFA)	   Challenge	   that	   was	   first	   held	   from	   September	  
2010	  to	  December	  2011120	  to	  select	  state	  of	  the	  art	  algorithms	  to	  compare	  to	  3D-­‐GLOBUS.	  	  In	  
this	   experiment,	   the	   participants	   were	   tasked	   with	   predicting	   Gene	   Ontology	   (GO)	   term	  
annotations	   for	   48,298	   uncharacterized	   sequences.	   A	   time	   lapse	   of	   11	  months	  was	   given	   to	  
allow	  accumulation	  of	  experimental	  functional	  annotations	  for	  some	  of	  these	  proteins.	  At	  the	  
end	   of	   this	   delay,	   866	   proteins	   from	   11	   species	   (A.	   thaliana,	   S.	   pneumonia,	   S.	   cerevisiae,	   X.	  
laevis,	  H.	  sapiens,	  M.	  musculus,	  R.	  norvegicus,	  D.	  discoideum,	  P.	  aeruginosa	  and	  E.	  coli	  K-­‐12)	  had	  
been	   functionally	   annotated.	   This	   was	   the	   basis	   for	   a	   target	   set	   on	   which	   all	   54	   submitted	  
algorithms	  were	   evaluated.	   This	   set	  was	   analyzed	   to	   reduce	   bias	   in	   terms	   of	   taxonomic	   and	  
functional	  coverage.	  The	  methods	  predicted	  both	  Molecular	  Function	  and	  Biological	  Processes	  
GO	   terms	  and	   they	  were	  evaluated	  on	   their	  ability	   to	  predict	  both	   functional	   categories.	  The	  
submitted	  algorithms	  were	   ranked	  according	   to	   the	  F-­‐measure	   (F-­‐max)	  which	  corresponds	   to	  
the	  maximum	  harmonic	  mean	  of	  precision	  and	  recall	  over	  the	  full	  range	  of	  sensitivity	  (eqn.	  1).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝐹!"# = max!
!.!" ! .!"(!)
!" ! !!"(!)
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
where	  pr(t)	  is	  	  the	  precision	  and	  rc(t)	  is	  the	  recall	  at	  a	  fixed	  threshold	  t.	  Molecular	  Function	  GO	  
terms	  map	  relatively	  well	  to	  EC	  numbers	  so	  that	  we	  were	  interested	  in	  the	  methods	  that	  scored	  
the	  best	  in	  predicting	  Molecular	  Function.	  The	  best	  performing	  method	  with	  a	  freely	  available	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algorithm	  is	  Argot2	  with	  Fmax	  =	  0.59.	  The	  specifics	  of	  this	  method	  are	  described	  in	  the	  following	  
section.	  
3.7.1	  Argot2	  	  
	   Argot2	   is	   a	   web	   server	   for	   functional	   annotation	   of	   a	   single	   or	   multiple	   genes.	   It	  
performs	  functional	  prediction	  by	  clustering	  the	  GO	  terms	  assigned	  to	  the	  best	  BLAST	  hits	  on	  
the	   basis	   of	   semantic	   similarities121.	   Furthermore,	   larger	   weights	   are	   given	   to	   the	   GO	   terms	  
associated	  with	   better	   hits	   (i.e.	   closer	   homologues	   to	   the	   query	   at	   the	   sequence	   level).	   The	  
method	  outputs	  a	  total	  score	  for	  each	  candidate	   location	  based	  on	   information	  content	  (how	  
specific	   is	  the	  GO	  term)	  and	  GO	  term	  weight	  (how	  often	  it	  occurs	  across	  BLAST	  hits).	  Because	  
Argot2	  maps	   to	   GO	   terms,	   and	   GO	   terms	  map	   to	   just	   under	   3,700	   distinct	   EC	   numbers,	   the	  
coverage	   of	   enzymatic	   functions	   by	   Argot2	   is	   lower	   than	   3D-­‐GLOBUS	   (4,049	   EC	   numbers).	  
Furthermore,	   in	  contrast	  to	  GLOBUS,	  functional	  assignments	  are	  made	  discrete	  as	  opposed	  to	  
genome-­‐wide.	   That	   is,	   the	   functional	   assignment	   of	   a	   given	   gene	   is	   not	   affected	   by	   the	  
functional	  assignment	  of	  other	  genes.	  	  
3.7.2	  EFICAZ:	  Enzyme	  function	  inference	  by	  a	  combined	  	  approach	  
	   EFICAz2.5	   is	  another	  computational	  function	  prediction	  method	  that	  extracts	  sequence-­‐
related	  features	  to	  predict	  protein	  function.	  It	  combines	  predictions	  from	  6	  different	  sequence-­‐
related	  feature;	  family-­‐specific	  functionally	  discriminating	  residues	  (FDRs),	  family-­‐specific	  global	  
sequence	   identity	  threshold,	  PROSITE	  patterns,	  enzyme	  family	  classification	  by	  support	  vector	  
machine	   (SVM),	   and	   PFAM	   classification	   by	   SVM54,122.	   EFICAz2.5	   predicts	   3-­‐digit	   or	   4-­‐digit	   EC	  
number	  for	  a	  query	  sequence.	  The	  consensus	  prediction	  across	  6	  components	  is	  the	  one	  that	  is	  
75	  
accepted	  since	  there	  is	  no	  integrative	  score.	  EFICAz	  has	  the	  lowest	  EC	  number	  coverage	  since	  it	  
is	  currently	  able	  to	  recognize	  2,757	  distinct	  EC	  numbers.	  
3.7.3	  Comparison	  of	  Argot2	  and	  EFICAZ2.5	  to	  3D-­‐GLOBUS	  
The	  performance	  of	  Argot2,	  EFICAZ2.5,	  3D-­‐GLOBUS	  was	  evaluated	  and	  compared	   in	  the	  
task	   of	   predicting	   function	   of	   B.	   subtilis	   (curated	   genome)	   and	  M.	   tuberculosis	   (less	   know	  
genome)	  enzymes.	  Then,	  the	  precision	  and	  recall	  for	  both	  E.	  coli	  and	  M.	  tuberculosis	  enzymatic	  
genomes	  was	  determined.	  As	  can	  be	  seen	   in	   figure	  3.11	   (A	  and	  B),	  3D-­‐GLOBUS	  performs	   the	  
best	   in	   the	  genome-­‐wide	   functional	  assignment	  of	  both	  genomes.	  Looking	  at	   the	  precision	  at	  
set	  recall	  (fig.	  3.11,	  C	  and	  E)	  and	  recall	  at	  set	  precision	  (fig.	  3.11,	  D	  and	  F),	  we	  find	  that	  the	  3D-­‐
GLOBUS	  outperforms	   the	  other	  methods	  more	  strikingly	  when	  considering	  enzymes	  with	   less	  
than	   40	  %	   sequence	   homology	   to	   any	   functionally	   characterized	   sequence.	   This	   is	   significant	  
because	   the	   majority	   of	   bacterial	   sequences	   uncovered	   by	   metagenomic	   studies	   fall	   in	   that	  
category.	   Argot2	   predicts	   GO	   term	   instead	   of	   EC	   number,	   and	   even	   though	   it	   is	   a	   more	  
sophisticated	   method	   than	   global	   sequence	   identity	   alone,	   it	   is	   based	   on	   BLAST	   sequence	  
homology	   results,	   so	   this	   can	   explain	   why	   Argot2	   performs	   worse	   than	   3D-­‐GLOBUS.	   As	   for	  
EFICAz2.5	   it	   has	   lower	   coverage	   of	   EC	   numbers	   (30%	   less	   EC	   numbers	   than	   GLOBUS).	   Also,	  
neither	   Argot2	   nor	   EFICAz2.5	   perform	   whole	   genome	   functional	   assignments.	   In	   addition	   to	  
having	  more	  sources	  of	  evidence	  for	  functional	  prediction	  than	  the	  other	  methods,	  3D-­‐GLOBUS	  
also	  has	   increased	  accuracy	  of	  prediction	  due	   to	   the	   fact	   that	  all	  predictions	  are	   taken	   in	   the	  
context	  of	  a	  network,	  and	  the	  whole	  network	  is	  optimized	  in	  the	  final	  solution.	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Figure	  3.11.	  Comparison	  of	  the	  performance	  of	  3D-­‐GLOBUS,	  Argot2	  and	  EFICAz2.5.	  
The	   proteome	   of	   E.	   coli	   and	   M.	   tuberculosis	   was	   submitted	   for	   genome-­‐wide	   functional	  
assignment	  using,	  3D-­‐GLOBUS,	  global	  sequence	  homology,	  Argot2	  and	  EFICAz2.5.	  Precision-­‐recall	  
curves	  were	  built	   for	  each	  method	   in	  order	  to	  compare	  their	  performance.	  A)	  Precision-­‐recall	  
curves	   for	  B.	   subtilis	   functional	   assignments.	   B)	   Precision-­‐recall	   for	  M.	   tuberculosis	   functional	  
assignments.	   C)	   Precision	   at	   90%	   Recall	   for	   the	   B.	   subtilis	   genome	   as	   a	   function	   of	   global	  
sequence	  identity	  to	  the	  best	  BLAST	  hit.	  D)	  Recall	  at	  70%	  Precision	  for	  the	  B.	  subtilis	  genome	  as	  
a	  function	  of	  global	  sequence	  identity	  to	  the	  best	  BLAST	  hit.	  E)	  Precision	  at	  90%	  Recall	  for	  the	  M.	  
tuberculosis	  genome	  as	  a	  function	  of	  global	  sequence	  identity	  to	  the	  best	  BLAST	  hit.	  F)	  Recall	  at	  
70%	  Precision	  for	  the	  M.	  tuberculosis	  genome	  as	  a	  function	  of	  global	  sequence	  identity	  to	  the	  
best	  BLAST	  hit.	  
	  
3.8	  DISCUSSION	  
Current	   computational	   methods	   for	   functional	   prediction	   have	   limitations,	   especially	  
when	   considering	   enzymes	   that	   have	   very	   low	   sequence	   and	   structure	   homology	   to	   well-­‐
annotated	   enzymes.	   We	   hypothesized	   that	   the	   active	   site	   region	   of	   an	   enzyme	   is	   more	  
conserved	  when	  compared	  to	  other	  enzymes	  with	  the	  same	  function	  than	  the	  global	  sequence.	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From	  this	  premise	  we	  have	  developed	  a	  structure-­‐based	  function	  prediction	  method	  where	  we	  
employ	   active	   site	   conservation	   in	   addition	   to	   global	   sequence	   homology	   for	   functional	  
characterization.	  We	  then	   integrated	  this	  method	  with	  a	  probabilistic	  whole-­‐genome	  function	  
prediction	   framework	   GLOBUS.	   The	   original	   version	   of	   GLOBUS	   uses	   sampling	   of	   probability	  
space	   to	   assign	   functions	   to	   all	   putative	  metabolic	   genes	   in	   an	   input	   genome	  by	   considering	  
sequence	  homology	  to	  known	  enzymes,	  gene-­‐gene	  context	  and	  EC	  co-­‐occurrence.	  
We	   showed	   that	   taking	   into	   account	   local	   sequence	   conservation	   via	   the	   use	   of	   a	  
structural	   template	   to	   identify	   active	   site	   location	   adds	   information	   that	   allows	   us	   to	   make	  
robust	   functional	   predictions.	   3D-­‐GLOBUS	   performs	   remarkably	   better	   than	   sequence-­‐based	  
homology	   methods	   when	   no	   close	   homologue	   can	   be	   found	   in	   Swiss-­‐Prot.	   3D-­‐GLOBUS	   also	  
performs	  better	  than	  GLOBUS	  for	  genes	  with	  less	  than	  40	  %	  sequence	  identity	  to	  a	  homologue	  
in	  Swiss-­‐Prot.	  Namely,	  3D-­‐GLOBUS	  shows	  a	  36	  %	  increase	  in	  precision	  over	  GLOBUS	  (precision	  
of	  0.6	  and	  0.44).	  Similarly,	  we	  observe	  a	  40	  %	  increase	  in	  recall	  over	  GLOBUS	  (recall	  of	  0.35	  and	  
0.25	   respectively).	   3D-­‐GLOBUS	   also	   outperforms	   Argot2	   and	   EFICAZ2.5,	   which	   where	   both	  
considered	  top	  methods	  in	  the	  field54,120,119.	  These	  results	  are	  significant	  because	  they	  validate	  
the	  use	  of	  3D-­‐GLOBUS	  for	  the	  genome-­‐wide	  functional	  annotation	  of	  bacterial	  metabolic	  genes.	  
Because	  the	  sequencing	  of	  bacterial	  genomes	  drives	  the	  rapid	  growth	  of	  sequence	  databases,	  
we	  propose	  3D-­‐GLOBUS	  as	  a	  fast	  and	  reliable	  first	  step	  for	  genome-­‐wide	  functional	  annotation,	  










4.1	  MYCOBACTERIUM	  TUBERCULOSIS	  AND	  DISEASE	  
	   Following	  the	  validation	  of	  our	  method’s	  performance	  on	  various	  genomes	  ranging	  from	  
well	  studied	  to	  partially	  characterized,	  we	  decided	  to	  deepen	  our	  analysis	  of	  the	  predictions	  for	  
a	   very	   important	   human	   pathogen,	  Mycobacterium	   tuberculosis,	  which	   is	   responsible	   for	   1.5	  
millions	  of	  deaths	  annually123.	  This	  bacteria	  is	  a	  major	  public	  health	  concern,	  however	  studying	  
it	   in	   the	   lab	   is	   difficult	   and	   requires	   Biosafety	   level	   3	   facilities	   to	   minimize	   the	   danger	   of	  
accidental	  exposure.	  
The	  genus	  Mycobacterium	  includes	  virulent	  pathogens	  responsible	  for	  infections	  such	  as	  
tuberculosis124,	   leprosy125	   and	   maybe	   even	   Crohn’s	   disease126.	   The	   bacteria	   responsible	   for	  
tuberculosis	   in	  different	  eukaryotic	  hosts	  (M.	  tuberculosis,	  M.	  africanum,	  M.	  bovis,	  M.	  caprae,	  
M.	  microti,	  M.	   pinnipedii)	   form	  what	   is	   called	   the	  Mycobacterium	   Tuberculosis	   Complex	   and	  




Figure	  4.1.	  Whole	  genome	  alignment	  of	  mycobacterial	  species.	  
The	   whole	   genomes	   of	  M.	   tuberculosis	   H37Rv,	  M.	   bovis	   AF2122/97,	  M.	   bovis	   BCG	   Pasteur	  
1173P2,	   M.	   africanum	   GM041182,	   M.	   canettii	   CIPT	   140010059,	   M.	   avium	   104	   and	   M.	  
smegmatis	   str.	   mc2	   155	   were	   aligned	   with	   the	   software	   MAUVE.	   The	   first	   five	   genomes	  
enclosed	  in	  brackets	  are	  members	  of	  the	  Mycobacterium	  Tuberculosis	  Complex,	  meaning	  that	  
these	  species	  are	  known	  to	  cause	  tuberculosis	  in	  humans	  and	  animal	  hosts.	  M.avium	  can	  cause	  
non-­‐pulmonary	   infections	   in	   birds	   and	   mammals.	   M.	   smegmatis	   str.	   mc2	   155	   is	   a	   non-­‐
pathogenic	   relative	   of	   the	   other	   six	   species.	   The	   colored	   boxes	   outline	   regions	   of	   local	  
collinearity,	  and	  the	  colored	  lines	  inside	  the	  boxes	  represent	  levels	  of	  sequence	  similarity.	  The	  
lines	   connect	   homologous	   regions.	   We	   observe	   genomic	   rearrangements	   in	   the	  M.	   avium	  
genomes	  relative	  to	  MTBC	  genomes	  where	  gene	  order	  is	  mostly	  conserved.	  
	  
The	  M.	  tuberculosis	  strain	  was	  discovered	  by	  German	  scientist	  Robert	  Koch	  in	  1882,	  but	  
has	  been	  around	  for	  thousands	  of	  years.	  It	  has	  been	  postulated	  that	  M.	  tuberculosis	  first	  started	  
M.	  bovis	  AF2122/97	  
M.	  bovis	  BCG	  str.	  Pasteur	  1173P2	  
M.	  africanum	  GM041182	  
M.	  canettii	  CIPT	  140010059	  
M.	  avium	  104	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affecting	  humans	   as	   a	   result	   of	   cattle	   domestication	   about	   10,000	   years	   ago.	  However	   some	  
new	  evidence	  suggests	   that	  humans	  may	  have	  been	  subject	   to	  tuberculosis	   infections	   for	   the	  
past	  50,000	  years124.	  Nowadays,	  the	  infection	  affects	  people	  worldwide,	  but	  the	  majority	  of	  the	  
casualties	  are	  in	  third	  world	  countries,	  as	  can	  be	  seen	  in	  the	  WHO	  map	  from	  2011	  (fig.	  4.2).	  
	  
Figure	  4.2.	  Estimated	  tuberculosis	  incidence	  rate	  in	  2012.	  
This	  map	  shows	  worldwide	  incidence	  of	  tuberculosis	  in	  2012.	  The	  heaviest	  burden	  is	  in	  the	  third	  
world,	   however	   the	   disease	   occurs	   everywhere	   (Reproduced	   from	   the	   World	   Health	  
Organization).	  
	  
A	  vaccine	  was	  developed	  by	  French	  doctors	  Camille	  Guerin	  and	  Albert	  Calmette	   in	  the	  
early	   twentieth	   century	   from	   the	   attenuated	   bovine-­‐targeting	   bacterium	  M.	  bovis,	   but	   it	   has	  
had	  mixed	  results,	  especially	  in	  developing	  countries	  where	  the	  disease	  burden	  is	  the	  highest127-­‐
129.	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Because	   of	   its	   unusual	   overall	   structure,	   a	   lot	   remains	   to	   be	   elucidated	   about	   M.	  
tuberculosis.	   First,	   it	   has	   an	   atypical	   glycolipid-­‐rich	   cell	   wall	   that	   makes	   the	   cell	   very	  
impermeable.	   The	   mycobacterial	   cell	   wall	   contains	   unusual	   lipids	   such	   as	   mycolic	   acids	   and	  
lipoarabinomannan	  (LAM)	  on	  top	  of	  a	  thin	  layer	  of	  peptidoglycan130.	  It	  has	  been	  said	  that	  up	  to	  
30	  %	  of	  M.	  tuberculosis	  genes	  may	  be	  devoted	  to	  lipid	  production	  and	  metabolism131.	  The	  thick	  
waxy	   cell	   wall	   constitutes	   a	   first	   line	   of	   defense	   of	   the	   bacterium	   against	   therapeutics.	  M.	  
tuberculosis	   also	   boasts	   an	   array	   of	   efflux	   mechanisms	   carried	   out	   by	   ATP	   transporters	   for	  
active	  efflux	  of	  drugs132.	  Additionally,	  M.	  tuberculosis	  has	  a	  slow	  doubling	  time	  when	  compared	  
to	   other	   bacteria,	  which	   appears	   to	   be	   a	   hallmark	   of	   pathogenic	  Mycobacteria	   and	  makes	   it	  
somewhat	  harder	  to	  study	  in	  vitro133.	  Also,	  the	  bacteria	  can	  exist	  in	  two	  distinct	  states;	  it	  can	  be	  
either	  active	  or	  dormant.	  During	  persistent	  infection,	  M.	  tuberculosis	  exists	  in	  a	  non-­‐replicating,	  
slow-­‐growing	   state.	   Little	   is	   known	   about	   the	   specifics	   of	  M.	   tuberculosis	   behavior	   in	   the	  
dormant	   state.	   Some	   studies	   have	   attempted	   to	   shed	   light	   on	   metabolic	   processes	   during	  
dormancy,	   and	   this	   is	   done	   by	   simulating	   hypoxic,	   low	   nutrient	   and/or	   acid	   stressed	  
environments134,135.	  One	  finding	  that	  emerged	  from	  these	  studies	   is	  that	  the	  bacteria	  strongly	  
downregulates	  genes	  associated	  with	  energy	  metabolism	  while	  upregulating	   lipid	  degradation	  
and	  fatty	  acid	  metabolism	  (i.e.	  β-­‐oxidation)136.	  
When	  harboring	  the	  bacteria	  in	  the	  dormant	  state,	  an	  infected	  individual	  will	  not	  show	  
symptoms	  so	  that	  the	  infection	  will	  go	  untreated.	  The	  WHO	  has	  estimated	  that	  about	  a	  third	  of	  
the	  world	  population	  carries	  the	  bacteria	   in	  a	   latent	  state,	  so	   it	   is	   like	  a	  ticking	  time	  bomb123.	  
Also,	  due	  to	  long	  times	  of	  co-­‐evolution	  with	  humans,	  M.	  tuberculosis	  has	  developed	  the	  ability	  
to	  hijack	   the	   immune	   system	  by	  being	   taken	  up	  by	  macrophages	  of	   the	   lungs	   and	   remaining	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inside	  in	  order	  to	  escape	  drug	  treatment	  and	  an	  immune	  response.	  It	  is	  able	  to	  survive	  within	  
the	  macrophage	   by	   using	   fatty	   acids	   or	   cholesterol	   as	   a	   substrate	   for	   growth,	   and	   prevents	  
macrophages	  from	  maturing	  and	  destroying	  it137,138.	  
A	   number	   of	   anti-­‐tuberculosis	   drugs	   have	   been	   developed	   since	   the	   1940s;	   notably,	  
isoniazid,	  pyrazinamide,	  ethambutol	  and	  rifampicin	  which	  are	  still	   in	  use	   today	  as	   first	   line	  of	  
treatment	  against	  non-­‐resistant	  TB123.	  The	  majority	  of	  them	  target	  some	  aspect	  of	  metabolism,	  
and	  some	  of	  these	  substances	  (e.g.	  streptomycin	  and	  rifampicin)	  are	  derived	  from	  soil-­‐dwelling	  
microbes	  so	  that	  non-­‐pathogenic	  bacteria	  which	  share	  a	  niche	  with	  these	  are	  not	  susceptible	  to	  
these	   antibacterial	   compounds139.	   Specifically,	   ethambutol	   and	   isoniazid	   affect	   cell	   wall	  
biosynthesis,	  while	  pyrazinamide	  inhibits	  fatty	  acid	  metabolism140.	  As	  for	  rifampicin,	   it	   inhibits	  
the	  transcription	  mechanism	  through	  inhibition	  of	  bacterial	  DNA-­‐dependent	  RNA	  polymerase140.	  
Therefore	  the	  first-­‐line	  drugs	  are	  only	  effective	  when	  cells	  are	  actively	  dividing.	  To	  prevent	  the	  
emergence	  of	  drug-­‐resistant	  bacteria,	  the	  first-­‐line	  of	  defense	  involves	  administering	  a	  cocktail	  
of	  drugs	  for	  an	  extended	  period	  of	  time.	  The	  increased	  prevalence	  of	  drug	  resistance	  is	  in	  part	  a	  
consequence	  of	  the	  5-­‐fold	  decrease	  of	  the	  rate	  of	  development	  and	  approval	  of	  new	  antibiotics	  
in	   the	   last	   twenty	   years141,142.	   Shortage	   of	   anti-­‐tuberculosis	   drugs	   is	   also	   a	   common	  
occurrence143,144.	  Another	  cause	  of	  drug	  resistance	  is	  that	  dormant	  bacterial	  cells	  escape	  drug	  
therapy,	  and	  can	  activate	  after	  treatment	  is	  terminated.	  Moreover,	  many	  affected	  patients	  fail	  
to	   comply	   with	   treatment	   for	   the	   recommended	   duration,	   so	   that	   more	   aggressive	   drug-­‐
resistant	   forms	   of	  M.	   tuberculosis	   have	   emerged145.	   Co-­‐morbidity	   of	   tuberculosis	  with	  HIV	   is	  
also	   a	   major	   problem146.	   Since	   the	   early	   1990s,	   the	   World	   Health	   Organization	   (WHO)	   has	  
declared	  tuberculosis	  a	  global	  emergency147	  .	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Good	  and	  complete	  annotations	  of	  the	  M.	  tuberculosis	  genome	  are	  lacking.	  We	  can	  use	  
3D-­‐GLOBUS	  probabilities	  to	  curate	  and	  update	  the	  previously	  published	  metabolic	  network.	  The	  
new	   model	   could	   then	   be	   used	   to	   test	   hypotheses	   (such	   as	   gene	   essentiality,	   nutrient	  
consumption,	  etc.)	  and	  to	  identify	  new	  drug	  targets.	  
	  
4.2	  MATERIALS	  AND	  METHODS	  
4.2.1	  Probabilistic	  annotation	  of	  the	  M.	  tuberculosis	  genome	  
To	  re-­‐annotate	  M.	  tuberculosis	  metabolic	  genes	  we	  obtained	  the	  protein	  sequences	  
assigned	   to	   strain	   H37Rv	   from	   the	   KEGG	   database148.	   The	   protein	   sequences	   were	   then	  
probabilistically	   annotated	  with	   Enzyme	   Commission15	   (EC)	   numbers	   using	   the	   GLOBUS	  
algorithm55.	  Briefly,	  GLOBUS	  uses	  Gibbs	  sampling	  to	  find	  the	  probability	  of	  a	  gene	  having	  
one	  of	  a	  set	  of	  possible	  enzymatic	  functions	  given	  a	  combination	  of	  sequence	  identity	  and	  
genomic	  context	  correlation	  data.	  Homology-­‐based	  descriptors	   for	  a	  given	  gene	   included:	  
sequence	  homology	  to	   the	  top	  BLAST	  hit	  against	  SwissProt	  enzymes,	  sequence	  homology	  
calculated	  only	  for	  residues	  predicted	  to	  be	  in	  the	  enzymes’	  active	  sites,	  and	  the	  presence	  of	  
annotated	   orthologs	   (bi-­‐directional	   best	   hits)	   in	   the	   SwissProt	   database.	   Context-­‐based	  
data	   included	   phylogenetic	   profile	   correlations,	   chromosomal	   gene	   clustering,	   gene	   co-­‐
expression,	   and	  EC	  number	   co-­‐occurrence55.	  The	  GLOBUS	  algorithm	   is	  based	  on	   the	   idea	  
that	  genes	  are	  more	   likely	   to	  be	  assigned	   to	   their	  correct	  metabolic	   function	   if	   they	  have	  
high	   sequence	   similarity	   to	   enzymes	   known	   to	   have	   such	   function	   and	   also	   if	   they	   have	  
strong	   functional	   correlations	   with	   genes	   annotated	   to	   neighboring	   enzymes	   in	   the	  
metabolic	  network,	  i.e.	  genes	  annotated	  to	  enzymes	  sharing	  metabolites.	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Context	   correlations	   were	   calculated	   as	   described55	   using	   data	   from	   KEGG.	   Gene	  
expression	  data	  used	  to	  calculate	  co-­‐expression	  were	  obtained	  from	  the	  GEO	  database149,	  
with	  accession	  numbers:	  GSE10391,	  GSE11096,	  GSE1642,	  GSE16811,	  GSE21114,	  GSE3201,	  
GSE3999,	  GSE8786,	  GSE8839	  and	  GSE9331.	  
4.2.2	  Structural	  representations	  
	   In	  order	  to	  investigate	  the	  veracity	  of	  functional	  predictions	  made	  for	  7	  candidate	  genes	  
of	  unknown	  function	   in	  Mycobacterium	  tuberculosis,	  homology	  models	  were	  built	   for	  each	  of	  
them	   using	   a	   sequence	   homologue	   with	   the	   candidate	   enzymatic	   function	   and	   an	  
experimentally	   determined	   3D	   structure.	   The	  models	   were	   retrieved	   from	  ModBase	   or	   built	  
with	   the	   homology	  modeling	   pipeline	  ModPipe,	  which	   uses	   PSI-­‐BLAST	   for	   template	   selection	  
and	  MODELLER	  for	  model	  building150).	  The	  quality	  of	  the	  models	  was	  evaluated	  through	  metrics	  
such	  as	  sequence	  identity,	  E-­‐value,	  GA341,	  MPQS	  and	  z-­‐DOPE	  scores	  .	  
Then	   in	  order	   to	  simulate	  molecular	   interactions	  between	   the	  model	  and	   its	  predicted	   ligand	  
we	   first	   needed	   to	   model	   the	   ligand	   in	   the	   homology	   model.	   To	   this	   end,	   we	   overlaid	   the	  
structures	  of	  the	  template	  and	  of	  the	  model	  so	  as	  to	  obtain	  the	  coordinates	  of	  the	  ligand	  in	  the	  
model	   structure.	  Subsequently,	  we	  used	  PyMol	   to	  visualize	   the	   relative	  position	  of	   the	  active	  
site	  region	  and	  of	  the	  ligand,	  and	  to	  determine	  which	  residues	  of	  the	  active	  site	  region	  are	  in	  a	  
position	  to	  have	  polar	  interactions	  with	  atoms	  of	  the	  ligand.	  This	  also	  allowed	  us	  to	  survey	  the	  
level	   of	   conservation	   of	   active	   site	   region	   residues	   in	   the	   query	   sequence	   relative	   to	   the	  
template.	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4.2.3	  Flux	  balance	  analysis	  
For	  a	  given	  organism,	  the	  metabolic	  network	  can	  be	  represented	  by	  the	  combination	  of	  
the	   a	   stoichiometry	   matrix	   S	   that	   contains	   the	   stoichiometric	   coefficients	   of	   all	   metabolites	  
involved	   in	   metabolism,	   and	   a	   flux	   matrix	   v.	   Flux	   balance	   analysis	   (FBA)	   is	   a	   mathematical	  
method	  to	  simulate	  metabolism	   in	  genome-­‐scale	   reconstructed	  metabolic	  networks	   (fig.	  4.3).	  
We	  simulate	  gene	  deletion	  with	  the	  CobraToolbox151	  and	  determined	  how	  deleting	  each	  gene	  
would	  affect	  growth	  (gene	  essentiality	  analysis).	  The	  current	  gold	  standard	  for	  gene	  essentiality	  
is	  a	  Transposon	  Site	  Hybridization	  (TraSH)	  study	  by	  Sassetti	  et	  al.152.	  TraSH	  is	  the	  equivalent	  of	  
high-­‐throughput	  gene	  knockout	  experiments	  where	  a	  single	  deleterious	  mutation	  is	  introduced	  
into	   each	   cell	   of	   a	   bacterial	   colony.	   After	   a	   period	   of	   time,	   the	   pool	   of	   cells	   is	   analyzed	   to	  
determine	   the	   ones	   that	   survived	   and	   grew,	   the	   ones	   that	   did	   not,	   and	   the	   identity	   of	   the	  
mutated	  gene.	  
An	  FBA	  problem	  can	  be	  resumed	  by	  the	  following	  equation:	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  S	  x	  v	  =	  b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
where	  S	  is	  the	  stoichiometry	  matrix,	  v	  is	  the	  vector	  of	  fluxes	  through	  the	  network	  and	  b	  is	  the	  
rate	   of	   change	   in	   concentration	   of	   all	   metabolites.	   At	   steady-­‐state	   when	   there	   is	   no	  
accumulation	  of	  metabolites,	  b	   =	   0	   so	   that	  we	  may	   solve	   equation	   (1)	   to	   determine	   the	   flux	  
vector	   v	   that	   best	   satisfies	   the	   equation.	   We	   may	   do	   this	   by	   imposing	   the	   requirement	   to	  
maximize	   an	   objective	   function	   (e.g.	   biomass	   production,	   ATP	   production).	   This	   considerably	  
collapses	  the	  space	  of	  possible	  solutions.	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Figure	  4.3.	  Illustration	  of	  flux	  balance	  analysis.	  
A	   metabolic	   network	   can	   be	   represented	   as	   the	   dot	   product	   of	   a	   stoichiometry	   matrix	   S	  
(contains	  the	  stoichiometric	  coefficients	  of	  all	  metabolites	   involved	   in	  all	  reactions)	  and	  a	  flux	  
matrix	  v	  (describes	  the	  flux	  through	  all	  reactions).	  At	  steady	  state	  S	  x	  v	  =	  0.	  
	  
4.2.4	  Gene	  essentiality	  analysis	  
Flux	  balance	  analysis	  uses	  linear	  programming	  to	  find	  a	  vector	  of	  metabolic	  fluxes	  that	  
maximizes	  an	  objective	  function	  (e.g.	  flux	  through	  the	  biomass	  reaction)	  while	  fulfilling	  steady-­‐
state,	   mass-­‐balance	   and	   flux	   volume	   constraints.	   To	   simulate	   gene	   deletions	   using	   FBA	   that	  
were	  comparable	  to	   in	  vivo	  and	   in	  vitro	  experimental	  results	  we	  defined	  two	  types	  of	   in	  silico	  
growth	  media153.	  For	  the	   in	  vitro	  case,	  we	  allowed	   influx	  of	  metabolites	  corresponding	  to	  the	  
composition	  of	  the	  Middlebrook	  7H9	  media154	  with	  a	  maximum	  rate	  of	  1mMol/gDW.	  For	  the	  in	  
vivo	  case,	  we	  only	   allowed	  uptake	  of	  metabolites	   identified	  as	  being	  most	   consistent	  with	   in	  
vivo	   gene	   essentiality	   predictions	   by	   Fang	   et	   al.155.	   Single	   gene	   deletion	   analyses	   were	  
performed	  under	  both	  media	  conditions	  using	  the	  COBRA	  toolbox151.	  Any	  gene	  whose	  deletion	  
resulted	   in	  a	  maximum	  growth	  yield	  of	   zero	  media	  was	  considered	   to	  be	  essential.	  Predicted	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gene	   essentiality	  was	   compared	   to	   high-­‐throughput	   in	   vitro	   experimental	   data	   by	   Sassetti	  et	  
al.152	  and	  the	  in	  vivo	  data	  by	  Sassetti	  et	  al.	  in	  a	  mouse	  model	  of	  infection156.	  
4.2.5	  Phenotype	  microarray	  analysis	  
Phenotype	   microarray	   data	   for	   carbon	   and	   nitrogen	   source	   utilization	   were	  
obtained	  from	  the	  study	  by	  Khatri	  et	  al.157.	  Following	  the	  original	  experimental	  analysis,	  a	  
threshold	  of	  three	  Omnilog	  units	  was	  used	  to	  identify	  a	  positive	  result.	  In	  order	  to	  simulate	  
growth	  on	  different	  carbon	  sources	  we	  defined	  a	  minimal	  media	  including	  Ca,	  Cl,	  Cu,	  Fe,	  H,	  
H2O,	  K,	  Na,	  NH4,	  O2,	  PO4,	  SO4	  with	  a	  maximum	  uptake	  rate	  of	  	  1mMol/gDW	  and	  Glycerol	  –
which	  was	  found	  to	  be	  essential–	  with	  a	  maximum	  uptake	  rate	  of	  	  0.06	  mMol/gDW.	  Then,	  
we	   allowed	   the	   uptake	   of	   each	   carbon	   compound	   tested	   with	   a	   maximum	   rate	   of	  
1mMol/gDW.	  If	  maximal	  biomass	  synthesis	  under	  these	  conditions	  was	  predicted	  to	  be	  at	  
least	  twice	  as	   large	  as	  on	  Glycerol	  alone,	  the	  corresponding	  compound	  was	  considered	  to	  
be	   a	   viable	   carbon	   source	   for	   biomass	   production.	   A	   similar	   approach	   was	   used	   to	   test	  
nitrogen	  sources,	  the	  only	  difference	  being	  that	  NH4	  was	  removed	  from	  the	  minimal	  media	  
and	  glycerol	  uptake	  was	  allowed	  a	  maximum	  rate	  of	  1mMol/gDW.	  
	  
4.3	  3D-­‐GLOBUS	  NOVEL	  PREDICTIONS	  
4.3.1	  Candidates	  for	  functional	  characterization	  	  
The	   utilization	   of	   structural	   data	   concurrently	   with	   global	   sequence	   homology	   and	   gene	  
context	   information	   (3D-­‐GLOBUS)	  allowed	  us	   to	  build	  a	  model	  of	  M.	   tuberculosis	  metabolism	  
which	   significantly	   improves	   on	   previously	   published	   models	   (table	   4.1).	   We	   compared	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probability	  predictions	  for	  all	  1,399	  predicted	  metabolic	  genes	  of	  M.	  tuberculosis	  with	  GLOBUS	  
and	  3D-­‐GLOBUS	  using	  the	  set	  of	  optimized	  weights	  obtained	  from	  training	  on	  the	  genome	  of	  E.	  
coli.	   We	   chose	   E.	   coli	   because	   it	   is	   also	   a	   bacteria,	   so	   that	   the	   set	   of	   weights	   learnt	   from	  
applying	  Gibbs	  sampling	  on	  the	  well-­‐curated	  genome	  of	  E.	  coli	  may	  better	  apply	  to	  the	  genomes	  
of	  other	  bacteria.	  The	  distribution	  of	  M.	   tuberculosis	   genes	  as	  a	   function	  of	   the	  difference	   in	  
prediction	  probability	  obtained	  from	  3D-­‐GLOBUS	  vs.	  GLOBUS	  is	  shown	  in	  figure	  4.4.	  	  
	  
Figure	  4.4.	  Difference	  between	  GLOBUS	  and	  3D-­‐GLOBUS	  probabilities	  for	  Mycobacterium	  
tuberculosis.	  
A	   large	  number	  of	   gene	  products	   have	   increased	  probability	   of	   being	   associated	   to	   their	   top	  
predicted	   function.	   This	   trend	   is	   visible	   in	   the	   genome-­‐wide	   set	   (blue	   bars)	   as	  well	   as	   in	   the	  
“twilight-­‐zone”	  set	  (green	  bars).	  
	  
About	   37%	   of	   genes	   have	   unchanged	   prediction	   probability	   between	   the	   two	   methods.	  
However,	   105	   genes	   have	   a	   significant	   decrease	   in	   probably	   from	   GLOBUS	   to	   3D-­‐GLOBUS,	  
probably	   because	   the	   addition	   of	   structure-­‐based	   information	   help	   us	   resolve	   inconclusive	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predictions	  by	  shifting	  the	  probability	  of	  a	  given	  function	  upwards	  or	  downwards.	  Conversely,	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  genes	  have	  a	  significant	  increase	  in	  prediction	  probability.	  If	  we	  focus	  on	  genes	  that	  share	  
40%	   of	   less	   sequence	   identity	   to	   their	   best	   hit	   in	   Swiss-­‐Prot,	   we	   find	   that	   this	   set	   of	   genes	  
account	  for	  almost	  all	  of	  the	  genes	  for	  which	  we	  observed	  a	  downward	  shift	  in	  probability,	  and	  
for	  about	  half	  of	  genes	  for	  which	  probability	  is	  shifted	  up	  significantly.	  
When	  selecting	  cases	  to	  further	  study	  and	  validate	  structurally	  and	  experimentally,	  we	  
sought	   the	   following	   requirements:	   1)	   Active	   site	   conservation	   had	   to	   be	   appreciably	   higher	  
than	   global	   sequence	   identity.	   2)	   The	   probability	   of	   the	   given	   functional	   assignment	   by	   3D-­‐
GLOBUS	  had	  to	  be	  at	   least	  50	  %.	  3)	  The	  proposed	  function	  of	   the	  genes	  had	  to	  be	  related	  to	  
pathogenesis.	  An	  examination	  of	  the	  genes	  that	  matched	  these	  conditions	  yielded	  7	  interesting	  
(table	   4.1).	   All	   the	   genes	   chosen	   for	   validation	   are	   involved	   in	   the	  metabolism	  of	   alternative	  
carbon	  sources	  for	  growth.	  
	  
Table	  4.1.	  Candidate	  genes	  for	  structural	  and	  experimental	  validation.	  
Gene  Function  %Global  %ASite  P(3D-
Globus)  
Pathway  Substrate  
Rv3255c  Mannose-6-phosphate 
isomerase (5.3.1.8)  




Rv2332  Malate dehydrogenase 
(1.1.1.38)  
42.55  66.67  69.0  Pyruvate 
metabolism  
(S)-malate  
Rv3811  N-acetylmuramoyl-L-alanine 
amidase (3.5.1.28)  
31.05  68.42  66.3  Cell wall 
metabolism  
Peptidoglycan  
Rv1592c  Triacylglycerol lipase (3.1.1.3)  32.47  50.00  72.4  Glycerolipid 
metabolism 
Triacylglycerol  
Rv0751c  3-hydroxybutyrate 
dehydrogenase (1.1.1.31)  




Rv3406  Taurine dioxygenase 
(1.14.11.17)  
38.08  47.06 53.9 Taurine 
metabolism 
Taurine  





The	   first	   step	   in	   investigating	   the	   veracity	   of	   the	   functional	   prediction	  made	  with	   3D-­‐
GLOBUS,	   was	   a	   structural	   examination.	   The	   goal	   was	   to	   visualize	   the	   possible	   interactions	  
between	  the	  ligand	  corresponding	  to	  the	  candidate	  function,	  and	  the	  conservation	  of	  the	  active	  
site	   region	   residues.	   In	   order	   to	   do	   this,	   we	   built	   homology	   models	   for	   6	   of	   the	   7	   genes;	  
selecting	   3D	   structural	   templates	   in	   the	   PDB	   with	   the	   same	   EC	   number	   annotation	   (see	  
methods).	   The	   3D	   structure	   for	   the	   remaining	   gene,	   Rv3406,	   has	   been	   experimentally	  
determined	  at	  resolution	  2.5	  Å	  and	  is	  in	  the	  PDB	  (code	  4FFA)158.	  Subsequently,	  for	  each	  gene	  of	  
interest,	   we	   aligned	   the	   homology	   model	   (or	   true	   structure)	   to	   that	   of	   the	   experimentally	  
determined	  structure	  of	  an	  enzyme	  known	  to	  have	  the	  candidate	  function	  and	  crystallized	  with	  
a	  ligand.	  Because	  the	  structures	  were	  overlaid,	  we	  determined	  the	  position	  of	  the	  ligand	  in	  the	  
uncharacterized	  enzymes	  by	  knowing	  its	  position	  in	  the	  known	  template.	  This	  method	  allowed	  
us	   to	   test	   whether	   the	   ligand	   could	   truly	   fit	   in	   the	   catalytic	   region	   of	   the	   uncharacterized	  
protein,	  as	  well	  as	  to	  identify	  putative	  catalytic	  residues.	  In	  all	  7	  cases	  the	  ligand	  sits	  in	  a	  pocket	  
and	  is	  within	  proximity	  of	  residues	  to	  form	  polar	  contacts	  (fig.	  4.5,	  apprendix	  4.1).	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Figure	  4.5.	  Homology	  models	  of	  target	  genes	  with	  ligand.	  
This	  figure	  representing	  the	  homology	  models	  for:	  A)Rv3255c,	  B)Rv2332,	  C)Rv3811,	  D)Rv1592c,	  
E)Rv0751c,	  F)Rv3406	  and	  G)Rv0891	  was	  created	  with	  PyMol74.	  The	  active	  site	  region	  residues	  
that	   are	   fully	   conserved	   between	   template	   and	   query	   are	   shown	   as	   blue	   spheres,	   and	   the	  
ligands	   are	   shown	   in	   magenta	   (spheres	   and	   stick	   models).	   To	   show	   which	   residues	   may	   be	  
involved	  in	  interactions	  with	  the	  ligand,	  the	  mesh	  surface	  representations	  to	  the	  right	  of	  each	  
panel	  are	  the	  residues	  in	  a	  4	  Å	  neighborhood	  around	  the	  ligand.	  The	  residues	  which	  have	  polar	  
interactions	  with	  the	  ligand	  are	  shown	  as	  green	  stick	  representations.	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4.3.2	  Cholesterol	  Degradation	  Pathway	  
	   Furthermore,	   we	   identified	   genes	   for	   a	   pathway	   that	   is	   absent	   from	   the	   previously	  
published	  models	  by	  the	  Jamshidi	  and	  Palsson154,	  Beste159	  and	  Fang155	  research	  groups.	  These	  
genes	   belong	   to	   the	   cholesterol	   degradation	   pathway,	  which	   allows	   the	   bacteria	   to	   grow	  on	  
cholesterol	  if	  other	  nutrients	  are	  not	  available.	  It	  turns	  out	  that	  during	  persistent	  infection,	  M.	  
tuberculosis	   is	   most	   often	   found	   in	   the	   lungs	   and	   takes	   up	   residence	   inside	   the	   alveolar	  
macrophages	   by	   the	   process	   of	   phagocytosis.	   At	   that	   stage,	   the	   macrophages	   should	   be	  
activated	  by	  T-­‐cell	  dependent	  cytokines	  and	  transfer	  the	  bacteria	  to	  lysosomes	  for	  destruction	  
by	  reactive	  oxygen	  and	  nitrogen	  species160-­‐162.	  However,	  some	  bacteria	  are	  able	  to	  escape	  this	  
process	   and	   remain	   sequestered	   inside	   the	   lipid-­‐rich	   foamy	   macrophages	   in	   a	  
macrophages/denditric	   cells/lymphocytes	   aggregate	   called	   granuloma137,138,163.	   These	  
macrophages	  have	  a	  high	  cholesterol	  content	  and	  therefore	   it	   is	  believed	  to	  be	  the	  prevalent	  
carbon	  source	  in	  the	  environment.	  
We	  were	  able	   to	  predict	  a	  gene	   for	  each	  step	  of	   the	  cholesterol	  degradation	  pathway	  
with	   high	  probability	   (fig.	   4.6,).	   This	   pathway	  produces	  metabolites	   that	  we	  believe	   are	   then	  
used	  in	  the	  TCA	  cycle	  for	  energy	  production	  and	  gluconeogenesis.	  Therefore,	  this	  pathway	  is	  of	  
interest	  when	  considering	  potential	  targets	  for	  new	  drug	  development	  against	  tuberculosis.	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Figure	  4.6.	  Cholesterol	  degradation	  pathway.	  
All	  steps	  of	  the	  cholesterol	  degradation	  pathway	  are	  shown	  here.	  The	  rings	  and	  side-­‐chains	  of	  
the	  cholesterol	  molecules	  are	  degraded,	  and	  the	  resulting	  molecules	  are	  acetyl-­‐CoA,	  pyruvate	  
and	  propionyl-­‐CoA.	  M.	  tuberculosis	  may	  use	  these	  compounds	  as	  substrates	  for	  the	  TCA	  cycle	  
for	  energy	  production,	  and	  for	  gluconeogenesis.	  
	  
	   Interestingly,	   starting	   with	   the	   discovery	   of	   the	   mycobacterial	   cholesterol	   transport	  
system	   mce4,	   several	   studies	   have	   been	   published	   in	   these	   past	   few	   years	   showing	   that	  
cholesterol	   is	   an	   important	   nutrient	   for	   M.	   tuberculosis	   persistence	   during	   infection164-­‐166.	  
However,	  at	  this	  time	  the	  exact	  mechanisms	  and	  genes	  involved	  had	  not	  been	  fully	  elucidated.	  
Our	  model	   of	   the	  metabolic	   network	   of	  M.	   tuberculosis	   reconstructed	   thanks	   to	   3D-­‐GLOBUS	  
may	   help	   further	   understand	   what	   happens	   during	   persistent	   infection,	   as	   well	   as	   help	   find	  
ways	  to	  affect	  bacterial	  proliferation	  and	  persistence.	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4.4	  RECONSTRUCTION	  OF	  THE	  M.	  TUBERCULOSIS	  METABOLIC	  NETWORK	  
4.4.1	  iMK917	  Metabolic	  model	  characteristics	  
	  	   In	   the	   past	   decade,	   several	   metabolic	   reconstructions	   have	   been	   published	   for	   M.	  
tuberculosis.	  In	  2007,	  Beste	  et	  al.159	  and	  Jamshidi	  and	  Palsson154	  independently	  built	  metabolic	  
network	  models	   of	  M.	   tuberculosis,	   each	   accounting	   for	   ~900	   reactions	   and	  ~700	   genes	   (see	  
table	   4.1);	   these	   reconstructions	   have	   been	   the	   basis	   for	   an	   in	   vivo	   compatible	   metabolic	  
reconstruction155,167and	  a	  semi-­‐automated	  merged	  model167.	  These	  models	  were	  used,	  among	  
others,	  to	  find	  reactions	  metabolically	  coupled	  to	  known	  TB	  drug	  targets154,	  and	  to	  investigate	  
in	  vivo	  growth	  conditions	  and	  metabolic	  adaptations	   to	  hypoxia	  and	   low	  pH155.	  Despite	   these	  
significant	  contributions,	  there	  are	  substantial	  differences	  between	  reconstructions	  of	  the	  same	  
TB	  strain,	  and	  the	  accuracy	  of	  growth	  and	  gene	  deletion	  phenotypes	  is	  still	  lower	  than	  achieved	  
by	   similar	  models	   in	  other	   species168.	  Additionally,	  metabolic	  processes	   such	  as	   the	   reactions	  
involved	  in	  cholesterol	  degradation,	  which	  play	  an	  important	  role	  in	  TB	  infection164,165,169,	  have	  
not	   been	  modeled	   in	   a	   genome-­‐scale	   context.	   	   These	   shortcomings	   are,	   to	   a	   great	   extent,	   a	  
consequence	  of	  the	  sparse	  biological	  knowledge	  about	  the	  parasite’s	  biology	  and	  incomplete	  or	  
incorrect	  gene	  annotations154.	  	  
Here,	  we	  use	  probabilistic	  gene	  annotations	  and	  careful	  manual	  curation	   to	  consolidate	  prior	  
reconstructions	   and	   to	   improve	   both	   the	   coverage	   and	   accuracy	   of	   the	   M.	   tuberculosis	  
metabolic	  model.	  The	  new	  model	  includes	  177	  genes	  and	  208	  reactions	  that	  were	  not	  present	  
in	   previous	   reconstructions;	   it	   also	   displays	   improved	   accuracy	   in	   the	   prediction	   of	   essential	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genes	   and	   growth	   on	   different	   nutrient	   sources.	   Using	   a	   combination	   of	   constraints-­‐based	  
simulations,	   sequence	   homology	   analyses	   and	   the	   interrogation	   of	   drug	   databases,	   we	  
produced	   a	   diverse	   catalog	   of	   candidate	   target	   genes	   paired	   with	   potential	   inhibitors	   which	  
could	   be	   useful	   to	   control	   parasite	   growth.	   We	   also	   use	   the	   updated	   model	   as	   a	   tool	   to	  
interpret	   recent	   data	   on	   the	   growth	  of	   TB	   cells	   at	   low	  pH	   in	   the	   presence	  of	   various	   carbon	  
sources.	  
	  
Table	  4.2.	  Comparison	  of	  Mycobacterium	  tuberculosis	  H37Rv	  metabolic	  reconstructions.	  
	  	   iMK917	   GSMN-­‐TB	  





(Fang	  et	  al.)	  
Number	  of	  genes	   917	   726	   661	   663	  
Number	  of	  reactions	   1240	   849	   939	   1049	  
Number	  of	  metabolites	   1012	   739	   828	   838	  
Number	  of	  exchange	  reactions	   111	   40	   86	   96	  
Fraction	  of	  orphan	  reactions	   0.12	   0.21	   0.23	   0.24	  
Fraction	  of	  no-­‐flux	  reactions	   0.19	   0.10	   0.22	   0.15	  
	  
Flux	  variability	  analysis	   (FVA)	   showed	   that	   the	   iMK917	  model	  allows	   the	  simulation	  of	  
fluxes	  through	  reactions	  that	  were	  blocked	   in	  prior	  reconstructions,	   i.e.	   reactions	  that	  cannot	  
carry	   flux	   under	   any	   condition.	   Overall,	   the	   fraction	   of	   orphan	   and	   blocked	   reactions	   in	   the	  
iMK917	   model	   is	   comparable	   if	   not	   lower	   to	   those	   of	   previous	   reconstructions	   despite	   the	  
increased	  number	  of	   reactions	   (table	  4.2).	  A	   large	   fraction	   (~15%)	  of	   the	  additional	   reactions	  
included	  in	  the	  iMK917	  model	  corresponds	  to	  the	  steroid	  degradation	  pathway,	  which	  is	  used	  
for	   the	   degradation	   of	   cholesterol	   into	   propanoyl-­‐CoA,	   acetyl-­‐CoA	   and	   pyruvate	   which	   may	  
subsequently	   act	   as	   substrates	   for	   central	   carbon	  metabolism	  and	   the	  TCA	   cycle.	   Cholesterol	  
degradation	   has	   been	   found	   to	   be	   necessary	   for	   growth	   of	   M.	   tuberculosis	   in	   chronically	  
infected	   mice164,166,170;	   therefore,	   addition	   of	   this	   catabolic	   route	   allows	   the	   study	   of	   this	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process	   in	   the	   context	   the	   entire	   metabolic	   network.	   Besides	   sterol	   degradation,	   additional	  
reactions	   were	   included	   in	   nucleotide,	   cell	   envelope,	   and	   redox	   metabolism.	   One	   notable	  
example	   is	   2-­‐oxoglutarate	   ferredoxin	  oxidourreductase	   (KOR,	   EC:	   1.2.7.3),	  which	   replaces	   the	  
typical	   2-­‐oxoglutarate	   dehydrogenase	   of	   the	   TCA	   cycle	   –absent	   from	  M.	   tuberculosis–	   and	  
provides	  an	  alternative	  route	  for	  the	  conversion	  2-­‐oxoglutarate	  to	  succinyl-­‐CoA.	  KOR	  has	  been	  
shown	  to	  operate	  concurrently	  with	  b-­‐oxidation	  during	  growth	  on	  lipid	  substrates171,	  suggesting	  
that	  the	  activity	  of	  this	  enzyme	  is	  relevant	  for	  the	  predominant	  in	  vivo	  growth	  conditions	  of	  M.	  
tuberculosis.	  	  
4.4.2	  Reconciliation	  with	  experimental	  data	  
Several	   high-­‐throughput	   experimental	   studies	   have	   been	   performed	   to	   determine	  M.	  
tuberculosis	  genes	  that	  are	  likely	  to	  be	  essential	  for	  growth	  or	  pathogenesis152,156,172.	  In	  order	  to	  
identify	   potential	   errors	   in	   the	   reconstruction	   of	   the	   metabolic	   network,	   we	   compared	  
predictions	  of	  gene	  essentiality	  made	  by	  FBA	  (see	  Methods)	  to	  these	  data.	  An	  initial	  accuracy	  of	  
74	  %	  and	  80	  %	  for	  predictions	  of	  in	  vivo	  and	  in	  vitro	  essentiality	  suggested	  several	  false	  positive	  
and	   false	   negative	   predictions	   that	   were	   studied	   in	   detail.	   We	   looked	   for	   missing	   gene	  
associations	  that	  could	  explain	  why	  certain	  genes	  were	  incorrectly	  predicted	  to	  be	  essential	  and	  
also	  looked	  for	  missing	  reactions	  and	  potential	  changes	  to	  the	  biomass	  objective	  function	  that	  
would	   explain	   these	   false	   predictions.	   For	   example,	   the	   presence	   of	   ribose	   in	   the	   biomass	  
reaction	   explained	   the	   false	   prediction	   of	   Rv3393	   (inosine	   hydrolase)	   as	   an	   essential	   gene.	  
Ribose	   in	   the	   biomass	   composition	   of	   M.	   tuberculosis	   is	   accounted	   by	   entirely	   by	  
ribonucleotides,	   for	   this	   reason,	   we	   did	   not	   consider	   this	   sugar	   as	   an	   essential	   biomass	  
component	  in	  the	  iMK917	  model.	  As	  shown	  in	  Table	  4.3,	  the	  final	  revised	  version	  of	  our	  model	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achieves	  an	  average	  accuracy	  of	  81	  %	  for	  the	  prediction	  of	  essential	  genes	  under	  in	  vitro	  and	  in	  
vivo	  conditions.	  This	  represents	  an	   improvement	  relative	  to	  prior	  models	  which	   is	  particularly	  
marked	  in	  terms	  of	  precision	  and	  specificity.	  This	  result	  is	  in	  part	  explained	  by	  a	  lower	  fraction	  
of	  false	  positives	  associated	  with	  the	  extended	  gene	  annotation	  and	  inclusion	  of	  new	  reactions	  
in	  the	  new	  model.	  
	  
Table	  4.3.	  Comparison	  of	  experimental	  and	  in	  silico	  gene	  essentiality	  predictions.	  
In	  vitro	   iMK916	   GSMN-­‐TB	  
(Beste	  et	  al.)	  
iNJ661	  
(Jamshidi	  and	  Palsson)	  
iNJ661v	  
(Fang	  et	  al.)	  
Accuracy	  	   0.78	   0.76	   0.71	   0.71	  
Precision	  	   0.81	   0.73	   0.68	   0.68	  
Recall	  	   0.53	   0.65	   0.65	   0.64	  
Specificity	  	   0.92	   0.84	   0.77	   0.77	  
In	  vivo	   	   	   	   	  
Accuracy	  	   0.86	   0.75	   0.69	   0.78	  
Precision	  	   0.40	   0.12	   0.14	   0.29	  
Recall	   0.57	   0.23	   0.44	   0.86	  
Specificity	  	   0.90	   0.81	   0.71	   0.77	  
Accuracy	  :	  (TP	  +	  TN)/(Total),	  Precision	  :	  TP/(TP+FP),	  Recall	  :	  TP/(TP+FN),	  Specificity	  :	  
TN/(FP+TN)	  
	   Similar	  to	  the	  essentiality	  results,	  we	  compared	  in	  silico	  predictions	  of	  the	  ability	  to	  
synthesize	  biomass	  from	  single	  carbon	  and	  nitrogen	  sources	  to	  published	  experimental	  results.	  
For	  this	  we	  used	  Phenotype	  microarray	  (PMs)173	  data	  produced	  in	  a	  recent	  study157.	  PMs	  allow	  
parallel	   testing	   of	  multiple	   growth	   conditions	   for	   which	   cell	   respiration	   –a	   proxy	   for	   cellular	  
growth–	   is	   measured	   by	   the	   reduction	   of	   a	   tetrazolium	   dye.	   An	   initial	   accuracy	   of	   57%	   in	  
reproducing	   the	  experimental	  phenotypes	  prompted	  us	   to	   investigate	  corresponding	  C	  and	  N	  
uptake	   and	   utilization	   pathways	   suggesting	   several	   important	  modifications	   to	   the	  model.	   In	  
particular,	  exchange	  and	  transport	  reactions	  for	  all	  positive	  C	  and	  N	  sources	  were	  initially	  added	  
to	   the	  model	   to	   see	   if	   this	   simple	  change	  would	  explain	   the	  disagreement	  with	  experimental	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results.	  	  This	  was	  the	  case	  for	  6	  of	  the	  tested	  compounds.	  In	  more	  complex	  cases,	  we	  manually	  
revised	   pathways	   associated	   with	   positive	   experimental	   results	   in	   order	   to	   identify	   simple	  
changes	  to	  the	  model	  that	  would	  allow	  growth	  on	  said	  nutrients.	  For	  example,	  butyric	  acid	  was	  
one	  of	  the	  compounds	  producing	  the	  largest	  dye	  reduction	  signals,	  but	  the	  original	  model	  could	  
not	   simulate	   growth	  on	   this	   substrate.	   The	  addition	  of	  butanoyl-­‐CoA:acetate	  CoA-­‐transferase	  
(EC:	  2.8.3.8),	  which	  converts	  butyric	  acid	  to	  butanoyl-­‐CoA,	  as	  an	  orphan	  reaction	  to	  the	  model	  
allowed	  in	  silico	  growth	  on	  butyric	  acid	  as	  the	  sole	  carbon	  source.	  
	   We	  also	  found	  cases	  in	  which	  the	  model	  predicted	  growth	  on	  particular	  substrates	  
that	  gave	  a	  negative	  result	  in	  the	  PM	  assay.	  This	  could	  be	  a	  result	  of	  the	  specific	  experimental	  
conditions;	   for	  example,	  negative	  experimental	   results	  were	  obtained	   for	   glucose,	  nitrite	  and	  
ammonia,	   which	   are	   known	   carbon	   and	   nitrogen	   sources	   for	  M.	   tuberculosis	   growth174,175.	  
However,	   negative	   growth	   results	   were	   also	   helpful	   for	   improving	   parts	   of	   the	   model.	  
Specifically,	   for	   the	  metabolites	   showing	  growth	   in	   silico	   but	  not	   in	   vitro,	  we	   tried	   to	   identify	  
model	  reactions	  that	  were	  not	  supported	  by	  gene	  annotations	  that	  were	  essential	   for	  growth	  
on	   those	   metabolites.	   For	   instance,	   the	   model	   predicted	   L-­‐arginine	   both	   as	   a	   carbon	   and	  
nitrogen	  source	  while	  no	  dye	  reduction	  was	  observed	  in	  the	  PM	  experiments.	  We	  found	  that	  in	  
the	   original	  model,	   the	   enzymes	   arginine	   succinyltransferase	   (EC:	   2.3.1.109),	   succinylarginine	  
dihydrolase	  (EC:	  3.5.3.23)	  and	  succinylglutamate	  desuccinylase	  (EC:	  3.5.1.96)	  were	  essential	  for	  
arginine	   utilization.	   The	   fact	   that	   all	   three	   reactions	   are	   orphan	   suggests	   that	   there	   is	   not	   a	  
metabolic	   route	   in	   M.	   tuberculosis	   from	   arginine	   to	   glutamate	   that	   uses	   these	   reactions.	  
Removing	  of	  these	  activities	  from	  the	  model	  correctly	  led	  to	  the	  prediction	  of	  no	  growth	  on	  L-­‐
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arginine.	  Following	  model	  curation	  guided	  by	  experimental	  results,	  the	  iMK917	  model	  was	  able	  
to	  reproduce	  81	  %	  of	  the	  experimentally	  measured	  phenotypes	  (fig.	  4.7).	  
	  
Figure	  4.7.	  Model	  predictions	  for	  growth	  on	  different	  carbon	  and	  nitrogen	  sources.	  	  
The	  figure	  shows	  the	  prediction	  results	  of	  growth/no-­‐growth	  phenotypes	   for	  sole	  carbon	  and	  
nitrogen	  sources.	  Predictions	  by	  four	  metabolic	  models	  were	  compared	  to	  experimental	  results	  
based	   on	   phenotype	   microarrays	   (PMs)157.	   The	   letters	   NT	   indicate	   that	   the	   corresponding	  
model	   lacks	   the	   transporters	   and	   exchange	   reactions	   associated	   with	   a	   specific	   metabolite.	  
Yellow	  cells	   indicate	  that	  although	  the	  PM	  produced	  a	  negative	  result,	  evidence	  exists	  for	  the	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utilization	  of	  the	  corresponding	  compound.	  *Evidence	  of	  cholesterol	  utilization	  is	  not	  based	  on	  
PMs	  but	  has	  been	  suggested	  by	  prior	  studies164,166.	  
	  
4.4.3	  Essential	  genes	  and	  candidate	  small	  molecule	  drugs	  
In	  order	  to	  suggest	  novel	  therapeutic	  research	  targets,	  we	  used	  the	  final	  version	  of	  the	  
iMK917	  model	   to	   predict	   and	   analyze	   essential	  M.	   tuberculosis	   genes.	   First,	   we	   ran	   a	   single	  
gene	  deletion	  analysis	  for	  every	  gene	  in	  the	  model	  using	  FBA	  under	  rich	  media	  conditions,	  i.e.	  
making	  all	  metabolites	  available	   to	  all	  modeled	   transport	   reactions.	  This	   resulted	   in	  56	  genes	  
that	   are	   predicted	   to	   be	   essential	   under	   any	   nutritional	   condition	   given	   the	   biomass	  
composition	  modeled	  in	  the	  iMK917	  model.	  Second,	  to	  identify	  a	  set	  of	  target	  genes	  that	  could	  
be	   subject	   to	   drug	   inhibition	  we	   performed	   a	   sequence	   homology	   search	   of	   these	   56	   genes	  
against	   4108	   known	   protein	   drug	   targets	   in	   the	   DrugBank	   database176.	   DrugBank	   stores	  
biochemical	  and	  pharmacological	  information	  about	  drugs,	  their	  mechanism	  and	  their	  targets.	  
The	   search	  produced	  a	   significant	  hit	   (e-­‐value	  <	  5*10-­‐3)	   for	  37	  of	   the	  FBA	  predicted	  essential	  
genes.	   Finally,	   we	   complemented	   the	   information	   in	   DrugBank	   with	   a	   literature	   search	   of	  
inhibitors	   tested	   against	   homologues	   of	   the	   in	   silico	   defined	   essential	   genes	   to	   produce	   a	  
catalog	   of	   candidate	   drug	   targets	   and	   potential	   small-­‐molecule	   inhibitors	   that,	   to	   our	  
knowledge,	  were	  not	  discussed	  before	  in	  the	  context	  of	  M.	  tuberculosis	  infection	  (appendix	  4.2).	  	  	  
Notably,	   the	   list	   of	   candidate	   drug	   targets	   includes	   mostly	   genes	   with	   no	   detectable	  
sequence	  homology	  to	  human	  proteins,	  or	  with	  homology	  to	  enzymes	  annotated	  to	  different	  
activities	  in	  the	  human	  genome	  (appendix	  4.2).	  This	  is	  desirable	  in	  order	  to	  avoid	  the	  potential	  
inhibition	  of	  host	  proteins	  by	  drugs	  targeting	  M.	  tuberculosis	  genes.	  Another	  important	  feature	  
of	  the	  results	  is	  that	  the	  functional	  roles	  of	  the	  identified	  essential	  genes	  are	  distributed	  across	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a	  wide	  span	  of	  distinct	  metabolic	  processes	  including	  sugar,	  vitamin,	  amino	  acid,	  and	  co-­‐factor	  
metabolism,	   which	   have	   not	   been	   typically	   targeted	   by	   TB	   drugs.	   Finally,	   for	   most	   of	   the	  
candidate	  targets	  in	  table,	  we	  could	  find	  additional	  experimental	  evidence	  supporting	  a	  critical	  
role	  for	  M.	  tuberculosis	  growth	  and	  infection.	  Our	  analysis	  makes	  a	  substantial	  addition	  to	  the	  
list	  of	  candidate	  TB	  drug	  targets	  (e.g.	  Mdlui	  et	  al.177)	  while	  suggesting	  several	  lead	  compounds	  
that	  can	  readily	  be	  tested	  to	  inhibit	  a	  variety	  of	  metabolic	  processes.	  Below	  we	  describe	  several	  
interesting	  examples	  (fig.	  4.8).	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Figure	  4.8.	  Candidate	  target	  genes	  in	  a	  diverse	  set	  of	  metabolic	  processes.	  
The	  figure	  shows	  the	  metabolic	  roles	  of	  proposed	  M.	  tuberculosis	  drug	  targets	  (blue),	  and	  
candidate	  compounds	  previously	  used	  to	  inhibit	  the	  activities	  of	  homologous	  genes	  in	  different	  
bacterial	  species.	  A.	  Glutamate	  racemase	  is	  essential	  for	  the	  synthesis	  of	  peptidoglycan	  and	  the	  
mycobacterial	  cell	  wall;	  potential	  inhibitors	  include	  (1)	  Pyrazolopyramidinediones	  (Minimum	  
Inhibitory	  Concentration	  in	  Helicobacter	  pylori:	  0.5-­‐8	  µg/mL178)	  and	  (2)	  1H-­‐benzimidazole-­‐2-­‐
sulfonate	  (Ki	  in	  B.	  subtilis	  =	  2.5	  µM179).	  B.	  8-­‐amino-­‐7-­‐oxoanoate	  synthase	  is	  essential	  for	  the	  
synthesis	  of	  biotin,	  a	  crucial	  cofactor	  for	  lipid	  biosynthesis;	  it	  was	  inhibited	  by	  (3)	  8-­‐Amino-­‐7-­‐
oxo-­‐8-­‐phosphonononaoate	  (Ki	  =	  7	  µM)	  and	  (4)	  4-­‐carboxybutyl(1-­‐amino-­‐1-­‐
carboxyethyl)phosphonate	  (Ki	  =	  68	  µM)	  in	  Bacillus	  sphaericus180	  C.	  3-­‐hydroxybutyrate	  
dehydrogenase	  was	  predicted	  as	  essential	  for	  siderophore	  biosynthesis	  and	  was	  inhibited	  by	  (5)	  
L-­‐3-­‐hydroxybutyrate	  in	  Pseudomonas	  fragi	  (Ki	  =	  800	  µM181)	  D.	  7,8-­‐dihydroxymethylpterin-­‐
pyrophosphokinase	  was	  predicted	  as	  essential	  for	  folate	  metabolism	  and	  was	  inhibited	  (IC50	  =	  





4.5	  DISCUSSION	   	  
Here	  we	  use	   a	   combination	  of	   probabilistic	   gene	   annotations	   and	  manual	   curation	   to	  
consolidate	   prior	   efforts	   and	   to	   expand	   the	   Mycobacterium	   tuberculosis	   H37Rv	   metabolic	  
reconstruction.	  The	  new	  model	  includes	  1240	  reaction	  and	  1012	  metabolites	  and	  accounts	  for	  
208	   reactions	   and	  177	  genes	  not	  present	   in	  previous	  models.	   These	   reactions	   involve	   critical	  
pathways	  for	  TB	  pathogenesis	  such	  as	  the	  route	  of	  cholesterol	  degradation,	  and	  also	  allow	  for	  
an	   increased	   accuracy	   in	   the	   prediction	   of	   essential	   genes	   (81	   %)	   and	   growth	   on	   different	  
substrates	   (80	  %).	  We	   use	   the	  model	   to	   predict	   20	   potential	   drug	   targets	   across	   8	   different	  
metabolic	   subsystems	   which	   not	   only	   have	   low	   or	   no	   similarity	   to	   human	   proteins,	   but	   are	  
homologous	  to	  proteins	  for	  which	  small-­‐molecule	  inhibitors	  have	  been	  identified.	  These	  genes	  
represent	  a	  rich	  set	  of	  targets	  and	  drug	  combinations	  to	  explore	  therapeutic	   interventions	  on	  
multiple	  fronts	  of	  the	  parasite’s	  metabolism.	  
New	  anti-­‐tuberculosis	  drugs	  are	  desperately	  needed	   to	  shorten	   the	   time	  of	   treatment	  
and	  attack	  non-­‐traditional	  targets	  that	  have	  already	  been	  weakened	  by	  the	  emergence	  of	  drug	  
resistance.	  	  
Notably,	   our	   predictions	   also	   allowed	   us	   to	   reconstruct	   the	   cholesterol	   degradation	  
pathway	  in	  M.	  tuberculosis,	  which	  has	  been	  implicated	  in	  bacterial	  persistence	  in	  the	  literature	  
but	   remains	   to	   be	   fully	   characterized.	   This	   pathway	   is	   absent	   from	   previously	   published	  
metabolic	  models	   of	  M.	   tuberculosis.	  Our	   new	  model	   can	   now	  be	  used	   to	   simulate	   different	  
104	  
environments	  and	  conditions	  in	  order	  to	  gain	  a	  better	  understanding	  of	  the	  metabolism	  of	  M.	  
tuberculosis	  and	  its	  ability	  to	  adapt	  to	  different	  environments	  and	  conditions	  when	  confronted	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Appendix	  2.1.	  Divergence	  times	  between	  pairs	  of	  species	  from	  TimeTree.org	  by	  Hedges	  et	  al60.	  
Species	  Pair	   Time	  (Byr)	   Species	  Pair	   Time	  (Byr)	  
H.sapiens-­‐R.norvegicus	   0.10	   O.sativa-­‐P.falciparum	   1.72	  
H.sapiens-­‐G.gallus	   0.33	   O.sativa-­‐E.coli	   2.60	  
H.sapiens-­‐X.laevis	   0.59	   O.sativa-­‐M.thermo	   3.97	  
H.sapiens-­‐D.rerio	   0.46	   S.cerevisiae-­‐T.brucei	   1.96	  
H.sapiens-­‐D.melanogaster	   0.89	   S.cerevisiae-­‐P.falciparum	   1.72	  
H.sapiens-­‐C.elegans	   0.99	   S.cerevisiae-­‐E.coli	   2.60	  
H.sapiens-­‐A.thaliana	   1.10	   S.cerevisiae-­‐M.thermo	   3.97	  
H.sapiens-­‐O.sativa	   1.10	   T.brucei-­‐P.falciparum	   0.94	  
H.sapiens-­‐S.cerevisiae	   1.30	   T.brucei-­‐E.coli	   2.60	  
H.sapiens-­‐T.brucei	   1.10	   T.brucei-­‐M.thermo	   3.97	  
H.sapiens-­‐P.falciparum	   1.10	   P.falciparum-­‐E.coli	   2.60	  
H.sapiens-­‐E.coli	   2.60	   P.falciparum-­‐M.thermo	   3.97	  
H.sapiens-­‐M.thermo	   3.97	   E.coli-­‐S.enterica	   0.10	  
R.norvegicus-­‐G.gallus	   0.33	   E.coli-­‐Y.pestis	   0.43	  
R.norvegicus-­‐X.laevis	   0.36	   E.coli-­‐H.influenzae	   0.68	  
R.norvegicus-­‐D.rerio	   0.46	   E.coli-­‐P.aeruginosa	   1.35	  
R.norvegicus-­‐D.melanogaster	   0.83	   E.coli-­‐A.tumefaciens	   2.36	  
R.norvegicus-­‐C.elegans	   1.13	   E.coli-­‐M.tuberculosis	   2.75	  
R.norvegicus-­‐A.thaliana	   1.10	   E.coli-­‐B.subtilis	   2.75	  
R.norvegicus-­‐O.sativa	   1.10	   E.coli-­‐T.maritima	   3.64	  
R.norvegicus-­‐S.cerevisiae	   1.39	   E.coli-­‐P.horikoshii	   3.78	  
R.norvegicus-­‐T.brucei	   1.10	   E.coli-­‐S.solfataricus	   3.78	  
R.norvegicus-­‐P.falciparum	   1.10	   E.coli-­‐M.thermo	   3.78	  
R.norvegicus-­‐E.coli	   2.60	   S.enterica-­‐Y.pestis	   0.43	  
R.norvegicus-­‐M.thermo	   3.97	   S.enterica-­‐H.influenzae	   0.68	  
G.gallus-­‐X.laevis	   0.36	   S.enterica-­‐P.aeruginosa	   1.35	  
G.gallus-­‐D.rerio	   0.46	   S.enterica-­‐A.tumefaciens	   2.36	  
G.gallus-­‐D.melanogaster	   0.83	   S.enterica-­‐M.tuberculosis	   2.75	  
G.gallus-­‐C.elegans	   1.13	   S.enterica-­‐B.subtilis	   2.75	  
G.gallus-­‐A.thaliana	   1.10	   S.enterica-­‐T.maritima	   3.64	  
G.gallus-­‐O.sativa	   1.10	   S.enterica-­‐P.horikoshii	   3.78	  
G.gallus-­‐S.cerevisiae	   1.27	   S.enterica-­‐S.solfataricus	   3.78	  
G.gallus-­‐T.brucei	   1.10	   S.enterica-­‐M.thermo	   3.78	  
G.gallus-­‐P.falciparum	   1.10	   Y.pestis-­‐H.influenzae	   0.68	  
G.gallus-­‐E.coli	   2.60	   Y.pestis-­‐P.aeruginosa	   1.35	  
G.gallus-­‐M.thermo	   3.97	   Y.pestis-­‐A.tumefaciens	   2.36	  
X.laevis-­‐D.rerio	   0.46	   Y.pestis-­‐M.tuberculosis	   2.75	  
X.laevis-­‐D.melanogaster	   0.83	   Y.pestis-­‐B.subtilis	   2.75	  
X.laevis-­‐C.elegans	   1.13	   Y.pestis-­‐T.maritima	   3.30	  
X.laevis-­‐A.thaliana	   1.10	   Y.pestis-­‐P.horikoshii	   3.78	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X.laevis-­‐O.sativa	   1.10	   Y.pestis-­‐S.solfataricus	   3.78	  
X.laevis-­‐S.cerevisiae	   1.27	   Y.pestis-­‐M.thermo	   3.78	  
X.laevis-­‐T.brucei	   1.10	   H.influenzae-­‐P.aeruginosa	   1.35	  
X.laevis-­‐P.falciparum	   1.10	   H.influenzae-­‐A.tumefaciens	   2.36	  
X.laevis-­‐E.coli	   2.60	   H.influenzae-­‐M.tuberculosis	   2.75	  
X.laevis-­‐M.thermo	   3.97	   H.influenzae-­‐B.subtilis	   2.75	  
D.rerio-­‐D.melanogaster	   0.46	   H.influenzae-­‐T.maritima	   3.64	  
D.rerio-­‐C.elegans	   1.13	   H.influenzae-­‐P.horikoshii	   3.78	  
D.rerio-­‐A.thaliana	   1.10	   H.influenzae-­‐S.solfataricus	   3.78	  
D.rerio-­‐O.sativa	   1.10	   H.influenzae-­‐M.thermo	   3.78	  
D.rerio-­‐S.cerevisiae	   0.99	   P.aeruginosa-­‐A.tumefaciens	   2.36	  
D.rerio-­‐T.brucei	   1.10	   P.aeruginosa-­‐M.tuberculosis	   2.75	  
D.rerio-­‐P.falciparum	   1.10	   P.aeruginosa-­‐B.subtilis	   2.75	  
D.rerio-­‐E.coli	   2.60	   P.aeruginosa-­‐T.maritima	   3.64	  
D.rerio-­‐M.thermo	   3.97	   P.aeruginosa-­‐P.horikoshii	   3.78	  
D.melanogaster-­‐C.elegans	   0.97	   P.aeruginosa-­‐S.solfataricus	   3.78	  
D.melanogaster-­‐A.thaliana	   1.67	   P.aeruginosa-­‐M.thermo	   3.78	  
D.melanogaster-­‐O.sativa	   1.67	   A.tumefaciens-­‐M.tuberculosis	   2.75	  
D.melanogaster-­‐S.cerevisiae	   1.39	   A.tumefaciens-­‐B.subtilis	   2.75	  
D.melanogaster-­‐T.brucei	   1.72	   A.tumefaciens-­‐T.maritima	   3.64	  
D.melanogaster-­‐P.falciparum	   1.72	   A.tumefaciens-­‐P.horikoshii	   3.78	  
D.melanogaster-­‐E.coli	   2.60	   A.tumefaciens-­‐S.solfataricus	   3.78	  
D.melanogaster-­‐M.thermo	   3.97	   A.tumefaciens-­‐M.thermo	   3.78	  
C.elegans-­‐A.thaliana	   1.53	   M.tuberculosis-­‐B.subtilis	   2.75	  
C.elegans-­‐O.sativa	   1.67	   M.tuberculosis-­‐T.maritima	   3.64	  
C.elegans-­‐S.cerevisiae	   1.54	   M.tuberculosis-­‐P.horikoshii	   3.78	  
C.elegans-­‐T.brucei	   1.10	   M.tuberculosis-­‐S.solfataricus	   3.78	  
C.elegans-­‐P.falciparum	   1.72	   M.tuberculosis-­‐M.thermo	   3.78	  
C.elegans-­‐E.coli	   2.60	   B.subtilis-­‐T.maritima	   3.64	  
C.elegans-­‐M.thermo	   3.97	   B.subtilis-­‐P.horikoshii	   3.78	  
A.thaliana-­‐O.sativa	   1.17	   B.subtilis-­‐S.solfataricus	   3.78	  
A.thaliana-­‐S.cerevisiae	   1.67	   B.subtilis-­‐M.thermo	   3.78	  
A.thaliana-­‐T.brucei	   1.72	   T.maritima-­‐P.horikoshii	   3.78	  
A.thaliana-­‐P.falciparum	   1.72	   T.maritima-­‐S.solfataricus	   3.78	  
A.thaliana-­‐E.coli	   2.60	   T.maritima-­‐M.thermo	   3.78	  
A.thaliana-­‐M.thermo	   3.97	   P.horikoshii-­‐S.solfataricus	   3.46	  
O.sativa-­‐S.cerevisiae	   1.39	   P.horikoshii-­‐M.thermo	   3.35	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  Hubble-­‐like	  derivation:	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  change	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Appendix	  2.5.	  Comparison	  of	  the	  non-­‐linear	  fit	  and	  linear	  fit	  of	  !"
!"
	  as	  a	  function	  of	  evolutionary	  
distance	  with	  the	  Akaike	  Information	  Criterion.	  
E.C. Number Better Model Non-linear AIC Weight Linear AIC Weight Likelihood Ratio 
6.2.1.1 Non-linear 1.00 0.00 230900.49 
1.8.1.4 Non-linear 1.00 0.00 86365.36 
5.3.1.6 Non-linear 1.00 0.00 78635.35 
5.4.2.8 Non-linear 1.00 0.00 6846.22 
4.1.2.13 Non-linear 1.00 0.00 2967.50 
6.3.2.6 Non-linear 1.00 0.00 2953.66 
5.4.2.2 Non-linear 1.00 0.00 756.58 
1.8.1.9 Non-linear 1.00 0.00 368.00 
2.4.2.9 Non-linear 0.99 0.01 158.24 
5.1.3.2 Non-linear 0.99 0.01 85.51 
5.3.1.1 Non-linear 0.98 0.02 61.42 
2.6.1.16 Non-linear 0.98 0.02 40.84 
6.3.4.4 Non-linear 0.97 0.03 36.74 
4.2.1.11 Non-linear 0.97 0.03 35.19 
2.7.6.1 Non-linear 0.97 0.03 34.88 
2.3.1.9 Non-linear 0.97 0.03 29.38 
2.4.2.14 Non-linear 0.96 0.04 21.46 
4.2.1.2 Non-linear 0.95 0.05 19.82 
6.2.1.5 Non-linear 0.95 0.05 19.45 
2.7.7.9 Non-linear 0.95 0.05 19.01 
5.4.2.1 Non-linear 0.95 0.05 18.68 
1.1.1.37 Non-linear 0.93 0.07 13.69 
2.7.7.23 Non-linear 0.93 0.07 13.43 
2.3.3.1 Non-linear 0.91 0.09 10.52 
1.1.1.205 Non-linear 0.91 0.09 9.77 
3.6.1.1 Non-linear 0.90 0.10 9.31 
2.7.2.3 Non-linear 0.89 0.11 8.48 
3.1.3.25 Non-linear 0.89 0.11 8.32 
2.1.1.45 Non-linear 0.89 0.11 8.31 






























Appendix	  3.1.	  Probability	  of	  correct	  function	  at	  different	  sequence	  identity	  levels	  given	  active	  
site	  region	  conservation.	  
Global Act. Site Act. Site Act. Site Act. Site Act. Site Act. Site Act. Site Act. Site Act. Site Act. Site 
(%) 0-10% 10-20% 20-30% 30-40% 40-50% 50-60% 60-70% 70-80% 80-90% 90-10 % 
0-10 0.000 0.015 0.012 0.006 0.003 0.016 0.021 0.021 0.026 0.103 
10-20 0.000 0.377 0.032 0.021 0.013 0.045 0.061 0.063 0.078 0.214 
20-30 0.005 0.090 0.085 0.069 0.058 0.123 0.163 0.174 0.212 0.395 
30-40 0.027 0.198 0.206 0.207 0.226 0.293 0.369 0.400 0.462 0.609 
40-50 0.129 0.383 0.421 0.480 0.579 0.550 0.638 0.679 0.733 0.788 
50-60 0.443 0.609 0.670 0.765 0.866 0.784 0.842 0.870 0.898 0.899 
60-70 0.957 0.957 0.957 0.957 0.968 0.957 0.957 0.957 0.966 0.957 
70-80 0.990 0.990 0.990 0.990 0.993 0.990 0.990 0.990 0.990 0.990 
80-90 0.990 0.998 0.998 0.998 0.999 0.998 0.998 0.998 0.998 0.998 

















Appendix	   3.2.	   Optimized	   set	   of	   parameters	   obtained	   from	   training	   GLOBUS	   (no	   structural-­‐
component)	   on	   the	   E.	   coli	   metabolic	   network	   iAF1260	   (red),	   3D-­‐GLOBUS	   on	   the	   E.	   coli	  




























Appendix	  4.1.	  Residues	  that	  form	  polar	  contacts	  with	  the	  ligand.	  
Gene Residues forming polar contact with ligand 
Rv3255c Pro-100, His-131, Lys-132, Ala-276, Asn-280 
Rv2332 Lys-169, Glu-240, Asp-264, Asn-410, Asn-454, Asn-455 
Rv3811 His-228, Thr-369, Asp-370 
Rv1592c Asp-116, Ser-205 
Rv0751c Asn-11, Met-12, Asp-31, Leu-65, Pro-66, Thr-93, Lys-243 
Rv3406 Thr-124, His-251, Arg-262, R-266 


















Appendix	  4.2.	  Catalogue	  of	  target	  genes	  in	  M.	  tuberculosis	  and	  homologous	  drug	  targets	  
with	  candidate	  drugs.	  
Gene	   Function	   Pathway	   Top	  DrugBank	  homologue	  
Candidate	  Inhibitors	  (plus	  
references)	  




Rv1185c	   Fatty-­‐acid-­‐CoA	  ligase	  	  (E.C:	  6.2.1.3)	  
Fatty	  acid	  
metabolism	   ACSL4_HUMAN	  
Icosapent183	  (inducer	  )	  
Rosiglitazone184	  
27.0	   156	  
Rv1235	   Sugar	  ABC	  transporter	  	  (E.C:	  na)	  
Sugar	  
transport	   MALE_ECOLI	   	   9.0	  
156,	  185,	  186	  
Rv1238	   Sugar	  ABC	  	  transporter	  	  (E.C:	  na)	  
Sugar	  
transport	   ABCA1_HUMAN	  
Glyburide187	  
Probucol188	   25.9	  
172,	  156,	  185,	  
186	  
Rv1338	   Glutamate	  racemase	  	  (E.C:	  5.1.1.3)	  
Glutamate	  
metabolism	   MURI_LISMO	  
Pyrazolopyrimidinediones178,189	  
1H-­‐benzimidazole-­‐2-­‐sulfonic	  acid179	   n/a	  
156,	  172,	  190,	  
191	  
Rv1569	   8-­‐amino-­‐7-­‐oxononanoate	  	  (EC:	  2.3.1.47)	  
Biotin	  





156,	  172,	  190,	  
191	  
Rv1589	   Biotin	  synthase	  	  (E.C:	  2.8.1.6)	  
Biotin	  
metabolism	   BIOB_ECOLI	  
5’-­‐deoxyadenosine192	  
S-­‐adenosyl-­‐L-­‐homocysteine192	   n/a	  
156,	  172,	  193	  
Rv1661	   Polyketide	  synthase	  	  (E.C:	  2.3.1.41)	  
Fatty	  acid	  
metabolism	   Q9ZGI2_STRVZ	   	   23.3	  
152,	  172,	  194	  
Rv1663	   Polyketide	  synthase	  	  (E.C:	  2.3.1.41)	  
Fatty	  acid	  
metabolism	   Q9ZGI2_STRVZ	   2-­‐Phenylamino-­‐4-­‐Methyl-­‐5-­‐Acetyl	  Thiazole
195	   26.7	   152,	  172	  
Rv1664	   Polyketide	  synthase	  	  (E.C:	  2.3.1.41)	  
Fatty	  acid	  
metabolism	   Q9ZGI2_STRVZ	  
2-­‐Phenylamino-­‐4-­‐Methyl-­‐5-­‐Acetyl	  Thiazole195	  
	   29.8	   	  
Rv2048c	   Polyketide	  synthase	  	  (E.C:	  2.3.1.41)	  
Fatty	  acid	  
metabolism	   Q9ZGI2_STRVZ	   2-­‐Phenylamino-­‐4-­‐Methyl-­‐5-­‐Acetyl	  Thiazole
195	   15.4	   156,	  172	  





















metabolism	   DCUP_HUMAN	  
PI-­‐16200	  (porphodimethene	  compound,	  anti-­‐
cancer)	   35.5*	  
172	  
Rv2946c	   Polyketide	  synthase	  	  (E.C:	  2.3.1.41)	  
Fatty	  acid	  
metabolism	   Q9ZGI2_STRVZ	   2-­‐Phenylamino-­‐4-­‐Methyl-­‐5-­‐Acetyl	  Thiazole
195	   28.8	   	  
Rv2957	   Glycosyltransferase	  	  (E.C:	  2.4.1.-­‐)	  
Membrane	  
metabolism	   SPSA_BACSU	   	   22.9	   	  
Rv2958c	   Glycosyltransferase	  	  (E.C:	  2.4.1.-­‐)	  
Membrane	  
metabolism	   UD3A1_HUMAN	   	   25.3	  
201	  
Rv2962c	   Rhamnosyltransferase	  (E.C:	  2.4.1.-­‐)	  
Membrane	  














metabolism	   FABG_ECOLI	  
	  (L)-­‐3-­‐hydroxybutyrate181	  













n/a	   202	  
Shaded	   rows	   are	  described	   in	  detail	   in	   the	   text	   and	   figure	  4.4.	   *Closest	   human	  homolog	   encodes	   the	   same	  
enzymatic	  activity	  
	  
